id	sid	tid	token	lemma	pos
aiua-10754	1	1	stesura	stesura	PROPN
aiua-10754	1	2	seveso	seveso	PROPN
aiua-10754	1	3	archivio	archivio	PROPN
aiua-10754	1	4	italiano	italiano	X
aiua-10754	1	5	di	di	X
aiua-10754	1	6	urologia	urologia	PROPN
aiua-10754	1	7	e	e	PROPN
aiua-10754	1	8	andrologia	andrologia	PROPN
aiua-10754	1	9	2022	2022	NUM
aiua-10754	1	10	;	;	PUNCT
aiua-10754	1	11	94	94	NUM
aiua-10754	1	12	,	,	PUNCT
aiua-10754	1	13	3274	3274	NUM
aiua-10754	1	14	original	original	ADJ
aiua-10754	1	15	paper	paper	NOUN
aiua-10754	1	16	no	no	DET
aiua-10754	1	17	conflict	conflict	NOUN
aiua-10754	1	18	of	of	ADP
aiua-10754	1	19	interest	interest	NOUN
aiua-10754	1	20	declared	declare	VERB
aiua-10754	1	21	.	.	PUNCT
aiua-10754	1	22	represents	represent	VERB
aiua-10754	1	23	psma	psma	NOUN
aiua-10754	1	24	expression	expression	NOUN
aiua-10754	1	25	,	,	PUNCT
aiua-10754	1	26	is	be	AUX
aiua-10754	1	27	highly	highly	ADV
aiua-10754	1	28	correlated	correlate	VERB
aiua-10754	1	29	with	with	ADP
aiua-10754	1	30	the	the	DET
aiua-10754	1	31	aggressiveness	aggressiveness	NOUN
aiua-10754	1	32	of	of	ADP
aiua-10754	1	33	the	the	DET
aiua-10754	1	34	primary	primary	ADJ
aiua-10754	1	35	prostatic	prostatic	ADJ
aiua-10754	1	36	tumour	tumour	NOUN
aiua-10754	1	37	(	(	PUNCT
aiua-10754	1	38	7	7	NUM
aiua-10754	1	39	,	,	PUNCT
aiua-10754	1	40	8)	8)	NUM
aiua-10754	1	41	.	.	PUNCT
aiua-10754	2	1	68ga	68ga	ADJ
aiua-10754	2	2	-	-	PUNCT
aiua-10754	2	3	psma	psma	NOUN
aiua-10754	2	4	positron	positron	NOUN
aiua-10754	2	5	emission	emission	NOUN
aiua-10754	2	6	tomography	tomography	NOUN
aiua-10754	2	7	/	/	SYM
aiua-10754	2	8	computed	compute	VERB
aiua-10754	2	9	tomography	tomography	NOUN
aiua-10754	2	10	(	(	PUNCT
aiua-10754	2	11	pet	pet	PROPN
aiua-10754	2	12	/	/	SYM
aiua-10754	2	13	ct	ct	NOUN
aiua-10754	2	14	)	)	PUNCT
aiua-10754	2	15	demonstrated	demonstrate	VERB
aiua-10754	2	16	to	to	PART
aiua-10754	2	17	be	be	AUX
aiua-10754	2	18	sensitive	sensitive	ADJ
aiua-10754	2	19	for	for	ADP
aiua-10754	2	20	the	the	DET
aiua-10754	2	21	detection	detection	NOUN
aiua-10754	2	22	of	of	ADP
aiua-10754	2	23	primary	primary	ADJ
aiua-10754	2	24	prostatic	prostatic	ADJ
aiua-10754	2	25	lesions	lesion	NOUN
aiua-10754	2	26	,	,	PUNCT
aiua-10754	2	27	regional	regional	ADJ
aiua-10754	2	28	lymphadenopathy	lymphadenopathy	ADJ
aiua-10754	2	29	(	(	PUNCT
aiua-10754	2	30	9	9	NUM
aiua-10754	2	31	)	)	PUNCT
aiua-10754	2	32	and	and	CCONJ
aiua-10754	2	33	clinical	clinical	ADJ
aiua-10754	2	34	metastases	metastasis	NOUN
aiua-10754	2	35	in	in	ADP
aiua-10754	2	36	case	case	NOUN
aiua-10754	2	37	of	of	ADP
aiua-10754	2	38	biochemical	biochemical	ADJ
aiua-10754	2	39	recurrence	recurrence	NOUN
aiua-10754	2	40	(	(	PUNCT
aiua-10754	2	41	10	10	NUM
aiua-10754	2	42	,	,	PUNCT
aiua-10754	2	43	11	11	NUM
aiua-10754	2	44	)	)	PUNCT
aiua-10754	2	45	.	.	PUNCT
aiua-10754	3	1	our	our	PRON
aiua-10754	3	2	study	study	NOUN
aiua-10754	3	3	prospectively	prospectively	ADV
aiua-10754	3	4	compared	compare	VERB
aiua-10754	3	5	the	the	DET
aiua-10754	3	6	diagnostic	diagnostic	ADJ
aiua-10754	3	7	accuracy	accuracy	NOUN
aiua-10754	3	8	of	of	ADP
aiua-10754	3	9	68ga	68ga	ADJ
aiua-10754	3	10	-	-	PUNCT
aiua-10754	3	11	psma	psma	NOUN
aiua-10754	3	12	pet	pet	NOUN
aiua-10754	3	13	/	/	SYM
aiua-10754	3	14	ct	ct	PROPN
aiua-10754	3	15	vs.	vs.	X
aiua-10754	3	16	mpmri	mpmri	PROPN
aiua-10754	3	17	targeted	target	VERB
aiua-10754	3	18	biopsy	biopsy	NOUN
aiua-10754	3	19	(	(	PUNCT
aiua-10754	3	20	tpbx	tpbx	NOUN
aiua-10754	3	21	)	)	PUNCT
aiua-10754	3	22	in	in	ADP
aiua-10754	3	23	the	the	DET
aiua-10754	3	24	diagnosis	diagnosis	NOUN
aiua-10754	3	25	of	of	ADP
aiua-10754	3	26	cspca	cspca	NOUN
aiua-10754	3	27	(	(	PUNCT
aiua-10754	3	28	grade	grade	NOUN
aiua-10754	3	29	group	group	NOUN
aiua-10754	3	30	≥	≥	NOUN
aiua-10754	3	31	2	2	NUM
aiua-10754	3	32	)	)	PUNCT
aiua-10754	3	33	(	(	PUNCT
aiua-10754	3	34	12	12	NUM
aiua-10754	3	35	)	)	PUNCT
aiua-10754	3	36	.	.	PUNCT
aiua-10754	4	1	materials	material	NOUN
aiua-10754	4	2	and	and	CCONJ
aiua-10754	4	3	methods	method	NOUN
aiua-10754	4	4	from	from	ADP
aiua-10754	4	5	january	january	PROPN
aiua-10754	4	6	2021	2021	NUM
aiua-10754	4	7	to	to	ADP
aiua-10754	4	8	june	june	PROPN
aiua-10754	4	9	2022	2022	NUM
aiua-10754	4	10	,	,	PUNCT
aiua-10754	4	11	100	100	NUM
aiua-10754	4	12	patients	patient	NOUN
aiua-10754	4	13	(	(	PUNCT
aiua-10754	4	14	median	median	ADJ
aiua-10754	4	15	age	age	NOUN
aiua-10754	4	16	:	:	PUNCT
aiua-10754	4	17	66	66	NUM
aiua-10754	4	18	years	year	NOUN
aiua-10754	4	19	;	;	PUNCT
aiua-10754	4	20	range	range	NOUN
aiua-10754	4	21	:	:	PUNCT
aiua-10754	4	22	49	49	NUM
aiua-10754	4	23	-	-	SYM
aiua-10754	4	24	79	79	NUM
aiua-10754	4	25	years	year	NOUN
aiua-10754	4	26	)	)	PUNCT
aiua-10754	4	27	with	with	ADP
aiua-10754	4	28	negative	negative	ADJ
aiua-10754	4	29	digital	digital	ADJ
aiua-10754	4	30	rectal	rectal	ADJ
aiua-10754	4	31	examination	examination	NOUN
aiua-10754	4	32	underwent	underwent	NOUN
aiua-10754	4	33	repeated	repeat	VERB
aiua-10754	4	34	transperineal	transperineal	NOUN
aiua-10754	4	35	prostate	prostate	NOUN
aiua-10754	4	36	biopsy	biopsy	NOUN
aiua-10754	4	37	for	for	ADP
aiua-10754	4	38	abnormal	abnormal	ADJ
aiua-10754	4	39	psa	psa	NOUN
aiua-10754	4	40	values	value	NOUN
aiua-10754	4	41	(	(	PUNCT
aiua-10754	4	42	median	median	PROPN
aiua-10754	4	43	7.5	7.5	NUM
aiua-10754	4	44	ng	ng	NOUN
aiua-10754	4	45	/	/	SYM
aiua-10754	4	46	ml	ml	PROPN
aiua-10754	4	47	;	;	PUNCT
aiua-10754	4	48	range	range	NOUN
aiua-10754	4	49	:	:	PUNCT
aiua-10754	4	50	4.5	4.5	NUM
aiua-10754	4	51	-	-	SYM
aiua-10754	4	52	83	83	NUM
aiua-10754	4	53	ng	ng	PROPN
aiua-10754	4	54	/	/	SYM
aiua-10754	4	55	ml	ml	NOUN
aiua-10754	4	56	)	)	PUNCT
aiua-10754	4	57	(	(	PUNCT
aiua-10754	4	58	13	13	NUM
aiua-10754	4	59	,	,	PUNCT
aiua-10754	4	60	14	14	NUM
aiua-10754	4	61	)	)	PUNCT
aiua-10754	4	62	.	.	PUNCT
aiua-10754	5	1	the	the	DET
aiua-10754	5	2	study	study	NOUN
aiua-10754	5	3	was	be	AUX
aiua-10754	5	4	approved	approve	VERB
aiua-10754	5	5	by	by	ADP
aiua-10754	5	6	the	the	DET
aiua-10754	5	7	ethics	ethic	NOUN
aiua-10754	5	8	committee	committee	PROPN
aiua-10754	5	9	of	of	ADP
aiua-10754	5	10	our	our	PRON
aiua-10754	5	11	hospital	hospital	NOUN
aiua-10754	5	12	.	.	PUNCT
aiua-10754	6	1	all	all	DET
aiua-10754	6	2	patients	patient	NOUN
aiua-10754	6	3	underwent	undergo	VERB
aiua-10754	6	4	prostate	prostate	NOUN
aiua-10754	6	5	biopsy	biopsy	NOUN
aiua-10754	6	6	mpmri	mpmri	PROPN
aiua-10754	6	7	and	and	CCONJ
aiua-10754	6	8	68gapet	68gapet	NUM
aiua-10754	6	9	/	/	SYM
aiua-10754	6	10	ct	ct	PROPN
aiua-10754	6	11	imaging	imaging	NOUN
aiua-10754	6	12	examinations	examination	NOUN
aiua-10754	6	13	;	;	PUNCT
aiua-10754	6	14	a	a	DET
aiua-10754	6	15	1.5	1.5	NUM
aiua-10754	6	16	tesla	tesla	NOUN
aiua-10754	6	17	scanner	scanner	NOUN
aiua-10754	6	18	equipped	equip	VERB
aiua-10754	6	19	with	with	ADP
aiua-10754	6	20	surface	surface	NOUN
aiua-10754	6	21	16	16	NUM
aiua-10754	6	22	channels	channel	NOUN
aiua-10754	6	23	phased	phase	VERB
aiua-10754	6	24	-	-	PUNCT
aiua-10754	6	25	array	array	NOUN
aiua-10754	6	26	coil	coil	NOUN
aiua-10754	6	27	placed	place	VERB
aiua-10754	6	28	around	around	ADP
aiua-10754	6	29	the	the	DET
aiua-10754	6	30	pelvic	pelvic	ADJ
aiua-10754	6	31	area	area	NOUN
aiua-10754	6	32	with	with	ADP
aiua-10754	6	33	the	the	DET
aiua-10754	6	34	patient	patient	NOUN
aiua-10754	6	35	in	in	ADP
aiua-10754	6	36	the	the	DET
aiua-10754	6	37	supine	supine	ADJ
aiua-10754	6	38	position	position	NOUN
aiua-10754	6	39	,	,	PUNCT
aiua-10754	6	40	multi	multi	ADJ
aiua-10754	6	41	-	-	ADJ
aiua-10754	6	42	planar	planar	ADJ
aiua-10754	6	43	turbo	turbo	NOUN
aiua-10754	6	44	spin	spin	NOUN
aiua-10754	6	45	-	-	PUNCT
aiua-10754	6	46	echo	echo	NOUN
aiua-10754	6	47	t2	t2	NOUN
aiua-10754	6	48	-	-	PUNCT
aiua-10754	6	49	weighted	weight	VERB
aiua-10754	6	50	imaging	imaging	NOUN
aiua-10754	6	51	,	,	PUNCT
aiua-10754	6	52	axial	axial	ADJ
aiua-10754	6	53	diffusion	diffusion	NOUN
aiua-10754	6	54	-	-	PUNCT
aiua-10754	6	55	weighted	weight	VERB
aiua-10754	6	56	imaging	imaging	NOUN
aiua-10754	6	57	,	,	PUNCT
aiua-10754	6	58	and	and	CCONJ
aiua-10754	6	59	axial	axial	ADJ
aiua-10754	6	60	dynamic	dynamic	ADJ
aiua-10754	6	61	contrast	contrast	NOUN
aiua-10754	6	62	(	(	PUNCT
aiua-10754	6	63	adc	adc	NOUN
aiua-10754	6	64	)	)	PUNCT
aiua-10754	6	65	enhanced	enhance	VERB
aiua-10754	6	66	mri	mri	NOUN
aiua-10754	6	67	were	be	AUX
aiua-10754	6	68	performed	perform	VERB
aiua-10754	6	69	for	for	ADP
aiua-10754	6	70	each	each	DET
aiua-10754	6	71	patient	patient	NOUN
aiua-10754	6	72	(	(	PUNCT
aiua-10754	6	73	15	15	NUM
aiua-10754	6	74	)	)	PUNCT
aiua-10754	6	75	.	.	PUNCT
aiua-10754	7	1	two	two	NUM
aiua-10754	7	2	radiologists	radiologist	NOUN
aiua-10754	7	3	,	,	PUNCT
aiua-10754	7	4	blinded	blind	VERB
aiua-10754	7	5	to	to	ADP
aiua-10754	7	6	preimaging	preimage	VERB
aiua-10754	7	7	clinical	clinical	ADJ
aiua-10754	7	8	parameters	parameter	NOUN
aiua-10754	7	9	,	,	PUNCT
aiua-10754	7	10	evaluated	evaluate	VERB
aiua-10754	7	11	the	the	DET
aiua-10754	7	12	mri	mri	NOUN
aiua-10754	7	13	data	datum	NOUN
aiua-10754	7	14	separately	separately	ADV
aiua-10754	7	15	and	and	CCONJ
aiua-10754	7	16	independently	independently	ADV
aiua-10754	7	17	.	.	PUNCT
aiua-10754	8	1	pet	pet	PROPN
aiua-10754	8	2	/	/	SYM
aiua-10754	8	3	ct	ct	PROPN
aiua-10754	8	4	imaging	imaging	NOUN
aiua-10754	8	5	was	be	AUX
aiua-10754	8	6	performed	perform	VERB
aiua-10754	8	7	using	use	VERB
aiua-10754	8	8	a	a	DET
aiua-10754	8	9	ct	ct	ADV
aiua-10754	8	10	-	-	PUNCT
aiua-10754	8	11	integrated	integrate	VERB
aiua-10754	8	12	pet	pet	ADJ
aiua-10754	8	13	scanner	scanner	NOUN
aiua-10754	8	14	(	(	PUNCT
aiua-10754	8	15	biograph	biograph	NOUN
aiua-10754	8	16	6	6	NUM
aiua-10754	8	17	;	;	PUNCT
aiua-10754	8	18	siemens	siemen	NOUN
aiua-10754	8	19	,	,	PUNCT
aiua-10754	8	20	knoxville	knoxville	PROPN
aiua-10754	8	21	,	,	PUNCT
aiua-10754	8	22	tn	tn	PROPN
aiua-10754	8	23	,	,	PUNCT
aiua-10754	8	24	usa	usa	PROPN
aiua-10754	8	25	)	)	PUNCT
aiua-10754	8	26	.	.	PUNCT
aiua-10754	9	1	68ga	68ga	ADJ
aiua-10754	9	2	-	-	PUNCT
aiua-10754	9	3	psma	psma	NOUN
aiua-10754	9	4	was	be	AUX
aiua-10754	9	5	prepared	prepare	VERB
aiua-10754	9	6	with	with	ADP
aiua-10754	9	7	a	a	DET
aiua-10754	9	8	fully	fully	ADV
aiua-10754	9	9	automated	automate	VERB
aiua-10754	9	10	radiopharmaceutical	radiopharmaceutical	ADJ
aiua-10754	9	11	synthesis	synthesis	NOUN
aiua-10754	9	12	device	device	NOUN
aiua-10754	9	13	based	base	VERB
aiua-10754	9	14	on	on	ADP
aiua-10754	9	15	a	a	DET
aiua-10754	9	16	modular	modular	ADJ
aiua-10754	9	17	concept	concept	NOUN
aiua-10754	9	18	(	(	PUNCT
aiua-10754	9	19	eckert	eckert	PROPN
aiua-10754	9	20	&	&	CCONJ
aiua-10754	9	21	ziegler	ziegler	PROPN
aiua-10754	9	22	eurotope	eurotope	PROPN
aiua-10754	9	23	,	,	PUNCT
aiua-10754	9	24	berlin	berlin	PROPN
aiua-10754	9	25	,	,	PUNCT
aiua-10754	9	26	germany	germany	PROPN
aiua-10754	9	27	)	)	PUNCT
aiua-10754	9	28	.	.	PUNCT
aiua-10754	10	1	68ga	68ga	ADJ
aiua-10754	10	2	-	-	PUNCT
aiua-10754	10	3	psma-11	psma-11	PROPN
aiua-10754	10	4	was	be	AUX
aiua-10754	10	5	given	give	VERB
aiua-10754	10	6	to	to	ADP
aiua-10754	10	7	patients	patient	NOUN
aiua-10754	10	8	via	via	ADP
aiua-10754	10	9	an	an	DET
aiua-10754	10	10	intravenous	intravenous	ADJ
aiua-10754	10	11	bolus	bolus	NOUN
aiua-10754	10	12	(	(	PUNCT
aiua-10754	10	13	mean	mean	ADJ
aiua-10754	10	14	,	,	PUNCT
aiua-10754	10	15	144	144	NUM
aiua-10754	10	16	±	±	NUM
aiua-10754	10	17	12	12	NUM
aiua-10754	10	18	mbq	mbq	NOUN
aiua-10754	10	19	;	;	PUNCT
aiua-10754	10	20	range	range	NOUN
aiua-10754	10	21	,	,	PUNCT
aiua-10754	10	22	122	122	NUM
aiua-10754	10	23	-	-	SYM
aiua-10754	10	24	188	188	NUM
aiua-10754	10	25	mbq	mbq	NOUN
aiua-10754	10	26	)	)	PUNCT
aiua-10754	10	27	,	,	PUNCT
aiua-10754	10	28	and	and	CCONJ
aiua-10754	10	29	the	the	DET
aiua-10754	10	30	pet	pet	ADJ
aiua-10754	10	31	acquisition	acquisition	NOUN
aiua-10754	10	32	was	be	AUX
aiua-10754	10	33	started	start	VERB
aiua-10754	10	34	at	at	ADP
aiua-10754	10	35	a	a	DET
aiua-10754	10	36	mean	mean	NOUN
aiua-10754	10	37	of	of	ADP
aiua-10754	10	38	58	58	NUM
aiua-10754	10	39	±	±	NUM
aiua-10754	10	40	12	12	NUM
aiua-10754	10	41	min	min	NOUN
aiua-10754	10	42	(	(	PUNCT
aiua-10754	10	43	range	range	NOUN
aiua-10754	10	44	,	,	PUNCT
aiua-10754	10	45	50	50	NUM
aiua-10754	10	46	-	-	SYM
aiua-10754	10	47	81	81	NUM
aiua-10754	10	48	min	min	NOUN
aiua-10754	10	49	)	)	PUNCT
aiua-10754	10	50	afterward	afterward	ADV
aiua-10754	10	51	.	.	PUNCT
aiua-10754	11	1	scans	scan	NOUN
aiua-10754	11	2	were	be	AUX
aiua-10754	11	3	acquired	acquire	VERB
aiua-10754	11	4	in	in	ADP
aiua-10754	11	5	3	3	NUM
aiua-10754	11	6	-	-	PUNCT
aiua-10754	11	7	dimensional	dimensional	ADJ
aiua-10754	11	8	mode	mode	NOUN
aiua-10754	11	9	with	with	ADP
aiua-10754	11	10	an	an	DET
aiua-10754	11	11	acquisition	acquisition	NOUN
aiua-10754	11	12	time	time	NOUN
aiua-10754	11	13	of	of	ADP
aiua-10754	11	14	3	3	NUM
aiua-10754	11	15	min	min	NOUN
aiua-10754	11	16	per	per	ADP
aiua-10754	11	17	bed	bed	NOUN
aiua-10754	11	18	position	position	NOUN
aiua-10754	11	19	.	.	PUNCT
aiua-10754	12	1	emission	emission	NOUN
aiua-10754	12	2	data	datum	NOUN
aiua-10754	12	3	were	be	AUX
aiua-10754	12	4	corrected	correct	VERB
aiua-10754	12	5	for	for	ADP
aiua-10754	12	6	randoms	random	NOUN
aiua-10754	12	7	,	,	PUNCT
aiua-10754	12	8	dead	dead	ADJ
aiua-10754	12	9	time	time	NOUN
aiua-10754	12	10	,	,	PUNCT
aiua-10754	12	11	scatter	scatter	NOUN
aiua-10754	12	12	,	,	PUNCT
aiua-10754	12	13	and	and	CCONJ
aiua-10754	12	14	attenuation	attenuation	NOUN
aiua-10754	12	15	and	and	CCONJ
aiua-10754	12	16	were	be	AUX
aiua-10754	12	17	reconstructed	reconstruct	VERB
aiua-10754	12	18	iteratively	iteratively	ADV
aiua-10754	12	19	using	use	VERB
aiua-10754	12	20	ordered	order	VERB
aiua-10754	12	21	-	-	PUNCT
aiua-10754	12	22	subsets	subset	NOUN
aiua-10754	12	23	expectation	expectation	NOUN
aiua-10754	12	24	maximization	maximization	NOUN
aiua-10754	12	25	(	(	PUNCT
aiua-10754	12	26	4	4	NUM
aiua-10754	12	27	iterations	iteration	NOUN
aiua-10754	12	28	,	,	PUNCT
aiua-10754	12	29	8	8	NUM
aiua-10754	12	30	subsets	subset	NOUN
aiua-10754	12	31	)	)	PUNCT
aiua-10754	12	32	followed	follow	VERB
aiua-10754	12	33	by	by	ADP
aiua-10754	12	34	a	a	DET
aiua-10754	12	35	post	post	NOUN
aiua-10754	12	36	reconstruction	reconstruction	NOUN
aiua-10754	12	37	smoothing	smooth	VERB
aiua-10754	12	38	gaussian	gaussian	ADJ
aiua-10754	12	39	filter	filter	NOUN
aiua-10754	12	40	(	(	PUNCT
aiua-10754	12	41	5	5	NUM
aiua-10754	12	42	mm	mm	NOUN
aiua-10754	12	43	in	in	ADP
aiua-10754	12	44	full	full	ADJ
aiua-10754	12	45	width	width	NOUN
aiua-10754	12	46	at	at	ADP
aiua-10754	12	47	half	half	NOUN
aiua-10754	12	48	maximum	maximum	ADJ
aiua-10754	12	49	)	)	PUNCT
aiua-10754	12	50	.	.	PUNCT
aiua-10754	13	1	for	for	ADP
aiua-10754	13	2	attenuation	attenuation	NOUN
aiua-10754	13	3	correction	correction	NOUN
aiua-10754	13	4	,	,	PUNCT
aiua-10754	13	5	a	a	DET
aiua-10754	13	6	low	low	ADJ
aiua-10754	13	7	dose	dose	NOUN
aiua-10754	13	8	unenhanced	unenhance	VERB
aiua-10754	13	9	ct	ct	PROPN
aiua-10754	13	10	scan	scan	PROPN
aiua-10754	13	11	introduction	introduction	NOUN
aiua-10754	13	12	:	:	PUNCT
aiua-10754	13	13	to	to	PART
aiua-10754	13	14	evaluate	evaluate	VERB
aiua-10754	13	15	the	the	DET
aiua-10754	13	16	diagnostic	diagnostic	ADJ
aiua-10754	13	17	accuracy	accuracy	NOUN
aiua-10754	13	18	of	of	ADP
aiua-10754	13	19	68ga	68ga	ADJ
aiua-10754	13	20	-	-	PUNCT
aiua-10754	13	21	prostate	prostate	NOUN
aiua-10754	13	22	-	-	PUNCT
aiua-10754	13	23	specific	specific	ADJ
aiua-10754	13	24	membrane	membrane	NOUN
aiua-10754	13	25	antigen	antigen	NOUN
aiua-10754	13	26	(	(	PUNCT
aiua-10754	13	27	psma	psma	NOUN
aiua-10754	13	28	)	)	PUNCT
aiua-10754	13	29	positron	positron	NOUN
aiua-10754	13	30	emission	emission	NOUN
aiua-10754	13	31	tomography	tomography	NOUN
aiua-10754	13	32	/	/	SYM
aiua-10754	13	33	computed	compute	VERB
aiua-10754	13	34	tomography	tomography	NOUN
aiua-10754	13	35	(	(	PUNCT
aiua-10754	13	36	pet	pet	PROPN
aiua-10754	13	37	/	/	SYM
aiua-10754	13	38	ct	ct	PROPN
aiua-10754	13	39	)	)	PUNCT
aiua-10754	13	40	vs.	vs.	ADP
aiua-10754	13	41	multiparametric	multiparametric	ADJ
aiua-10754	13	42	magnetic	magnetic	ADJ
aiua-10754	13	43	resonance	resonance	NOUN
aiua-10754	13	44	imaging	imaging	NOUN
aiua-10754	13	45	(	(	PUNCT
aiua-10754	13	46	mpmri	mpmri	PROPN
aiua-10754	13	47	)	)	PUNCT
aiua-10754	13	48	targeted	target	VERB
aiua-10754	13	49	biopsy	biopsy	NOUN
aiua-10754	13	50	(	(	PUNCT
aiua-10754	13	51	tpbx	tpbx	NOUN
aiua-10754	13	52	)	)	PUNCT
aiua-10754	13	53	in	in	ADP
aiua-10754	13	54	the	the	DET
aiua-10754	13	55	diagnosis	diagnosis	NOUN
aiua-10754	13	56	of	of	ADP
aiua-10754	13	57	clinically	clinically	ADV
aiua-10754	13	58	significant	significant	ADJ
aiua-10754	13	59	prostate	prostate	NOUN
aiua-10754	13	60	cancer	cancer	NOUN
aiua-10754	13	61	(	(	PUNCT
aiua-10754	13	62	cspca	cspca	NOUN
aiua-10754	13	63	:	:	PUNCT
aiua-10754	13	64	grade	grade	NOUN
aiua-10754	13	65	group	group	NOUN
aiua-10754	13	66	≥	≥	NOUN
aiua-10754	13	67	2	2	NUM
aiua-10754	13	68	)	)	PUNCT
aiua-10754	13	69	.	.	PUNCT
aiua-10754	14	1	materials	material	NOUN
aiua-10754	14	2	and	and	CCONJ
aiua-10754	14	3	methods	method	NOUN
aiua-10754	14	4	:	:	PUNCT
aiua-10754	14	5	from	from	ADP
aiua-10754	14	6	january	january	PROPN
aiua-10754	14	7	2021	2021	NUM
aiua-10754	14	8	to	to	ADP
aiua-10754	14	9	june	june	PROPN
aiua-10754	14	10	2022	2022	NUM
aiua-10754	14	11	,	,	PUNCT
aiua-10754	14	12	100	100	NUM
aiua-10754	14	13	patients	patient	NOUN
aiua-10754	14	14	(	(	PUNCT
aiua-10754	14	15	median	median	ADJ
aiua-10754	14	16	age	age	NOUN
aiua-10754	14	17	:	:	PUNCT
aiua-10754	14	18	66	66	NUM
aiua-10754	14	19	years	year	NOUN
aiua-10754	14	20	)	)	PUNCT
aiua-10754	14	21	with	with	ADP
aiua-10754	14	22	negative	negative	ADJ
aiua-10754	14	23	digital	digital	ADJ
aiua-10754	14	24	rectal	rectal	ADJ
aiua-10754	14	25	examination	examination	NOUN
aiua-10754	14	26	underwent	underwent	NOUN
aiua-10754	14	27	transperineal	transperineal	NOUN
aiua-10754	14	28	prostate	prostate	NOUN
aiua-10754	14	29	biopsy	biopsy	NOUN
aiua-10754	14	30	for	for	ADP
aiua-10754	14	31	abnormal	abnormal	ADJ
aiua-10754	14	32	psa	psa	NOUN
aiua-10754	14	33	values	value	NOUN
aiua-10754	14	34	(	(	PUNCT
aiua-10754	14	35	median	median	PROPN
aiua-10754	14	36	7.5	7.5	NUM
aiua-10754	14	37	ng	ng	PROPN
aiua-10754	14	38	/	/	SYM
aiua-10754	14	39	ml	ml	NOUN
aiua-10754	14	40	)	)	PUNCT
aiua-10754	14	41	.	.	PUNCT
aiua-10754	15	1	before	before	ADP
aiua-10754	15	2	prostate	prostate	NOUN
aiua-10754	15	3	biopsy	biopsy	NOUN
aiua-10754	15	4	,	,	PUNCT
aiua-10754	15	5	all	all	DET
aiua-10754	15	6	patients	patient	NOUN
aiua-10754	15	7	underwent	undergo	VERB
aiua-10754	15	8	mpmri	mpmri	PROPN
aiua-10754	15	9	and	and	CCONJ
aiua-10754	15	10	68ga	68ga	ADJ
aiua-10754	15	11	-	-	PUNCT
aiua-10754	15	12	pet	pet	ADJ
aiua-10754	15	13	/	/	SYM
aiua-10754	15	14	ct	ct	NOUN
aiua-10754	15	15	examinations	examination	NOUN
aiua-10754	15	16	and	and	CCONJ
aiua-10754	15	17	mpmri	mpmri	PROPN
aiua-10754	15	18	(	(	PUNCT
aiua-10754	15	19	pi	pi	NOUN
aiua-10754	15	20	-	-	PUNCT
aiua-10754	15	21	rads	rad	NOUN
aiua-10754	15	22	version	version	NOUN
aiua-10754	15	23	2	2	NUM
aiua-10754	15	24	≥	≥	NOUN
aiua-10754	15	25	3	3	NUM
aiua-10754	15	26	)	)	PUNCT
aiua-10754	15	27	or	or	CCONJ
aiua-10754	15	28	68ga	68ga	ADJ
aiua-10754	15	29	-	-	PUNCT
aiua-10754	15	30	pet	pet	ADJ
aiua-10754	15	31	/	/	SYM
aiua-10754	15	32	ct	ct	PROPN
aiua-10754	15	33	index	index	NOUN
aiua-10754	15	34	lesions	lesion	NOUN
aiua-10754	15	35	suspicious	suspicious	ADJ
aiua-10754	15	36	for	for	ADP
aiua-10754	15	37	cancer	cancer	NOUN
aiua-10754	15	38	(	(	PUNCT
aiua-10754	15	39	suvmax	suvmax	ADV
aiua-10754	15	40	>	>	X
aiua-10754	15	41	5	5	NUM
aiua-10754	15	42	g	g	NOUN
aiua-10754	15	43	/	/	SYM
aiua-10754	15	44	ml	ml	NOUN
aiua-10754	15	45	)	)	PUNCT
aiua-10754	15	46	underwent	underwent	ADJ
aiua-10754	15	47	cognitive	cognitive	ADJ
aiua-10754	15	48	targeted	target	VERB
aiua-10754	15	49	cores	core	NOUN
aiua-10754	15	50	(	(	PUNCT
aiua-10754	15	51	mpmri	mpmri	PROPN
aiua-10754	15	52	-	-	PUNCT
aiua-10754	15	53	tpbx	tpbx	PROPN
aiua-10754	15	54	and	and	CCONJ
aiua-10754	15	55	psma	psma	PROPN
aiua-10754	15	56	-	-	PUNCT
aiua-10754	15	57	tpbx	tpbx	NOUN
aiua-10754	15	58	:	:	PUNCT
aiua-10754	15	59	four	four	NUM
aiua-10754	15	60	cores	core	NOUN
aiua-10754	15	61	)	)	PUNCT
aiua-10754	15	62	combined	combine	VERB
aiua-10754	15	63	with	with	ADP
aiua-10754	15	64	extended	extended	ADJ
aiua-10754	15	65	systematic	systematic	ADJ
aiua-10754	15	66	prostate	prostate	NOUN
aiua-10754	15	67	biopsy	biopsy	NOUN
aiua-10754	15	68	(	(	PUNCT
aiua-10754	15	69	espbx	espbx	NOUN
aiua-10754	15	70	:	:	PUNCT
aiua-10754	15	71	median	median	NOUN
aiua-10754	15	72	18	18	NUM
aiua-10754	15	73	cores	core	NOUN
aiua-10754	15	74	)	)	PUNCT
aiua-10754	15	75	.	.	PUNCT
aiua-10754	16	1	the	the	DET
aiua-10754	16	2	procedure	procedure	NOUN
aiua-10754	16	3	was	be	AUX
aiua-10754	16	4	performed	perform	VERB
aiua-10754	16	5	transperineally	transperineally	ADV
aiua-10754	16	6	using	use	VERB
aiua-10754	16	7	a	a	DET
aiua-10754	16	8	tru	tru	NOUN
aiua-10754	16	9	-	-	PUNCT
aiua-10754	16	10	cut	cut	VERB
aiua-10754	16	11	18	18	NUM
aiua-10754	16	12	-	-	PUNCT
aiua-10754	16	13	gauge	gauge	NOUN
aiua-10754	16	14	needle	needle	NOUN
aiua-10754	16	15	under	under	ADP
aiua-10754	16	16	sedation	sedation	NOUN
aiua-10754	16	17	and	and	CCONJ
aiua-10754	16	18	antibiotic	antibiotic	ADJ
aiua-10754	16	19	prophylaxis	prophylaxis	NOUN
aiua-10754	16	20	.	.	PUNCT
aiua-10754	17	1	results	result	NOUN
aiua-10754	17	2	:	:	PUNCT
aiua-10754	17	3	pca	pca	PROPN
aiua-10754	17	4	was	be	AUX
aiua-10754	17	5	found	find	VERB
aiua-10754	17	6	in	in	ADP
aiua-10754	17	7	58/100	58/100	PROPN
aiua-10754	17	8	(	(	PUNCT
aiua-10754	17	9	58.0	58.0	NUM
aiua-10754	17	10	%	%	NOUN
aiua-10754	17	11	)	)	PUNCT
aiua-10754	17	12	men	man	NOUN
aiua-10754	17	13	;	;	PUNCT
aiua-10754	17	14	in	in	ADP
aiua-10754	17	15	detail	detail	NOUN
aiua-10754	17	16	,	,	PUNCT
aiua-10754	17	17	44/58	44/58	NUM
aiua-10754	17	18	(	(	PUNCT
aiua-10754	17	19	75.9	75.9	NUM
aiua-10754	17	20	%	%	NOUN
aiua-10754	17	21	)	)	PUNCT
aiua-10754	17	22	were	be	AUX
aiua-10754	17	23	cspca	cspca	ADJ
aiua-10754	17	24	;	;	PUNCT
aiua-10754	17	25	mpmri	mpmri	PROPN
aiua-10754	17	26	and	and	CCONJ
aiua-10754	17	27	68ga	68ga	ADJ
aiua-10754	17	28	-	-	PUNCT
aiua-10754	17	29	psma	psma	NOUN
aiua-10754	17	30	showed	show	VERB
aiua-10754	17	31	66/100	66/100	NUM
aiua-10754	17	32	(	(	PUNCT
aiua-10754	17	33	66	66	NUM
aiua-10754	17	34	%	%	NOUN
aiua-10754	17	35	)	)	PUNCT
aiua-10754	17	36	and	and	CCONJ
aiua-10754	17	37	62/100	62/100	NUM
aiua-10754	17	38	(	(	PUNCT
aiua-10754	17	39	60	60	NUM
aiua-10754	17	40	%	%	NOUN
aiua-10754	17	41	)	)	PUNCT
aiua-10754	17	42	lesions	lesion	NOUN
aiua-10754	17	43	suspicious	suspicious	ADJ
aiua-10754	17	44	for	for	ADP
aiua-10754	17	45	pca	pca	NOUN
aiua-10754	17	46	,	,	PUNCT
aiua-10754	17	47	respectively	respectively	ADV
aiua-10754	17	48	.	.	PUNCT
aiua-10754	18	1	68ga	68ga	ADJ
aiua-10754	18	2	-	-	PUNCT
aiua-10754	18	3	psma	psma	NOUN
aiua-10754	18	4	-	-	PUNCT
aiua-10754	18	5	tpbx	tpbx	PROPN
aiua-10754	18	6	vs.	vs.	ADP
aiua-10754	18	7	mpmri	mpmri	PROPN
aiua-10754	18	8	-	-	PUNCT
aiua-10754	18	9	tpbx	tpbx	PROPN
aiua-10754	18	10	vs.	vs.	X
aiua-10754	18	11	espbx	espbx	PROPN
aiua-10754	18	12	diagnosed	diagnose	VERB
aiua-10754	18	13	42	42	NUM
aiua-10754	18	14	(	(	PUNCT
aiua-10754	18	15	95.4	95.4	NUM
aiua-10754	18	16	%	%	NOUN
aiua-10754	18	17	)	)	PUNCT
aiua-10754	19	1	vs.	vs.	ADP
aiua-10754	19	2	36	36	NUM
aiua-10754	19	3	(	(	PUNCT
aiua-10754	19	4	81.8	81.8	NUM
aiua-10754	19	5	%	%	NOUN
aiua-10754	19	6	)	)	PUNCT
aiua-10754	19	7	vs.	vs.	ADP
aiua-10754	19	8	30	30	NUM
aiua-10754	19	9	(	(	PUNCT
aiua-10754	19	10	68.2	68.2	NUM
aiua-10754	19	11	%	%	NOUN
aiua-10754	19	12	)	)	PUNCT
aiua-10754	19	13	cspca	cspca	PROPN
aiua-10754	19	14	,	,	PUNCT
aiua-10754	19	15	respectively	respectively	ADV
aiua-10754	19	16	;	;	PUNCT
aiua-10754	19	17	mpmri	mpmri	PROPN
aiua-10754	19	18	-	-	PUNCT
aiua-10754	19	19	tpbx	tpbx	PROPN
aiua-10754	19	20	vs.	vs.	ADP
aiua-10754	19	21	68ga	68ga	ADJ
aiua-10754	19	22	-	-	PUNCT
aiua-10754	19	23	psma	psma	NOUN
aiua-10754	19	24	-	-	PUNCT
aiua-10754	19	25	tpbx	tpbx	PROPN
aiua-10754	19	26	showed	show	VERB
aiua-10754	19	27	a	a	DET
aiua-10754	19	28	diagnostic	diagnostic	ADJ
aiua-10754	19	29	accuracy	accuracy	NOUN
aiua-10754	19	30	of	of	ADP
aiua-10754	19	31	76.9	76.9	NUM
aiua-10754	19	32	%	%	NOUN
aiua-10754	19	33	vs.	vs.	ADP
aiua-10754	19	34	84.9	84.9	NUM
aiua-10754	19	35	%	%	NOUN
aiua-10754	19	36	in	in	ADP
aiua-10754	19	37	diagnosing	diagnose	VERB
aiua-10754	19	38	cspca	cspca	NOUN
aiua-10754	19	39	.	.	PUNCT
aiua-10754	20	1	conclusions	conclusion	NOUN
aiua-10754	20	2	:	:	PUNCT
aiua-10754	20	3	68gapsma	68gapsma	PROPN
aiua-10754	20	4	pet	pet	PROPN
aiua-10754	20	5	/	/	SYM
aiua-10754	20	6	ct	ct	PROPN
aiua-10754	20	7	tpbx	tpbx	PROPN
aiua-10754	20	8	demonstrated	demonstrate	VERB
aiua-10754	20	9	good	good	ADJ
aiua-10754	20	10	accuracy	accuracy	NOUN
aiua-10754	20	11	in	in	ADP
aiua-10754	20	12	the	the	DET
aiua-10754	20	13	diagnosis	diagnosis	NOUN
aiua-10754	20	14	of	of	ADP
aiua-10754	20	15	cspca	cspca	NOUN
aiua-10754	20	16	,	,	PUNCT
aiua-10754	20	17	which	which	PRON
aiua-10754	20	18	was	be	AUX
aiua-10754	20	19	not	not	PART
aiua-10754	20	20	inferior	inferior	ADJ
aiua-10754	20	21	to	to	ADP
aiua-10754	20	22	mpmri	mpmri	PROPN
aiua-10754	20	23	tpbx	tpbx	PROPN
aiua-10754	20	24	(	(	PUNCT
aiua-10754	20	25	84.9	84.9	NUM
aiua-10754	20	26	%	%	NOUN
aiua-10754	20	27	vs.	vs.	ADP
aiua-10754	20	28	76.9	76.9	NUM
aiua-10754	20	29	%	%	NOUN
aiua-10754	20	30	)	)	PUNCT
aiua-10754	20	31	improving	improve	VERB
aiua-10754	20	32	the	the	DET
aiua-10754	20	33	detection	detection	NOUN
aiua-10754	20	34	rate	rate	NOUN
aiua-10754	20	35	for	for	ADP
aiua-10754	20	36	cancer	cancer	NOUN
aiua-10754	20	37	of	of	ADP
aiua-10754	20	38	systematic	systematic	ADJ
aiua-10754	20	39	biopsy	biopsy	NOUN
aiua-10754	20	40	.	.	PUNCT
aiua-10754	21	1	key	key	ADJ
aiua-10754	21	2	words	word	NOUN
aiua-10754	21	3	:	:	PUNCT
aiua-10754	21	4	prostate	prostate	NOUN
aiua-10754	21	5	cancer	cancer	NOUN
aiua-10754	21	6	;	;	PUNCT
aiua-10754	21	7	68ga	68ga	ADJ
aiua-10754	21	8	-	-	PUNCT
aiua-10754	21	9	psma	psma	NOUN
aiua-10754	21	10	pet	pet	NOUN
aiua-10754	21	11	/	/	SYM
aiua-10754	21	12	ct	ct	PROPN
aiua-10754	21	13	;	;	PUNCT
aiua-10754	21	14	mpmri	mpmri	PROPN
aiua-10754	21	15	;	;	PUNCT
aiua-10754	21	16	targeted	target	VERB
aiua-10754	21	17	prostate	prostate	NOUN
aiua-10754	21	18	biopsy	biopsy	NOUN
aiua-10754	21	19	.	.	PUNCT
aiua-10754	21	20	submitted	submit	VERB
aiua-10754	21	21	21	21	NUM
aiua-10754	21	22	july	july	NOUN
aiua-10754	21	23	2022	2022	NUM
aiua-10754	21	24	;	;	PUNCT
aiua-10754	21	25	accepted	accept	VERB
aiua-10754	21	26	6	6	NUM
aiua-10754	21	27	august	august	PROPN
aiua-10754	21	28	2022	2022	NUM
aiua-10754	21	29	introduction	introduction	NOUN
aiua-10754	21	30	although	although	SCONJ
aiua-10754	21	31	multiparametric	multiparametric	ADJ
aiua-10754	21	32	magnetic	magnetic	ADJ
aiua-10754	21	33	resonance	resonance	NOUN
aiua-10754	21	34	imaging	imaging	NOUN
aiua-10754	21	35	(	(	PUNCT
aiua-10754	21	36	mpmri	mpmri	PROPN
aiua-10754	21	37	)	)	PUNCT
aiua-10754	21	38	has	have	AUX
aiua-10754	21	39	improved	improve	VERB
aiua-10754	21	40	diagnostic	diagnostic	ADJ
aiua-10754	21	41	accuracy	accuracy	NOUN
aiua-10754	21	42	of	of	ADP
aiua-10754	21	43	systematic	systematic	ADJ
aiua-10754	21	44	prostate	prostate	NOUN
aiua-10754	21	45	biopsy	biopsy	NOUN
aiua-10754	21	46	in	in	ADP
aiua-10754	21	47	the	the	DET
aiua-10754	21	48	diagnosis	diagnosis	NOUN
aiua-10754	21	49	of	of	ADP
aiua-10754	21	50	clinically	clinically	ADV
aiua-10754	21	51	significant	significant	ADJ
aiua-10754	21	52	prostate	prostate	NOUN
aiua-10754	21	53	cancer	cancer	NOUN
aiua-10754	21	54	(	(	PUNCT
aiua-10754	21	55	cspca	cspca	PROPN
aiua-10754	21	56	)	)	PUNCT
aiua-10754	21	57	,	,	PUNCT
aiua-10754	21	58	about	about	ADV
aiua-10754	21	59	20	20	NUM
aiua-10754	21	60	-	-	SYM
aiua-10754	21	61	35	35	NUM
aiua-10754	21	62	%	%	NOUN
aiua-10754	21	63	of	of	ADP
aiua-10754	21	64	pca	pca	NOUN
aiua-10754	21	65	could	could	AUX
aiua-10754	21	66	be	be	AUX
aiua-10754	21	67	missed	miss	VERB
aiua-10754	21	68	by	by	ADP
aiua-10754	21	69	mpmri	mpmri	PROPN
aiua-10754	21	70	targeted	target	VERB
aiua-10754	21	71	biopsy	biopsy	NOUN
aiua-10754	21	72	(	(	PUNCT
aiua-10754	21	73	1	1	NUM
aiua-10754	21	74	)	)	PUNCT
aiua-10754	21	75	.	.	PUNCT
aiua-10754	22	1	prostate	prostate	NOUN
aiua-10754	22	2	-	-	PUNCT
aiua-10754	22	3	specific	specific	ADJ
aiua-10754	22	4	membrane	membrane	NOUN
aiua-10754	22	5	antigen	antigen	NOUN
aiua-10754	22	6	(	(	PUNCT
aiua-10754	22	7	psma	psma	PROPN
aiua-10754	22	8	)	)	PUNCT
aiua-10754	22	9	is	be	AUX
aiua-10754	22	10	expressed	express	VERB
aiua-10754	22	11	in	in	ADP
aiua-10754	22	12	most	most	ADV
aiua-10754	22	13	primitive	primitive	ADJ
aiua-10754	22	14	and	and	CCONJ
aiua-10754	22	15	metastatic	metastatic	ADJ
aiua-10754	22	16	pca	pca	NOUN
aiua-10754	22	17	(	(	PUNCT
aiua-10754	22	18	2	2	NUM
aiua-10754	22	19	,	,	PUNCT
aiua-10754	22	20	3	3	NUM
aiua-10754	22	21	)	)	PUNCT
aiua-10754	22	22	,	,	PUNCT
aiua-10754	22	23	and	and	CCONJ
aiua-10754	22	24	psma	psma	VERB
aiua-10754	22	25	inhibitors	inhibitor	NOUN
aiua-10754	22	26	conjugated	conjugate	VERB
aiua-10754	22	27	with	with	ADP
aiua-10754	22	28	the	the	DET
aiua-10754	22	29	radionuclides	radionuclide	NOUN
aiua-10754	22	30	gallium	gallium	NOUN
aiua-10754	22	31	68	68	NUM
aiua-10754	22	32	(	(	PUNCT
aiua-10754	22	33	68ga	68ga	ADJ
aiua-10754	22	34	)	)	PUNCT
aiua-10754	22	35	and	and	CCONJ
aiua-10754	22	36	fluoride	fluoride	NOUN
aiua-10754	22	37	18	18	NUM
aiua-10754	22	38	(	(	PUNCT
aiua-10754	22	39	18f	18f	NUM
aiua-10754	22	40	)	)	PUNCT
aiua-10754	22	41	have	have	AUX
aiua-10754	22	42	been	be	AUX
aiua-10754	22	43	evaluated	evaluate	VERB
aiua-10754	22	44	in	in	ADP
aiua-10754	22	45	clinical	clinical	ADJ
aiua-10754	22	46	practice	practice	NOUN
aiua-10754	22	47	for	for	ADP
aiua-10754	22	48	the	the	DET
aiua-10754	22	49	diagnosis	diagnosis	NOUN
aiua-10754	22	50	of	of	ADP
aiua-10754	22	51	pca	pca	NOUN
aiua-10754	22	52	(	(	PUNCT
aiua-10754	22	53	4	4	NUM
aiua-10754	22	54	-	-	SYM
aiua-10754	22	55	6	6	NUM
aiua-10754	22	56	)	)	PUNCT
aiua-10754	22	57	;	;	PUNCT
aiua-10754	23	1	morever	morever	X
aiua-10754	23	2	,	,	PUNCT
aiua-10754	23	3	tumour	tumour	NOUN
aiua-10754	23	4	uptake	uptake	NOUN
aiua-10754	23	5	,	,	PUNCT
aiua-10754	23	6	which	which	PRON
aiua-10754	23	7	targeted	target	VERB
aiua-10754	23	8	prostate	prostate	NOUN
aiua-10754	23	9	biopsy	biopsy	NOUN
aiua-10754	23	10	:	:	PUNCT
aiua-10754	23	11	68ga	68ga	ADJ
aiua-10754	23	12	-	-	PUNCT
aiua-10754	23	13	psma	psma	NOUN
aiua-10754	23	14	pet	pet	NOUN
aiua-10754	23	15	/	/	SYM
aiua-10754	23	16	ct	ct	PROPN
aiua-10754	23	17	vs.	vs.	X
aiua-10754	23	18	mpmri	mpmri	PROPN
aiua-10754	23	19	in	in	ADP
aiua-10754	23	20	the	the	DET
aiua-10754	23	21	diagnosis	diagnosis	NOUN
aiua-10754	23	22	of	of	ADP
aiua-10754	23	23	prostate	prostate	NOUN
aiua-10754	23	24	cancer	cancer	NOUN
aiua-10754	23	25	pietro	pietro	NOUN
aiua-10754	23	26	pepe	pepe	PROPN
aiua-10754	23	27	1	1	NUM
aiua-10754	23	28	,	,	PUNCT
aiua-10754	23	29	ludovica	ludovica	PROPN
aiua-10754	23	30	pepe	pepe	PROPN
aiua-10754	23	31	1	1	NUM
aiua-10754	23	32	,	,	PUNCT
aiua-10754	23	33	maria	maria	PROPN
aiua-10754	23	34	tamburo	tamburo	PROPN
aiua-10754	23	35	2	2	NUM
aiua-10754	23	36	,	,	PUNCT
aiua-10754	23	37	giulia	giulia	NOUN
aiua-10754	23	38	marletta	marletta	NOUN
aiua-10754	23	39	2	2	NUM
aiua-10754	23	40	,	,	PUNCT
aiua-10754	23	41	michele	michele	PROPN
aiua-10754	23	42	pennisi	pennisi	VERB
aiua-10754	23	43	1	1	NUM
aiua-10754	23	44	,	,	PUNCT
aiua-10754	23	45	filippo	filippo	X
aiua-10754	23	46	fraggetta	fraggetta	VERB
aiua-10754	23	47	3	3	NUM
aiua-10754	23	48	1	1	NUM
aiua-10754	23	49	urology	urology	NOUN
aiua-10754	23	50	unit	unit	NOUN
aiua-10754	23	51	,	,	PUNCT
aiua-10754	23	52	cannizzaro	cannizzaro	NOUN
aiua-10754	23	53	hospital	hospital	PROPN
aiua-10754	23	54	,	,	PUNCT
aiua-10754	23	55	catania	catania	PROPN
aiua-10754	23	56	,	,	PUNCT
aiua-10754	23	57	italy	italy	PROPN
aiua-10754	23	58	;	;	PUNCT
aiua-10754	23	59	2	2	NUM
aiua-10754	23	60	radiotherapy	radiotherapy	NOUN
aiua-10754	23	61	unit	unit	NOUN
aiua-10754	23	62	,	,	PUNCT
aiua-10754	23	63	cannizzaro	cannizzaro	NOUN
aiua-10754	23	64	hospital	hospital	PROPN
aiua-10754	23	65	,	,	PUNCT
aiua-10754	23	66	catania	catania	PROPN
aiua-10754	23	67	,	,	PUNCT
aiua-10754	23	68	italy	italy	PROPN
aiua-10754	23	69	;	;	PUNCT
aiua-10754	23	70	3	3	NUM
aiua-10754	23	71	pathology	pathology	NOUN
aiua-10754	23	72	unit	unit	NOUN
aiua-10754	23	73	,	,	PUNCT
aiua-10754	23	74	cannizzaro	cannizzaro	NOUN
aiua-10754	23	75	hospital	hospital	PROPN
aiua-10754	23	76	,	,	PUNCT
aiua-10754	23	77	catania	catania	PROPN
aiua-10754	23	78	,	,	PUNCT
aiua-10754	23	79	italy	italy	PROPN
aiua-10754	23	80	.	.	PUNCT
aiua-10754	24	1	doi	doi	PROPN
aiua-10754	24	2	:	:	PUNCT
aiua-10754	24	3	10.4081	10.4081	NUM
aiua-10754	24	4	/	/	SYM
aiua-10754	24	5	aiua.2022.3.274	aiua.2022.3.274	NOUN
aiua-10754	24	6	summary	summary	NOUN
aiua-10754	24	7	275archivio	275archivio	PROPN
aiua-10754	24	8	italiano	italiano	NOUN
aiua-10754	24	9	di	di	NOUN
aiua-10754	24	10	urologia	urologia	PROPN
aiua-10754	24	11	e	e	PROPN
aiua-10754	24	12	andrologia	andrologia	PROPN
aiua-10754	24	13	2022	2022	NUM
aiua-10754	24	14	;	;	PUNCT
aiua-10754	24	15	94	94	NUM
aiua-10754	24	16	,	,	PUNCT
aiua-10754	24	17	3	3	NUM
aiua-10754	24	18	68ga	68ga	ADJ
aiua-10754	24	19	-	-	PUNCT
aiua-10754	24	20	psma	psma	NOUN
aiua-10754	24	21	pet	pet	NOUN
aiua-10754	24	22	/	/	SYM
aiua-10754	24	23	ct	ct	PROPN
aiua-10754	24	24	and	and	CCONJ
aiua-10754	24	25	pca	pca	NOUN
aiua-10754	24	26	diagnosis	diagnosis	NOUN
aiua-10754	24	27	was	be	AUX
aiua-10754	24	28	performed	perform	VERB
aiua-10754	24	29	from	from	ADP
aiua-10754	24	30	the	the	DET
aiua-10754	24	31	skull	skull	NOUN
aiua-10754	24	32	base	base	NOUN
aiua-10754	24	33	to	to	ADP
aiua-10754	24	34	the	the	DET
aiua-10754	24	35	middle	middle	NOUN
aiua-10754	24	36	of	of	ADP
aiua-10754	24	37	the	the	DET
aiua-10754	24	38	thigh	thigh	NOUN
aiua-10754	24	39	.	.	PUNCT
aiua-10754	25	1	images	image	NOUN
aiua-10754	25	2	were	be	AUX
aiua-10754	25	3	processed	process	VERB
aiua-10754	25	4	to	to	PART
aiua-10754	25	5	obtain	obtain	VERB
aiua-10754	25	6	pet	pet	ADJ
aiua-10754	25	7	,	,	PUNCT
aiua-10754	25	8	ct	ct	PROPN
aiua-10754	25	9	,	,	PUNCT
aiua-10754	25	10	and	and	CCONJ
aiua-10754	25	11	petct	petct	NOUN
aiua-10754	25	12	fusion	fusion	NOUN
aiua-10754	25	13	sections	section	NOUN
aiua-10754	25	14	in	in	ADP
aiua-10754	25	15	the	the	DET
aiua-10754	25	16	axial	axial	ADJ
aiua-10754	25	17	,	,	PUNCT
aiua-10754	25	18	coronal	coronal	NOUN
aiua-10754	25	19	,	,	PUNCT
aiua-10754	25	20	and	and	CCONJ
aiua-10754	25	21	sagittal	sagittal	ADJ
aiua-10754	25	22	planes	plane	NOUN
aiua-10754	25	23	with	with	ADP
aiua-10754	25	24	a	a	DET
aiua-10754	25	25	thickness	thickness	NOUN
aiua-10754	25	26	of	of	ADP
aiua-10754	25	27	approximately	approximately	ADV
aiua-10754	25	28	0.5	0.5	NUM
aiua-10754	25	29	~	~	SYM
aiua-10754	25	30	cm	cm	NOUN
aiua-10754	25	31	by	by	ADP
aiua-10754	25	32	two	two	NUM
aiua-10754	25	33	experienced	experienced	ADJ
aiua-10754	25	34	nuclear	nuclear	ADJ
aiua-10754	25	35	medicine	medicine	NOUN
aiua-10754	25	36	specialists	specialist	NOUN
aiua-10754	25	37	,	,	PUNCT
aiua-10754	25	38	who	who	PRON
aiua-10754	25	39	were	be	AUX
aiua-10754	25	40	blinded	blind	VERB
aiua-10754	25	41	to	to	ADP
aiua-10754	25	42	the	the	DET
aiua-10754	25	43	clinical	clinical	ADJ
aiua-10754	25	44	data	datum	NOUN
aiua-10754	25	45	.	.	PUNCT
aiua-10754	26	1	the	the	DET
aiua-10754	26	2	location	location	NOUN
aiua-10754	26	3	of	of	ADP
aiua-10754	26	4	focal	focal	ADJ
aiua-10754	26	5	uptake	uptake	NOUN
aiua-10754	26	6	on	on	ADP
aiua-10754	26	7	68ga	68ga	ADJ
aiua-10754	26	8	-	-	PUNCT
aiua-10754	26	9	psma	psma	NOUN
aiua-10754	26	10	pet	pet	NOUN
aiua-10754	26	11	/	/	SYM
aiua-10754	26	12	tc	tc	PROPN
aiua-10754	26	13	(	(	PUNCT
aiua-10754	26	14	figure	figure	NOUN
aiua-10754	26	15	1	1	NUM
aiua-10754	26	16	)	)	PUNCT
aiua-10754	26	17	,	,	PUNCT
aiua-10754	26	18	three	three	NUM
aiua-10754	26	19	-	-	PUNCT
aiua-10754	26	20	dimensional	dimensional	ADJ
aiua-10754	26	21	size	size	NOUN
aiua-10754	26	22	,	,	PUNCT
aiua-10754	26	23	and	and	CCONJ
aiua-10754	26	24	standardised	standardise	VERB
aiua-10754	26	25	uptake	uptake	ADJ
aiua-10754	26	26	value	value	NOUN
aiua-10754	26	27	(	(	PUNCT
aiua-10754	26	28	suvmax	suvmax	ADJ
aiua-10754	26	29	)	)	PUNCT
aiua-10754	26	30	values	value	NOUN
aiua-10754	26	31	were	be	AUX
aiua-10754	26	32	reported	report	VERB
aiua-10754	26	33	on	on	ADP
aiua-10754	26	34	a	a	DET
aiua-10754	26	35	per	per	ADP
aiua-10754	26	36	-	-	PUNCT
aiua-10754	26	37	lesion	lesion	NOUN
aiua-10754	26	38	basis	basis	NOUN
aiua-10754	26	39	with	with	ADP
aiua-10754	26	40	a	a	DET
aiua-10754	26	41	sexstant	sexstant	ADJ
aiua-10754	26	42	scheme	scheme	NOUN
aiua-10754	26	43	(	(	PUNCT
aiua-10754	26	44	apex	apex	NOUN
aiua-10754	26	45	,	,	PUNCT
aiua-10754	26	46	midgland	midgland	NOUN
aiua-10754	26	47	,	,	PUNCT
aiua-10754	26	48	and	and	CCONJ
aiua-10754	26	49	base	base	NOUN
aiua-10754	26	50	,	,	PUNCT
aiua-10754	26	51	each	each	PRON
aiua-10754	26	52	split	split	VERB
aiua-10754	26	53	into	into	ADP
aiua-10754	26	54	left	left	ADJ
aiua-10754	26	55	and	and	CCONJ
aiua-10754	26	56	right	right	ADJ
aiua-10754	26	57	)	)	PUNCT
aiua-10754	26	58	(	(	PUNCT
aiua-10754	26	59	5	5	NUM
aiua-10754	26	60	)	)	PUNCT
aiua-10754	26	61	.	.	PUNCT
aiua-10754	27	1	all	all	DET
aiua-10754	27	2	mpmri	mpmri	PROPN
aiua-10754	27	3	(	(	PUNCT
aiua-10754	27	4	prostate	prostate	NOUN
aiua-10754	27	5	imaging	imaging	NOUN
aiua-10754	27	6	reporting	reporting	NOUN
aiua-10754	27	7	and	and	CCONJ
aiua-10754	27	8	data	datum	NOUN
aiua-10754	27	9	system	system	NOUN
aiua-10754	27	10	“	"	PUNCT
aiua-10754	27	11	pi	pi	NOUN
aiua-10754	27	12	-	-	PUNCT
aiua-10754	27	13	rads	rad	NOUN
aiua-10754	27	14	”	"	PUNCT
aiua-10754	27	15	version	version	NOUN
aiua-10754	27	16	2	2	NUM
aiua-10754	27	17	≥	≥	NOUN
aiua-10754	27	18	3	3	NUM
aiua-10754	27	19	)	)	PUNCT
aiua-10754	27	20	and	and	CCONJ
aiua-10754	27	21	68gapsma	68gapsma	X
aiua-10754	27	22	-	-	PUNCT
aiua-10754	27	23	pet	pet	NOUN
aiua-10754	27	24	/	/	SYM
aiua-10754	27	25	ct	ct	PROPN
aiua-10754	27	26	(	(	PUNCT
aiua-10754	27	27	suvmax	suvmax	X
aiua-10754	27	28	>	>	X
aiua-10754	27	29	5	5	NUM
aiua-10754	27	30	g	g	NOUN
aiua-10754	27	31	/	/	SYM
aiua-10754	27	32	ml	ml	NOUN
aiua-10754	27	33	)	)	PUNCT
aiua-10754	27	34	index	index	NOUN
aiua-10754	27	35	lesions	lesion	NOUN
aiua-10754	27	36	underwent	undergo	VERB
aiua-10754	27	37	targeted	target	VERB
aiua-10754	27	38	cores	core	NOUN
aiua-10754	27	39	(	(	PUNCT
aiua-10754	27	40	mpmri	mpmri	PROPN
aiua-10754	27	41	-	-	PUNCT
aiua-10754	27	42	tpbx	tpbx	PROPN
aiua-10754	27	43	and	and	CCONJ
aiua-10754	27	44	psma	psma	PROPN
aiua-10754	27	45	-	-	PUNCT
aiua-10754	27	46	tpbx	tpbx	NOUN
aiua-10754	27	47	:	:	PUNCT
aiua-10754	27	48	four	four	NUM
aiua-10754	27	49	cores	core	NOUN
aiua-10754	27	50	)	)	PUNCT
aiua-10754	27	51	combined	combine	VERB
aiua-10754	27	52	with	with	ADP
aiua-10754	27	53	extended	extended	ADJ
aiua-10754	27	54	systematic	systematic	ADJ
aiua-10754	27	55	prostate	prostate	NOUN
aiua-10754	27	56	biopsy	biopsy	NOUN
aiua-10754	27	57	(	(	PUNCT
aiua-10754	27	58	espbx	espbx	NOUN
aiua-10754	27	59	:	:	PUNCT
aiua-10754	27	60	median	median	NOUN
aiua-10754	27	61	18	18	NUM
aiua-10754	27	62	cores	core	NOUN
aiua-10754	27	63	)	)	PUNCT
aiua-10754	27	64	(	(	PUNCT
aiua-10754	27	65	2	2	NUM
aiua-10754	27	66	,	,	PUNCT
aiua-10754	27	67	14	14	NUM
aiua-10754	27	68	)	)	PUNCT
aiua-10754	27	69	.	.	PUNCT
aiua-10754	28	1	the	the	DET
aiua-10754	28	2	procedure	procedure	NOUN
aiua-10754	28	3	was	be	AUX
aiua-10754	28	4	performed	perform	VERB
aiua-10754	28	5	transperineally	transperineally	ADV
aiua-10754	28	6	using	use	VERB
aiua-10754	28	7	a	a	DET
aiua-10754	28	8	tru	tru	NOUN
aiua-10754	28	9	-	-	PUNCT
aiua-10754	28	10	cut	cut	VERB
aiua-10754	28	11	18	18	NUM
aiua-10754	28	12	-	-	PUNCT
aiua-10754	28	13	gauge	gauge	NOUN
aiua-10754	28	14	needle	needle	NOUN
aiua-10754	28	15	(	(	PUNCT
aiua-10754	28	16	bard	bard	NOUN
aiua-10754	28	17	,	,	PUNCT
aiua-10754	28	18	covington	covington	PROPN
aiua-10754	28	19	,	,	PUNCT
aiua-10754	28	20	ga	ga	PROPN
aiua-10754	28	21	,	,	PUNCT
aiua-10754	28	22	usa	usa	PROPN
aiua-10754	28	23	)	)	PUNCT
aiua-10754	28	24	under	under	ADP
aiua-10754	28	25	sedation	sedation	NOUN
aiua-10754	28	26	and	and	CCONJ
aiua-10754	28	27	antibiotic	antibiotic	ADJ
aiua-10754	28	28	prophylaxis	prophylaxis	NOUN
aiua-10754	28	29	(	(	PUNCT
aiua-10754	28	30	17	17	NUM
aiua-10754	28	31	)	)	PUNCT
aiua-10754	28	32	.	.	PUNCT
aiua-10754	29	1	prostate	prostate	NOUN
aiua-10754	29	2	-	-	PUNCT
aiua-10754	29	3	targeted	target	VERB
aiua-10754	29	4	cores	core	NOUN
aiua-10754	29	5	were	be	AUX
aiua-10754	29	6	obtained	obtain	VERB
aiua-10754	29	7	using	use	VERB
aiua-10754	29	8	a	a	DET
aiua-10754	29	9	hitachi	hitachi	PROPN
aiua-10754	29	10	70	70	NUM
aiua-10754	29	11	arietta	arietta	PROPN
aiua-10754	29	12	echograph	echograph	NOUN
aiua-10754	29	13	(	(	PUNCT
aiua-10754	29	14	chiba	chiba	PROPN
aiua-10754	29	15	,	,	PUNCT
aiua-10754	29	16	japan	japan	PROPN
aiua-10754	29	17	)	)	PUNCT
aiua-10754	29	18	supplied	supply	VERB
aiua-10754	29	19	by	by	ADP
aiua-10754	29	20	a	a	DET
aiua-10754	29	21	bi	bi	ADJ
aiua-10754	29	22	-	-	ADJ
aiua-10754	29	23	planar	planar	ADJ
aiua-10754	29	24	trans	trans	ADJ
aiua-10754	29	25	-	-	ADJ
aiua-10754	29	26	rectal	rectal	ADJ
aiua-10754	29	27	probe	probe	NOUN
aiua-10754	29	28	(	(	PUNCT
aiua-10754	29	29	14	14	NUM
aiua-10754	29	30	)	)	PUNCT
aiua-10754	29	31	by	by	ADP
aiua-10754	29	32	one	one	NUM
aiua-10754	29	33	urologist	urologist	NOUN
aiua-10754	29	34	with	with	ADP
aiua-10754	29	35	10	10	NUM
aiua-10754	29	36	years	year	NOUN
aiua-10754	29	37	of	of	ADP
aiua-10754	29	38	experience	experience	NOUN
aiua-10754	29	39	in	in	ADP
aiua-10754	29	40	cognitive	cognitive	ADJ
aiua-10754	29	41	targeted	target	VERB
aiua-10754	29	42	biopsy	biopsy	NOUN
aiua-10754	29	43	.	.	PUNCT
aiua-10754	30	1	data	datum	NOUN
aiua-10754	30	2	were	be	AUX
aiua-10754	30	3	collected	collect	VERB
aiua-10754	30	4	following	follow	VERB
aiua-10754	30	5	start	start	NOUN
aiua-10754	30	6	criteria	criterion	NOUN
aiua-10754	30	7	(	(	PUNCT
aiua-10754	30	8	18	18	NUM
aiua-10754	30	9	)	)	PUNCT
aiua-10754	30	10	.	.	PUNCT
aiua-10754	31	1	results	result	NOUN
aiua-10754	31	2	pca	pca	PROPN
aiua-10754	31	3	was	be	AUX
aiua-10754	31	4	found	find	VERB
aiua-10754	31	5	in	in	ADP
aiua-10754	31	6	58/100	58/100	PROPN
aiua-10754	31	7	(	(	PUNCT
aiua-10754	31	8	58	58	NUM
aiua-10754	31	9	%	%	NOUN
aiua-10754	31	10	)	)	PUNCT
aiua-10754	31	11	men	man	NOUN
aiua-10754	31	12	;	;	PUNCT
aiua-10754	31	13	in	in	ADP
aiua-10754	31	14	detail	detail	NOUN
aiua-10754	31	15	,	,	PUNCT
aiua-10754	31	16	44/100	44/100	PROPN
aiua-10754	31	17	(	(	PUNCT
aiua-10754	31	18	44	44	NUM
aiua-10754	31	19	%	%	NOUN
aiua-10754	31	20	)	)	PUNCT
aiua-10754	31	21	were	be	AUX
aiua-10754	31	22	cspca	cspca	ADJ
aiua-10754	31	23	:	:	PUNCT
aiua-10754	31	24	30/44	30/44	NUM
aiua-10754	31	25	(	(	PUNCT
aiua-10754	31	26	75	75	NUM
aiua-10754	31	27	%	%	NOUN
aiua-10754	31	28	)	)	PUNCT
aiua-10754	31	29	and	and	CCONJ
aiua-10754	31	30	14	14	NUM
aiua-10754	31	31	(	(	PUNCT
aiua-10754	31	32	25	25	NUM
aiua-10754	31	33	%	%	NOUN
aiua-10754	31	34	)	)	PUNCT
aiua-10754	31	35	were	be	AUX
aiua-10754	31	36	located	locate	VERB
aiua-10754	31	37	in	in	ADP
aiua-10754	31	38	the	the	DET
aiua-10754	31	39	peripheral	peripheral	ADJ
aiua-10754	31	40	and	and	CCONJ
aiua-10754	31	41	anterior	anterior	ADJ
aiua-10754	31	42	zones	zone	NOUN
aiua-10754	31	43	of	of	ADP
aiua-10754	31	44	the	the	DET
aiua-10754	31	45	gland	gland	NOUN
aiua-10754	31	46	,	,	PUNCT
aiua-10754	31	47	respectively	respectively	ADV
aiua-10754	31	48	.	.	PUNCT
aiua-10754	32	1	clinical	clinical	ADJ
aiua-10754	32	2	parameters	parameter	NOUN
aiua-10754	32	3	of	of	ADP
aiua-10754	32	4	men	man	NOUN
aiua-10754	32	5	with	with	ADP
aiua-10754	32	6	pca	pca	PROPN
aiua-10754	32	7	are	be	AUX
aiua-10754	32	8	reported	report	VERB
aiua-10754	32	9	in	in	ADP
aiua-10754	32	10	table	table	NOUN
aiua-10754	32	11	1	1	NUM
aiua-10754	32	12	;	;	PUNCT
aiua-10754	32	13	in	in	ADP
aiua-10754	32	14	detail	detail	NOUN
aiua-10754	32	15	,	,	PUNCT
aiua-10754	32	16	mpmri	mpmri	PROPN
aiua-10754	32	17	and	and	CCONJ
aiua-10754	32	18	68ga	68ga	ADJ
aiua-10754	32	19	-	-	PUNCT
aiua-10754	32	20	psma	psma	NOUN
aiua-10754	32	21	showed	show	VERB
aiua-10754	32	22	66/100	66/100	NUM
aiua-10754	32	23	(	(	PUNCT
aiua-10754	32	24	66	66	NUM
aiua-10754	32	25	%	%	NOUN
aiua-10754	32	26	)	)	PUNCT
aiua-10754	32	27	and	and	CCONJ
aiua-10754	32	28	62/100	62/100	NUM
aiua-10754	32	29	(	(	PUNCT
aiua-10754	32	30	60	60	NUM
aiua-10754	32	31	%	%	NOUN
aiua-10754	32	32	)	)	PUNCT
aiua-10754	32	33	lesions	lesion	NOUN
aiua-10754	32	34	suspicious	suspicious	ADJ
aiua-10754	32	35	for	for	ADP
aiua-10754	32	36	pca	pca	NOUN
aiua-10754	32	37	,	,	PUNCT
aiua-10754	32	38	respectively	respectively	ADV
aiua-10754	32	39	.	.	PUNCT
aiua-10754	33	1	these	these	PRON
aiua-10754	33	2	were	be	AUX
aiua-10754	33	3	submitted	submit	VERB
aiua-10754	33	4	to	to	ADP
aiua-10754	33	5	targeted	target	VERB
aiua-10754	33	6	cores	core	NOUN
aiua-10754	33	7	combined	combine	VERB
aiua-10754	33	8	with	with	ADP
aiua-10754	33	9	espbx	espbx	PROPN
aiua-10754	33	10	.	.	PUNCT
aiua-10754	34	1	the	the	DET
aiua-10754	34	2	diagnostic	diagnostic	ADJ
aiua-10754	34	3	accuracy	accuracy	NOUN
aiua-10754	34	4	of	of	ADP
aiua-10754	34	5	mpmri	mpmri	PROPN
aiua-10754	34	6	tpbx	tpbx	PROPN
aiua-10754	34	7	vs.	vs.	ADP
aiua-10754	34	8	68ga	68ga	ADJ
aiua-10754	34	9	-	-	PUNCT
aiua-10754	34	10	psma	psma	NOUN
aiua-10754	34	11	tpbx	tpbx	PROPN
aiua-10754	34	12	is	be	AUX
aiua-10754	34	13	shown	show	VERB
aiua-10754	34	14	in	in	ADP
aiua-10754	34	15	table	table	NOUN
aiua-10754	34	16	2	2	NUM
aiua-10754	34	17	.	.	PUNCT
aiua-10754	35	1	none	none	NOUN
aiua-10754	35	2	of	of	ADP
aiua-10754	35	3	the	the	DET
aiua-10754	35	4	patients	patient	NOUN
aiua-10754	35	5	had	have	VERB
aiua-10754	35	6	clinical	clinical	ADJ
aiua-10754	35	7	complications	complication	NOUN
aiua-10754	35	8	following	follow	VERB
aiua-10754	35	9	prostate	prostate	NOUN
aiua-10754	35	10	biopsy	biopsy	NOUN
aiua-10754	35	11	(	(	PUNCT
aiua-10754	35	12	dindo	dindo	NOUN
aiua-10754	35	13	-	-	PUNCT
aiua-10754	35	14	clavien	clavien	NOUN
aiua-10754	35	15	grade1	grade1	NOUN
aiua-10754	35	16	)	)	PUNCT
aiua-10754	35	17	(	(	PUNCT
aiua-10754	35	18	19	19	NUM
aiua-10754	35	19	)	)	PUNCT
aiua-10754	35	20	.	.	PUNCT
aiua-10754	36	1	the	the	DET
aiua-10754	36	2	average	average	ADJ
aiua-10754	36	3	intraprostatic	intraprostatic	ADJ
aiua-10754	36	4	suvmax	suvmax	NOUN
aiua-10754	36	5	was	be	AUX
aiua-10754	36	6	8.5	8.5	NUM
aiua-10754	36	7	g	g	NOUN
aiua-10754	36	8	/	/	SYM
aiua-10754	36	9	ml	ml	NOUN
aiua-10754	36	10	(	(	PUNCT
aiua-10754	36	11	range	range	NOUN
aiua-10754	36	12	=	=	SYM
aiua-10754	36	13	4	4	NUM
aiua-10754	36	14	-	-	SYM
aiua-10754	36	15	49	49	NUM
aiua-10754	36	16	g	g	NOUN
aiua-10754	36	17	/	/	SYM
aiua-10754	36	18	ml	ml	NOUN
aiua-10754	36	19	)	)	PUNCT
aiua-10754	36	20	and	and	CCONJ
aiua-10754	36	21	the	the	DET
aiua-10754	36	22	average	average	ADJ
aiua-10754	36	23	maximal	maximal	ADJ
aiua-10754	36	24	intraprostatic	intraprostatic	ADJ
aiua-10754	36	25	tumor	tumor	NOUN
aiua-10754	36	26	dimension	dimension	NOUN
aiua-10754	36	27	was	be	AUX
aiua-10754	36	28	12	12	NUM
aiua-10754	36	29	mm	mm	NOUN
aiua-10754	36	30	(	(	PUNCT
aiua-10754	36	31	range	range	NOUN
aiua-10754	36	32	=	=	SYM
aiua-10754	36	33	8	8	NUM
aiua-10754	36	34	-	-	SYM
aiua-10754	36	35	23	23	NUM
aiua-10754	36	36	mm	mm	NOUN
aiua-10754	36	37	)	)	PUNCT
aiua-10754	36	38	.	.	PUNCT
aiua-10754	37	1	68ga	68ga	ADJ
aiua-10754	37	2	-	-	PUNCT
aiua-10754	37	3	psmatpbx	psmatpbx	NOUN
aiua-10754	37	4	vs.	vs.	ADP
aiua-10754	37	5	mpmri	mpmri	PROPN
aiua-10754	37	6	-	-	PUNCT
aiua-10754	37	7	tpbx	tpbx	PROPN
aiua-10754	37	8	vs.	vs.	X
aiua-10754	37	9	espbx	espbx	PROPN
aiua-10754	37	10	missed	miss	VERB
aiua-10754	37	11	2	2	NUM
aiua-10754	37	12	(	(	PUNCT
aiua-10754	37	13	4.5	4.5	NUM
aiua-10754	37	14	%	%	NOUN
aiua-10754	37	15	)	)	PUNCT
aiua-10754	38	1	vs.	vs.	ADP
aiua-10754	38	2	8	8	NUM
aiua-10754	38	3	(	(	PUNCT
aiua-10754	38	4	18.2	18.2	NUM
aiua-10754	38	5	%	%	NOUN
aiua-10754	38	6	)	)	PUNCT
aiua-10754	38	7	vs.	vs.	ADP
aiua-10754	38	8	14	14	NUM
aiua-10754	38	9	(	(	PUNCT
aiua-10754	38	10	31.8	31.8	NUM
aiua-10754	38	11	%	%	NOUN
aiua-10754	38	12	)	)	PUNCT
aiua-10754	38	13	cspca	cspca	PROPN
aiua-10754	38	14	,	,	PUNCT
aiua-10754	38	15	respectively	respectively	ADV
aiua-10754	38	16	.	.	PUNCT
aiua-10754	39	1	discussion	discussion	NOUN
aiua-10754	39	2	to	to	PART
aiua-10754	39	3	reduce	reduce	VERB
aiua-10754	39	4	the	the	DET
aiua-10754	39	5	risk	risk	NOUN
aiua-10754	39	6	of	of	ADP
aiua-10754	39	7	overdiagnosis	overdiagnosis	NOUN
aiua-10754	39	8	following	follow	VERB
aiua-10754	39	9	screening	screen	VERB
aiua-10754	39	10	protocols	protocol	NOUN
aiua-10754	39	11	for	for	ADP
aiua-10754	39	12	pca	pca	PROPN
aiua-10754	39	13	,	,	PUNCT
aiua-10754	39	14	mpmri	mpmri	PROPN
aiua-10754	39	15	has	have	AUX
aiua-10754	39	16	been	be	AUX
aiua-10754	39	17	recommended	recommend	VERB
aiua-10754	39	18	to	to	PART
aiua-10754	39	19	decrease	decrease	VERB
aiua-10754	39	20	the	the	DET
aiua-10754	39	21	risk	risk	NOUN
aiua-10754	39	22	of	of	ADP
aiua-10754	39	23	overtreatment	overtreatment	NOUN
aiua-10754	39	24	;	;	PUNCT
aiua-10754	39	25	on	on	ADP
aiua-10754	39	26	the	the	DET
aiua-10754	39	27	other	other	ADJ
aiua-10754	39	28	hand	hand	NOUN
aiua-10754	39	29	,	,	PUNCT
aiua-10754	39	30	systematic	systematic	ADJ
aiua-10754	39	31	prostate	prostate	NOUN
aiua-10754	39	32	biopsy	biopsy	NOUN
aiua-10754	39	33	should	should	AUX
aiua-10754	39	34	always	always	ADV
aiua-10754	39	35	be	be	AUX
aiua-10754	39	36	combined	combine	VERB
aiua-10754	39	37	with	with	ADP
aiua-10754	39	38	mpmri	mpmri	PROPN
aiua-10754	39	39	/	/	SYM
aiua-10754	39	40	trus	trus	NOUN
aiua-10754	39	41	fusion	fusion	NOUN
aiua-10754	39	42	biopsy	biopsy	NOUN
aiua-10754	39	43	because	because	SCONJ
aiua-10754	39	44	of	of	ADP
aiua-10754	39	45	the	the	DET
aiua-10754	39	46	false	false	ADJ
aiua-10754	39	47	negative	negative	ADJ
aiua-10754	39	48	rate	rate	NOUN
aiua-10754	39	49	of	of	ADP
aiua-10754	39	50	mpmri	mpmri	PROPN
aiua-10754	39	51	(	(	PUNCT
aiua-10754	39	52	pca	pca	PROPN
aiua-10754	39	53	with	with	ADP
aiua-10754	39	54	low	low	ADJ
aiua-10754	39	55	volume	volume	NOUN
aiua-10754	39	56	and	and	CCONJ
aiua-10754	39	57	grade	grade	NOUN
aiua-10754	39	58	group	group	NOUN
aiua-10754	39	59	>	>	X
aiua-10754	39	60	2	2	NUM
aiua-10754	39	61	)	)	PUNCT
aiua-10754	39	62	(	(	PUNCT
aiua-10754	39	63	20	20	NUM
aiua-10754	39	64	,	,	PUNCT
aiua-10754	39	65	21	21	NUM
aiua-10754	39	66	)	)	PUNCT
aiua-10754	39	67	.	.	PUNCT
aiua-10754	40	1	recently	recently	ADV
aiua-10754	40	2	,	,	PUNCT
aiua-10754	40	3	68ga	68ga	ADJ
aiua-10754	40	4	-	-	PUNCT
aiua-10754	40	5	psma	psma	NOUN
aiua-10754	40	6	-	-	PUNCT
aiua-10754	40	7	pet	pet	NOUN
aiua-10754	40	8	/	/	SYM
aiua-10754	40	9	ct	ct	PROPN
aiua-10754	40	10	has	have	AUX
aiua-10754	40	11	been	be	AUX
aiua-10754	40	12	suggested	suggest	VERB
aiua-10754	40	13	to	to	PART
aiua-10754	40	14	improve	improve	VERB
aiua-10754	40	15	the	the	DET
aiua-10754	40	16	clinical	clinical	ADJ
aiua-10754	40	17	staging	staging	NOUN
aiua-10754	40	18	of	of	ADP
aiua-10754	40	19	highrisk	highrisk	NOUN
aiua-10754	40	20	pca	pca	PROPN
aiua-10754	40	21	and	and	CCONJ
aiua-10754	40	22	disease	disease	NOUN
aiua-10754	40	23	recurrence	recurrence	NOUN
aiua-10754	40	24	(	(	PUNCT
aiua-10754	40	25	5	5	NUM
aiua-10754	40	26	,	,	PUNCT
aiua-10754	40	27	10	10	NUM
aiua-10754	40	28	,	,	PUNCT
aiua-10754	40	29	22	22	NUM
aiua-10754	40	30	)	)	PUNCT
aiua-10754	40	31	;	;	PUNCT
aiua-10754	40	32	similarly	similarly	ADV
aiua-10754	40	33	,	,	PUNCT
aiua-10754	40	34	psma	psma	VERB
aiua-10754	40	35	pet	pet	PROPN
aiua-10754	40	36	/	/	SYM
aiua-10754	40	37	ct	ct	PROPN
aiua-10754	40	38	has	have	AUX
aiua-10754	40	39	been	be	AUX
aiua-10754	40	40	proposed	propose	VERB
aiua-10754	40	41	for	for	ADP
aiua-10754	40	42	the	the	DET
aiua-10754	40	43	diagnosis	diagnosis	NOUN
aiua-10754	40	44	of	of	ADP
aiua-10754	40	45	primary	primary	ADJ
aiua-10754	40	46	intraprostatic	intraprostatic	ADJ
aiua-10754	40	47	cancer	cancer	NOUN
aiua-10754	40	48	.	.	PUNCT
aiua-10754	41	1	the	the	DET
aiua-10754	41	2	presence	presence	NOUN
aiua-10754	41	3	of	of	ADP
aiua-10754	41	4	focal	focal	ADJ
aiua-10754	41	5	uptake	uptake	NOUN
aiua-10754	41	6	on	on	ADP
aiua-10754	41	7	psma	psma	NOUN
aiua-10754	41	8	-	-	PUNCT
aiua-10754	41	9	pet	pet	NOUN
aiua-10754	41	10	/	/	SYM
aiua-10754	41	11	ct	ct	PROPN
aiua-10754	41	12	,	,	PUNCT
aiua-10754	41	13	suvmax	suvmax	ADV
aiua-10754	41	14	,	,	PUNCT
aiua-10754	41	15	and	and	CCONJ
aiua-10754	41	16	the	the	DET
aiua-10754	41	17	maximal	maximal	ADJ
aiua-10754	41	18	dimensions	dimension	NOUN
aiua-10754	41	19	of	of	ADP
aiua-10754	41	20	pet	pet	ADJ
aiua-10754	41	21	-	-	PUNCT
aiua-10754	41	22	avid	avid	NOUN
aiua-10754	41	23	lesions	lesion	NOUN
aiua-10754	41	24	have	have	AUX
aiua-10754	41	25	been	be	AUX
aiua-10754	41	26	correlated	correlate	VERB
aiua-10754	41	27	with	with	ADP
aiua-10754	41	28	the	the	DET
aiua-10754	41	29	presence	presence	NOUN
aiua-10754	41	30	of	of	ADP
aiua-10754	41	31	cspca	cspca	NOUN
aiua-10754	41	32	(	(	PUNCT
aiua-10754	41	33	23	23	NUM
aiua-10754	41	34	-	-	SYM
aiua-10754	41	35	25	25	NUM
aiua-10754	41	36	)	)	PUNCT
aiua-10754	41	37	.	.	PUNCT
aiua-10754	42	1	there	there	PRON
aiua-10754	42	2	is	be	VERB
aiua-10754	42	3	a	a	DET
aiua-10754	42	4	range	range	NOUN
aiua-10754	42	5	of	of	ADP
aiua-10754	42	6	proposed	propose	VERB
aiua-10754	42	7	cutoffs	cutoff	NOUN
aiua-10754	42	8	to	to	PART
aiua-10754	42	9	detect	detect	VERB
aiua-10754	42	10	cspca	cspca	NOUN
aiua-10754	42	11	from	from	ADP
aiua-10754	42	12	suvmax	suvmax	ADJ
aiua-10754	42	13	3.15	3.15	NUM
aiua-10754	42	14	to	to	ADP
aiua-10754	42	15	suvmax	suvmax	ADJ
aiua-10754	42	16	9.1	9.1	NUM
aiua-10754	42	17	(	(	PUNCT
aiua-10754	42	18	26	26	NUM
aiua-10754	42	19	,	,	PUNCT
aiua-10754	42	20	27	27	NUM
aiua-10754	42	21	)	)	PUNCT
aiua-10754	42	22	;	;	PUNCT
aiua-10754	42	23	in	in	ADP
aiua-10754	42	24	addition	addition	NOUN
aiua-10754	42	25	,	,	PUNCT
aiua-10754	42	26	psma	psma	NOUN
aiua-10754	42	27	-	-	PUNCT
aiua-10754	42	28	pet	pet	NOUN
aiua-10754	42	29	/	/	SYM
aiua-10754	42	30	ct	ct	PROPN
aiua-10754	42	31	demonstrated	demonstrate	VERB
aiua-10754	42	32	high	high	ADJ
aiua-10754	42	33	correlation	correlation	NOUN
aiua-10754	42	34	between	between	ADP
aiua-10754	42	35	the	the	DET
aiua-10754	42	36	isup	isup	ADJ
aiua-10754	42	37	grade	grade	NOUN
aiua-10754	42	38	group	group	NOUN
aiua-10754	42	39	and	and	CCONJ
aiua-10754	42	40	suvmax	suvmax	ADJ
aiua-10754	42	41	table	table	NOUN
aiua-10754	42	42	1	1	NUM
aiua-10754	42	43	.	.	PUNCT
aiua-10754	43	1	clinical	clinical	ADJ
aiua-10754	43	2	parameters	parameter	NOUN
aiua-10754	43	3	of	of	ADP
aiua-10754	43	4	44	44	NUM
aiua-10754	43	5	men	man	NOUN
aiua-10754	43	6	with	with	ADP
aiua-10754	43	7	clinically	clinically	ADV
aiua-10754	43	8	significant	significant	ADJ
aiua-10754	43	9	prostate	prostate	NOUN
aiua-10754	43	10	cancer	cancer	NOUN
aiua-10754	43	11	(	(	PUNCT
aiua-10754	43	12	cspca	cspca	NOUN
aiua-10754	43	13	)	)	PUNCT
aiua-10754	43	14	.	.	PUNCT
aiua-10754	44	1	clinical	clinical	ADJ
aiua-10754	44	2	and	and	CCONJ
aiua-10754	44	3	biopsy	biopsy	PROPN
aiua-10754	44	4	findings	finding	NOUN
aiua-10754	44	5	gg2	gg2	PROPN
aiua-10754	44	6	15	15	NUM
aiua-10754	44	7	pz	pz	NOUN
aiua-10754	44	8	gg3	gg3	PROPN
aiua-10754	44	9	11	11	NUM
aiua-10754	44	10	pz	pz	PROPN
aiua-10754	44	11	gg4	gg4	PROPN
aiua-10754	44	12	10	10	NUM
aiua-10754	44	13	gg5	gg5	ADJ
aiua-10754	44	14	8	8	NUM
aiua-10754	44	15	initial	initial	ADJ
aiua-10754	44	16	biopsy	biopsy	NOUN
aiua-10754	44	17	9	9	NUM
aiua-10754	44	18	6	6	NUM
aiua-10754	44	19	6	6	NUM
aiua-10754	44	20	6	6	NUM
aiua-10754	44	21	repeated	repeat	VERB
aiua-10754	44	22	biopsy	biopsy	NOUN
aiua-10754	44	23	6	6	NUM
aiua-10754	44	24	5	5	NUM
aiua-10754	44	25	4	4	NUM
aiua-10754	44	26	2	2	NUM
aiua-10754	44	27	median	median	NOUN
aiua-10754	44	28	psa	psa	NOUN
aiua-10754	44	29	(	(	PUNCT
aiua-10754	44	30	range	range	NOUN
aiua-10754	44	31	:	:	PUNCT
aiua-10754	44	32	4.5	4.5	NUM
aiua-10754	44	33	-	-	SYM
aiua-10754	44	34	83	83	NUM
aiua-10754	44	35	ng	ng	PROPN
aiua-10754	44	36	/	/	SYM
aiua-10754	44	37	ml	ml	VERB
aiua-10754	44	38	)	)	PUNCT
aiua-10754	44	39	6.3	6.3	NUM
aiua-10754	44	40	9.5	9.5	NUM
aiua-10754	44	41	16	16	NUM
aiua-10754	44	42	26	26	NUM
aiua-10754	44	43	median	median	NOUN
aiua-10754	44	44	gpc	gpc	PROPN
aiua-10754	44	45	30	30	NUM
aiua-10754	44	46	%	%	NOUN
aiua-10754	44	47	45	45	NUM
aiua-10754	44	48	%	%	NOUN
aiua-10754	44	49	70	70	NUM
aiua-10754	44	50	%	%	NOUN
aiua-10754	44	51	90	90	NUM
aiua-10754	44	52	%	%	NOUN
aiua-10754	44	53	number	number	NOUN
aiua-10754	44	54	of	of	ADP
aiua-10754	44	55	positive	positive	ADJ
aiua-10754	44	56	cores	core	NOUN
aiua-10754	44	57	overall	overall	ADJ
aiua-10754	44	58	6	6	NUM
aiua-10754	44	59	9	9	NUM
aiua-10754	44	60	11	11	NUM
aiua-10754	44	61	13	13	NUM
aiua-10754	44	62	mpmri	mpmri	PROPN
aiua-10754	44	63	pi	pi	NOUN
aiua-10754	44	64	-	-	PUNCT
aiua-10754	44	65	rads	rad	NOUN
aiua-10754	44	66	score	score	NOUN
aiua-10754	44	67	≥	≥	NOUN
aiua-10754	44	68	3	3	NUM
aiua-10754	44	69	9	9	NUM
aiua-10754	44	70	8	8	NUM
aiua-10754	44	71	8	8	NUM
aiua-10754	44	72	7	7	NUM
aiua-10754	44	73	68ga	68ga	ADJ
aiua-10754	44	74	-	-	PUNCT
aiua-10754	44	75	psma	psma	NOUN
aiua-10754	44	76	pet	pet	NOUN
aiua-10754	44	77	/	/	SYM
aiua-10754	44	78	tc	tc	NOUN
aiua-10754	44	79	suspicious	suspicious	ADJ
aiua-10754	44	80	for	for	ADP
aiua-10754	44	81	pca	pca	PROPN
aiua-10754	44	82	7	7	NUM
aiua-10754	44	83	11	11	NUM
aiua-10754	44	84	10	10	NUM
aiua-10754	44	85	8	8	NUM
aiua-10754	44	86	gg	gg	NOUN
aiua-10754	44	87	:	:	PUNCT
aiua-10754	44	88	international	international	ADJ
aiua-10754	44	89	society	society	NOUN
aiua-10754	44	90	of	of	ADP
aiua-10754	44	91	urological	urological	ADJ
aiua-10754	44	92	pathology	pathology	PROPN
aiua-10754	44	93	grade	grade	NOUN
aiua-10754	44	94	group	group	NOUN
aiua-10754	44	95	;	;	PUNCT
aiua-10754	44	96	mpmri	mpmri	PROPN
aiua-10754	44	97	:	:	PUNCT
aiua-10754	44	98	multiparametric	multiparametric	PROPN
aiua-10754	44	99	magnetic	magnetic	ADJ
aiua-10754	44	100	resonance	resonance	NOUN
aiua-10754	44	101	imaging	imaging	NOUN
aiua-10754	44	102	;	;	PUNCT
aiua-10754	44	103	psa	psa	VERB
aiua-10754	44	104	:	:	PUNCT
aiua-10754	44	105	prostate	prostate	NOUN
aiua-10754	44	106	specific	specific	ADJ
aiua-10754	44	107	antigen	antigen	NOUN
aiua-10754	44	108	;	;	PUNCT
aiua-10754	44	109	gpc	gpc	PROPN
aiua-10754	44	110	:	:	PUNCT
aiua-10754	44	111	greatest	great	ADJ
aiua-10754	44	112	percentage	percentage	NOUN
aiua-10754	44	113	of	of	ADP
aiua-10754	44	114	cancer	cancer	NOUN
aiua-10754	44	115	;	;	PUNCT
aiua-10754	44	116	psma	psma	NOUN
aiua-10754	44	117	:	:	PUNCT
aiua-10754	44	118	prostate	prostate	NOUN
aiua-10754	44	119	specific	specific	ADJ
aiua-10754	44	120	membrane	membrane	NOUN
aiua-10754	44	121	antigen	antigen	NOUN
aiua-10754	44	122	;	;	PUNCT
aiua-10754	44	123	pi	pi	NOUN
aiua-10754	44	124	-	-	PUNCT
aiua-10754	44	125	rads	rad	NOUN
aiua-10754	44	126	:	:	PUNCT
aiua-10754	44	127	prostate	prostate	NOUN
aiua-10754	44	128	imaging	imaging	NOUN
aiua-10754	44	129	reporting	reporting	NOUN
aiua-10754	44	130	and	and	CCONJ
aiua-10754	44	131	data	datum	NOUN
aiua-10754	44	132	system	system	NOUN
aiua-10754	44	133	;	;	PUNCT
aiua-10754	44	134	pet	pet	NOUN
aiua-10754	44	135	/	/	SYM
aiua-10754	44	136	tc	tc	NOUN
aiua-10754	44	137	:	:	PUNCT
aiua-10754	44	138	positron	positron	NOUN
aiua-10754	44	139	emission	emission	NOUN
aiua-10754	44	140	tomography	tomography	NOUN
aiua-10754	44	141	/	/	SYM
aiua-10754	44	142	computed	compute	VERB
aiua-10754	44	143	tomography	tomography	NOUN
aiua-10754	44	144	.	.	PUNCT
aiua-10754	45	1	figure	figure	NOUN
aiua-10754	45	2	1	1	NUM
aiua-10754	45	3	.	.	PUNCT
aiua-10754	46	1	68ga	68ga	ADJ
aiua-10754	46	2	-	-	PUNCT
aiua-10754	46	3	prostate	prostate	NOUN
aiua-10754	46	4	-	-	PUNCT
aiua-10754	46	5	specific	specific	ADJ
aiua-10754	46	6	membrane	membrane	NOUN
aiua-10754	46	7	antigen	antigen	NOUN
aiua-10754	46	8	(	(	PUNCT
aiua-10754	46	9	psma	psma	NOUN
aiua-10754	46	10	)	)	PUNCT
aiua-10754	46	11	pet	pet	NOUN
aiua-10754	46	12	/	/	SYM
aiua-10754	46	13	ct	ct	PROPN
aiua-10754	46	14	:	:	PUNCT
aiua-10754	46	15	presence	presence	NOUN
aiua-10754	46	16	of	of	ADP
aiua-10754	46	17	high	high	ADJ
aiua-10754	46	18	suspicious	suspicious	ADJ
aiua-10754	46	19	area	area	NOUN
aiua-10754	46	20	fo	fo	ADP
aiua-10754	46	21	prostate	prostate	NOUN
aiua-10754	46	22	cancer	cancer	NOUN
aiua-10754	46	23	(	(	PUNCT
aiua-10754	46	24	suvmax	suvmax	ADV
aiua-10754	46	25	20	20	NUM
aiua-10754	46	26	)	)	PUNCT
aiua-10754	46	27	in	in	ADP
aiua-10754	46	28	both	both	DET
aiua-10754	46	29	lobe	lobe	NOUN
aiua-10754	46	30	of	of	ADP
aiua-10754	46	31	the	the	DET
aiua-10754	46	32	prostate	prostate	NOUN
aiua-10754	46	33	(	(	PUNCT
aiua-10754	46	34	axial	axial	ADJ
aiua-10754	46	35	evaluation	evaluation	NOUN
aiua-10754	46	36	)	)	PUNCT
aiua-10754	46	37	.	.	PUNCT
aiua-10754	47	1	table	table	NOUN
aiua-10754	47	2	2	2	NUM
aiua-10754	47	3	.	.	PUNCT
aiua-10754	48	1	diagnostic	diagnostic	ADJ
aiua-10754	48	2	accuracy	accuracy	NOUN
aiua-10754	48	3	of	of	ADP
aiua-10754	48	4	mpmri	mpmri	PROPN
aiua-10754	48	5	-	-	PUNCT
aiua-10754	48	6	tpbx	tpbx	PROPN
aiua-10754	48	7	vs.	vs.	ADP
aiua-10754	48	8	68ga	68ga	ADJ
aiua-10754	48	9	-	-	PUNCT
aiua-10754	48	10	psma	psma	NOUN
aiua-10754	48	11	-	-	PUNCT
aiua-10754	48	12	tpbx	tpbx	NOUN
aiua-10754	48	13	in	in	ADP
aiua-10754	48	14	the	the	DET
aiua-10754	48	15	diagnosis	diagnosis	NOUN
aiua-10754	48	16	of	of	ADP
aiua-10754	48	17	clinically	clinically	ADV
aiua-10754	48	18	significant	significant	ADJ
aiua-10754	48	19	prostate	prostate	NOUN
aiua-10754	48	20	cancer	cancer	NOUN
aiua-10754	48	21	(	(	PUNCT
aiua-10754	48	22	cspca	cspca	NOUN
aiua-10754	48	23	)	)	PUNCT
aiua-10754	48	24	.	.	PUNCT
aiua-10754	49	1	number	number	NOUN
aiua-10754	49	2	of	of	ADP
aiua-10754	49	3	cspca	cspca	PROPN
aiua-10754	49	4	mpmri	mpmri	PROPN
aiua-10754	49	5	tpbx	tpbx	ADJ
aiua-10754	49	6	68ga	68ga	ADJ
aiua-10754	49	7	-	-	PUNCT
aiua-10754	49	8	psma	psma	NOUN
aiua-10754	49	9	pet	pet	NOUN
aiua-10754	49	10	/	/	SYM
aiua-10754	49	11	ct	ct	PROPN
aiua-10754	49	12	tpbx	tpbx	PROPN
aiua-10754	49	13	(	(	PUNCT
aiua-10754	49	14	44	44	NUM
aiua-10754	49	15	cases	case	NOUN
aiua-10754	49	16	)	)	PUNCT
aiua-10754	49	17	36	36	NUM
aiua-10754	49	18	cases	case	NOUN
aiua-10754	49	19	42	42	NUM
aiua-10754	49	20	cases	case	NOUN
aiua-10754	49	21	sensitivity	sensitivity	NOUN
aiua-10754	49	22	81.8	81.8	NUM
aiua-10754	49	23	%	%	NOUN
aiua-10754	49	24	95.4	95.4	NUM
aiua-10754	49	25	%	%	NOUN
aiua-10754	49	26	specificity	specificity	NOUN
aiua-10754	49	27	71.8	71.8	NUM
aiua-10754	49	28	%	%	NOUN
aiua-10754	49	29	80.0	80.0	NUM
aiua-10754	49	30	%	%	NOUN
aiua-10754	49	31	positive	positive	ADJ
aiua-10754	49	32	predictive	predictive	ADJ
aiua-10754	49	33	value	value	NOUN
aiua-10754	49	34	54.5	54.5	NUM
aiua-10754	49	35	%	%	NOUN
aiua-10754	49	36	73.4	73.4	NUM
aiua-10754	49	37	%	%	NOUN
aiua-10754	49	38	negative	negative	ADJ
aiua-10754	49	39	predictive	predictive	ADJ
aiua-10754	49	40	value	value	NOUN
aiua-10754	49	41	87.5	87.5	NUM
aiua-10754	49	42	%	%	NOUN
aiua-10754	49	43	96.5	96.5	NUM
aiua-10754	49	44	%	%	NOUN
aiua-10754	49	45	diagnostic	diagnostic	ADJ
aiua-10754	49	46	accuracy	accuracy	NOUN
aiua-10754	49	47	76.9	76.9	NUM
aiua-10754	49	48	%	%	NOUN
aiua-10754	49	49	84.7	84.7	NUM
aiua-10754	49	50	%	%	NOUN
aiua-10754	49	51	psma	psma	NOUN
aiua-10754	49	52	:	:	PUNCT
aiua-10754	49	53	prostate	prostate	NOUN
aiua-10754	49	54	specific	specific	ADJ
aiua-10754	49	55	membrane	membrane	NOUN
aiua-10754	49	56	antigen	antigen	NOUN
aiua-10754	49	57	;	;	PUNCT
aiua-10754	49	58	mpmri	mpmri	PROPN
aiua-10754	49	59	:	:	PUNCT
aiua-10754	49	60	multiparametric	multiparametric	PROPN
aiua-10754	49	61	magnetic	magnetic	ADJ
aiua-10754	49	62	resonance	resonance	NOUN
aiua-10754	49	63	imaging	imaging	NOUN
aiua-10754	49	64	;	;	PUNCT
aiua-10754	49	65	pet	pet	NOUN
aiua-10754	49	66	/	/	SYM
aiua-10754	49	67	tc	tc	PROPN
aiua-10754	49	68	:	:	PUNCT
aiua-10754	49	69	positron	positron	NOUN
aiua-10754	49	70	emission	emission	NOUN
aiua-10754	49	71	tomography	tomography	NOUN
aiua-10754	49	72	/	/	SYM
aiua-10754	49	73	computed	compute	VERB
aiua-10754	49	74	tomography	tomography	NOUN
aiua-10754	49	75	;	;	PUNCT
aiua-10754	49	76	tpbx	tpbx	NOUN
aiua-10754	49	77	:	:	PUNCT
aiua-10754	49	78	targeted	target	VERB
aiua-10754	49	79	prostate	prostate	NOUN
aiua-10754	49	80	biopsy	biopsy	NOUN
aiua-10754	49	81	.	.	PUNCT
aiua-10754	50	1	archivio	archivio	NOUN
aiua-10754	50	2	italiano	italiano	PROPN
aiua-10754	50	3	di	di	PROPN
aiua-10754	50	4	urologia	urologia	PROPN
aiua-10754	50	5	e	e	PROPN
aiua-10754	50	6	andrologia	andrologia	PROPN
aiua-10754	50	7	2022	2022	NUM
aiua-10754	50	8	;	;	PUNCT
aiua-10754	50	9	94	94	NUM
aiua-10754	50	10	,	,	PUNCT
aiua-10754	50	11	3	3	NUM
aiua-10754	50	12	p.	p.	NOUN
aiua-10754	50	13	pepe	pepe	PROPN
aiua-10754	50	14	,	,	PUNCT
aiua-10754	50	15	l.	l.	PROPN
aiua-10754	50	16	pepe	pepe	PROPN
aiua-10754	50	17	,	,	PUNCT
aiua-10754	50	18	m.	m.	NOUN
aiua-10754	50	19	tamburo	tamburo	NOUN
aiua-10754	50	20	,	,	PUNCT
aiua-10754	50	21	g.	g.	PROPN
aiua-10754	50	22	marletta	marletta	PROPN
aiua-10754	50	23	,	,	PUNCT
aiua-10754	50	24	m.	m.	NOUN
aiua-10754	50	25	pennisi	pennisi	PROPN
aiua-10754	50	26	,	,	PUNCT
aiua-10754	50	27	f.	f.	PROPN
aiua-10754	50	28	fraggetta	fraggetta	PROPN
aiua-10754	50	29	276	276	NUM
aiua-10754	50	30	and	and	CCONJ
aiua-10754	50	31	maximal	maximal	ADJ
aiua-10754	50	32	dimension	dimension	NOUN
aiua-10754	50	33	of	of	ADP
aiua-10754	50	34	the	the	DET
aiua-10754	50	35	lesion	lesion	NOUN
aiua-10754	50	36	.	.	PUNCT
aiua-10754	51	1	zhang	zhang	PROPN
aiua-10754	51	2	et	et	PROPN
aiua-10754	51	3	al	al	PROPN
aiua-10754	51	4	.	.	PROPN
aiua-10754	52	1	(	(	PUNCT
aiua-10754	52	2	28	28	NUM
aiua-10754	52	3	)	)	PUNCT
aiua-10754	52	4	reported	report	VERB
aiua-10754	52	5	a	a	DET
aiua-10754	52	6	higher	high	ADJ
aiua-10754	52	7	detection	detection	NOUN
aiua-10754	52	8	rate	rate	NOUN
aiua-10754	52	9	for	for	ADP
aiua-10754	52	10	cspca	cspca	NOUN
aiua-10754	52	11	performing	perform	VERB
aiua-10754	52	12	a	a	DET
aiua-10754	52	13	single	single	ADJ
aiua-10754	52	14	transgluteal	transgluteal	NOUN
aiua-10754	52	15	psma	psma	NOUN
aiua-10754	52	16	pet	pet	PROPN
aiua-10754	52	17	/	/	SYM
aiua-10754	52	18	ct	ct	NUM
aiua-10754	52	19	targeted	target	VERB
aiua-10754	52	20	core	core	NOUN
aiua-10754	52	21	(	(	PUNCT
aiua-10754	52	22	suvmax	suvmax	X
aiua-10754	52	23	>	>	X
aiua-10754	52	24	8)	8)	NUM
aiua-10754	52	25	in	in	ADP
aiua-10754	52	26	comparison	comparison	NOUN
aiua-10754	52	27	with	with	ADP
aiua-10754	52	28	systematic	systematic	ADJ
aiua-10754	52	29	prostate	prostate	NOUN
aiua-10754	52	30	biopsy	biopsy	NOUN
aiua-10754	52	31	(	(	PUNCT
aiua-10754	52	32	40	40	NUM
aiua-10754	52	33	vs.	vs.	ADP
aiua-10754	52	34	25	25	NUM
aiua-10754	52	35	%	%	NOUN
aiua-10754	52	36	of	of	ADP
aiua-10754	52	37	the	the	DET
aiua-10754	52	38	cases	case	NOUN
aiua-10754	52	39	)	)	PUNCT
aiua-10754	52	40	.	.	PUNCT
aiua-10754	53	1	liu	liu	PROPN
aiua-10754	53	2	et	et	PROPN
aiua-10754	53	3	al	al	PROPN
aiua-10754	53	4	.	.	PROPN
aiua-10754	53	5	(	(	PUNCT
aiua-10754	53	6	29	29	NUM
aiua-10754	53	7	)	)	PUNCT
aiua-10754	53	8	,	,	PUNCT
aiua-10754	53	9	found	find	VERB
aiua-10754	53	10	85.5	85.5	NUM
aiua-10754	53	11	%	%	NOUN
aiua-10754	53	12	of	of	ADP
aiua-10754	53	13	cspca	cspca	NOUN
aiua-10754	53	14	(	(	PUNCT
aiua-10754	53	15	47/55	47/55	NUM
aiua-10754	53	16	cases	case	NOUN
aiua-10754	53	17	)	)	PUNCT
aiua-10754	53	18	performing	perform	VERB
aiua-10754	53	19	pet	pet	ADJ
aiua-10754	53	20	/	/	SYM
aiua-10754	53	21	ct	ct	PROPN
aiua-10754	53	22	psma	psma	NOUN
aiua-10754	53	23	targeted	target	VERB
aiua-10754	53	24	cores	core	NOUN
aiua-10754	53	25	;	;	PUNCT
aiua-10754	53	26	kalapara	kalapara	PROPN
aiua-10754	53	27	et	et	PROPN
aiua-10754	53	28	al	al	PROPN
aiua-10754	53	29	.	.	PROPN
aiua-10754	54	1	(	(	PUNCT
aiua-10754	54	2	30	30	NUM
aiua-10754	54	3	)	)	PUNCT
aiua-10754	54	4	compared	compare	VERB
aiua-10754	54	5	the	the	DET
aiua-10754	54	6	accuracy	accuracy	NOUN
aiua-10754	54	7	of	of	ADP
aiua-10754	54	8	68ga	68ga	ADJ
aiua-10754	54	9	-	-	PUNCT
aiua-10754	54	10	psma	psma	NOUN
aiua-10754	54	11	pet	pet	NOUN
aiua-10754	54	12	/	/	SYM
aiua-10754	54	13	ct	ct	PROPN
aiua-10754	54	14	with	with	ADP
aiua-10754	54	15	mpmri	mpmri	PROPN
aiua-10754	54	16	in	in	ADP
aiua-10754	54	17	205	205	NUM
aiua-10754	54	18	men	man	NOUN
aiua-10754	54	19	who	who	PRON
aiua-10754	54	20	underwent	undergo	VERB
aiua-10754	54	21	radical	radical	ADJ
aiua-10754	54	22	prostatectomy	prostatectomy	NOUN
aiua-10754	54	23	and	and	CCONJ
aiua-10754	54	24	showed	show	VERB
aiua-10754	54	25	an	an	DET
aiua-10754	54	26	accuracy	accuracy	NOUN
aiua-10754	54	27	of	of	ADP
aiua-10754	54	28	96	96	NUM
aiua-10754	54	29	%	%	NOUN
aiua-10754	54	30	vs.	vs.	ADP
aiua-10754	54	31	91	91	NUM
aiua-10754	54	32	%	%	NOUN
aiua-10754	54	33	for	for	ADP
aiua-10754	54	34	the	the	DET
aiua-10754	54	35	detection	detection	NOUN
aiua-10754	54	36	of	of	ADP
aiua-10754	54	37	cspca	cspca	NOUN
aiua-10754	54	38	.	.	PUNCT
aiua-10754	55	1	xue	xue	PROPN
aiua-10754	55	2	et	et	PROPN
aiua-10754	55	3	al	al	PROPN
aiua-10754	55	4	.	.	PROPN
aiua-10754	55	5	showed	show	VERB
aiua-10754	55	6	that	that	SCONJ
aiua-10754	55	7	a	a	DET
aiua-10754	55	8	suvmax	suvmax	ADJ
aiua-10754	55	9	cut	cut	NOUN
aiua-10754	55	10	-	-	PUNCT
aiua-10754	55	11	off	off	NOUN
aiua-10754	55	12	of	of	ADP
aiua-10754	55	13	5.4	5.4	NUM
aiua-10754	55	14	predicted	predict	VERB
aiua-10754	55	15	pathological	pathological	ADJ
aiua-10754	55	16	upgrading	upgrading	NOUN
aiua-10754	55	17	at	at	ADP
aiua-10754	55	18	definitive	definitive	ADJ
aiua-10754	55	19	histology	histology	NOUN
aiua-10754	55	20	,	,	PUNCT
aiua-10754	55	21	showing	show	VERB
aiua-10754	55	22	91	91	NUM
aiua-10754	55	23	%	%	NOUN
aiua-10754	55	24	specificity	specificity	NOUN
aiua-10754	55	25	and	and	CCONJ
aiua-10754	55	26	94	94	NUM
aiua-10754	55	27	%	%	NOUN
aiua-10754	55	28	negative	negative	ADJ
aiua-10754	55	29	predictive	predictive	ADJ
aiua-10754	55	30	value	value	NOUN
aiua-10754	55	31	(	(	PUNCT
aiua-10754	55	32	31	31	NUM
aiua-10754	55	33	)	)	PUNCT
aiua-10754	55	34	.	.	PUNCT
aiua-10754	56	1	ferraro	ferraro	PROPN
aiua-10754	56	2	et	et	PROPN
aiua-10754	56	3	al	al	PROPN
aiua-10754	56	4	.	.	PROPN
aiua-10754	57	1	(	(	PUNCT
aiua-10754	57	2	32	32	NUM
aiua-10754	57	3	)	)	PUNCT
aiua-10754	57	4	in	in	ADP
aiua-10754	57	5	49	49	NUM
aiua-10754	57	6	men	man	NOUN
aiua-10754	57	7	who	who	PRON
aiua-10754	57	8	underwent	undergo	VERB
aiua-10754	57	9	68gapsma	68gapsma	PROPN
aiua-10754	57	10	pet	pet	ADJ
aiua-10754	57	11	/	/	SYM
aiua-10754	57	12	mri	mri	NOUN
aiua-10754	57	13	plus	plus	CCONJ
aiua-10754	57	14	template	template	NOUN
aiua-10754	57	15	biopsy	biopsy	NOUN
aiua-10754	57	16	demonstrated	demonstrate	VERB
aiua-10754	57	17	a	a	DET
aiua-10754	57	18	diagnostic	diagnostic	ADJ
aiua-10754	57	19	accuracy	accuracy	NOUN
aiua-10754	57	20	of	of	ADP
aiua-10754	57	21	pet	pet	NOUN
aiua-10754	57	22	/	/	SYM
aiua-10754	57	23	mri	mri	NOUN
aiua-10754	57	24	targeted	target	VERB
aiua-10754	57	25	cores	core	NOUN
aiua-10754	57	26	of	of	ADP
aiua-10754	57	27	90	90	NUM
aiua-10754	57	28	%	%	NOUN
aiua-10754	57	29	with	with	ADP
aiua-10754	57	30	only	only	ADV
aiua-10754	57	31	one	one	NUM
aiua-10754	57	32	false	false	ADJ
aiua-10754	57	33	negative	negative	ADJ
aiua-10754	57	34	result	result	NOUN
aiua-10754	57	35	.	.	PUNCT
aiua-10754	58	1	in	in	ADP
aiua-10754	58	2	definitive	definitive	ADJ
aiua-10754	58	3	,	,	PUNCT
aiua-10754	58	4	the	the	DET
aiua-10754	58	5	use	use	NOUN
aiua-10754	58	6	of	of	ADP
aiua-10754	58	7	more	more	ADJ
aiua-10754	58	8	parameters	parameter	NOUN
aiua-10754	58	9	(	(	PUNCT
aiua-10754	58	10	i.e.	i.e.	X
aiua-10754	58	11	genetic	genetic	ADJ
aiua-10754	58	12	evaluation	evaluation	NOUN
aiua-10754	58	13	,	,	PUNCT
aiua-10754	58	14	diagnostic	diagnostic	ADJ
aiua-10754	58	15	imaging	imaging	NOUN
aiua-10754	58	16	,	,	PUNCT
aiua-10754	58	17	psa	psa	VERB
aiua-10754	58	18	density	density	NOUN
aiua-10754	58	19	)	)	PUNCT
aiua-10754	58	20	(	(	PUNCT
aiua-10754	58	21	5	5	NUM
aiua-10754	58	22	,	,	PUNCT
aiua-10754	58	23	33	33	NUM
aiua-10754	58	24	)	)	PUNCT
aiua-10754	58	25	included	include	VERB
aiua-10754	58	26	in	in	ADP
aiua-10754	58	27	risk	risk	NOUN
aiua-10754	58	28	calculator	calculator	NOUN
aiua-10754	58	29	could	could	AUX
aiua-10754	58	30	better	well	ADV
aiua-10754	58	31	select	select	VERB
aiua-10754	58	32	men	man	NOUN
aiua-10754	58	33	at	at	ADP
aiua-10754	58	34	risk	risk	NOUN
aiua-10754	58	35	for	for	ADP
aiua-10754	58	36	cspca	cspca	NOUN
aiua-10754	58	37	who	who	PRON
aiua-10754	58	38	should	should	AUX
aiua-10754	58	39	underwent	underwent	VERB
aiua-10754	58	40	prostate	prostate	NOUN
aiua-10754	58	41	biopsy	biopsy	NOUN
aiua-10754	58	42	allowing	allow	VERB
aiua-10754	58	43	to	to	PART
aiua-10754	58	44	omit	omit	VERB
aiua-10754	58	45	unnecessary	unnecessary	ADJ
aiua-10754	58	46	procedures	procedure	NOUN
aiua-10754	58	47	also	also	ADV
aiua-10754	58	48	in	in	ADP
aiua-10754	58	49	case	case	NOUN
aiua-10754	58	50	of	of	ADP
aiua-10754	58	51	active	active	ADJ
aiua-10754	58	52	surveillance	surveillance	NOUN
aiua-10754	58	53	(	(	PUNCT
aiua-10754	58	54	34	34	NUM
aiua-10754	58	55	)	)	PUNCT
aiua-10754	58	56	reducing	reduce	VERB
aiua-10754	58	57	complications	complication	NOUN
aiua-10754	58	58	rate	rate	NOUN
aiua-10754	58	59	(	(	PUNCT
aiua-10754	58	60	35	35	NUM
aiua-10754	58	61	)	)	PUNCT
aiua-10754	58	62	.	.	PUNCT
aiua-10754	59	1	in	in	ADP
aiua-10754	59	2	our	our	PRON
aiua-10754	59	3	series	series	NOUN
aiua-10754	59	4	,	,	PUNCT
aiua-10754	59	5	among	among	ADP
aiua-10754	59	6	the	the	DET
aiua-10754	59	7	44/100	44/100	PROPN
aiua-10754	59	8	(	(	PUNCT
aiua-10754	59	9	44.0	44.0	NUM
aiua-10754	59	10	%	%	NOUN
aiua-10754	59	11	)	)	PUNCT
aiua-10754	59	12	men	man	NOUN
aiua-10754	59	13	with	with	ADP
aiua-10754	59	14	cspca	cspca	PROPN
aiua-10754	59	15	,	,	PUNCT
aiua-10754	59	16	mpmri	mpmri	PROPN
aiua-10754	59	17	-	-	PUNCT
aiua-10754	59	18	tpbx	tpbx	PROPN
aiua-10754	59	19	vs.	vs.	ADP
aiua-10754	59	20	68ga	68ga	ADJ
aiua-10754	59	21	-	-	PUNCT
aiua-10754	59	22	psma	psma	NOUN
aiua-10754	59	23	-	-	PUNCT
aiua-10754	59	24	tpbx	tpbx	PROPN
aiua-10754	59	25	showed	show	VERB
aiua-10754	59	26	a	a	DET
aiua-10754	59	27	diagnostic	diagnostic	ADJ
aiua-10754	59	28	accuracy	accuracy	NOUN
aiua-10754	59	29	of	of	ADP
aiua-10754	59	30	76.9	76.9	NUM
aiua-10754	59	31	%	%	NOUN
aiua-10754	59	32	vs.	vs.	ADP
aiua-10754	59	33	84.9	84.9	NUM
aiua-10754	59	34	%	%	NOUN
aiua-10754	59	35	;	;	PUNCT
aiua-10754	59	36	68ga	68ga	ADJ
aiua-10754	59	37	-	-	PUNCT
aiua-10754	59	38	psma	psma	NOUN
aiua-10754	59	39	-	-	PUNCT
aiua-10754	59	40	tpbx	tpbx	PROPN
aiua-10754	59	41	vs.	vs.	ADP
aiua-10754	59	42	mpmri	mpmri	PROPN
aiua-10754	59	43	-	-	PUNCT
aiua-10754	59	44	tpbx	tpbx	PROPN
aiua-10754	59	45	vs.	vs.	X
aiua-10754	59	46	espbx	espbx	PROPN
aiua-10754	59	47	missed	miss	VERB
aiua-10754	59	48	2	2	NUM
aiua-10754	59	49	(	(	PUNCT
aiua-10754	59	50	4.5	4.5	NUM
aiua-10754	59	51	%	%	NOUN
aiua-10754	59	52	)	)	PUNCT
aiua-10754	60	1	vs.	vs.	ADP
aiua-10754	60	2	8	8	NUM
aiua-10754	60	3	(	(	PUNCT
aiua-10754	60	4	18.1	18.1	NUM
aiua-10754	60	5	%	%	NOUN
aiua-10754	60	6	)	)	PUNCT
aiua-10754	60	7	vs.	vs.	ADP
aiua-10754	60	8	14	14	NUM
aiua-10754	60	9	(	(	PUNCT
aiua-10754	60	10	31.8	31.8	NUM
aiua-10754	60	11	%	%	NOUN
aiua-10754	60	12	)	)	PUNCT
aiua-10754	60	13	cspca	cspca	PROPN
aiua-10754	60	14	,	,	PUNCT
aiua-10754	60	15	respectively	respectively	ADV
aiua-10754	60	16	.	.	PUNCT
aiua-10754	61	1	although	although	SCONJ
aiua-10754	61	2	prospective	prospective	ADJ
aiua-10754	61	3	and	and	CCONJ
aiua-10754	61	4	randomized	randomized	ADJ
aiua-10754	61	5	studies	study	NOUN
aiua-10754	61	6	are	be	AUX
aiua-10754	61	7	awaited	await	VERB
aiua-10754	61	8	,	,	PUNCT
aiua-10754	61	9	including	include	VERB
aiua-10754	61	10	a	a	DET
aiua-10754	61	11	greater	great	ADJ
aiua-10754	61	12	number	number	NOUN
aiua-10754	61	13	of	of	ADP
aiua-10754	61	14	patients	patient	NOUN
aiua-10754	61	15	,	,	PUNCT
aiua-10754	61	16	68ga	68ga	ADJ
aiua-10754	61	17	-	-	PUNCT
aiua-10754	61	18	psma	psma	NOUN
aiua-10754	61	19	pet	pet	NOUN
aiua-10754	61	20	/	/	SYM
aiua-10754	61	21	ct	ct	PROPN
aiua-10754	61	22	evaluation	evaluation	NOUN
aiua-10754	61	23	could	could	AUX
aiua-10754	61	24	be	be	AUX
aiua-10754	61	25	proposed	propose	VERB
aiua-10754	61	26	in	in	ADP
aiua-10754	61	27	men	man	NOUN
aiua-10754	61	28	with	with	ADP
aiua-10754	61	29	negative	negative	ADJ
aiua-10754	61	30	mpmri	mpmri	PROPN
aiua-10754	61	31	or	or	CCONJ
aiua-10754	61	32	in	in	ADP
aiua-10754	61	33	the	the	DET
aiua-10754	61	34	presence	presence	NOUN
aiua-10754	61	35	of	of	ADP
aiua-10754	61	36	claustrophobia	claustrophobia	NOUN
aiua-10754	61	37	,	,	PUNCT
aiua-10754	61	38	cardiac	cardiac	ADJ
aiua-10754	61	39	pacemaker	pacemaker	NOUN
aiua-10754	61	40	and	and	CCONJ
aiua-10754	61	41	severe	severe	ADJ
aiua-10754	61	42	obesity	obesity	NOUN
aiua-10754	61	43	.	.	PUNCT
aiua-10754	62	1	our	our	PRON
aiua-10754	62	2	study	study	NOUN
aiua-10754	62	3	has	have	VERB
aiua-10754	62	4	some	some	DET
aiua-10754	62	5	limitations	limitation	NOUN
aiua-10754	62	6	.	.	PUNCT
aiua-10754	63	1	first	first	ADV
aiua-10754	63	2	,	,	PUNCT
aiua-10754	63	3	the	the	DET
aiua-10754	63	4	number	number	NOUN
aiua-10754	63	5	of	of	ADP
aiua-10754	63	6	patients	patient	NOUN
aiua-10754	63	7	evaluated	evaluate	VERB
aiua-10754	63	8	was	be	AUX
aiua-10754	63	9	low	low	ADJ
aiua-10754	63	10	.	.	PUNCT
aiua-10754	64	1	second	second	ADJ
aiua-10754	64	2	,	,	PUNCT
aiua-10754	64	3	the	the	DET
aiua-10754	64	4	results	result	NOUN
aiua-10754	64	5	should	should	AUX
aiua-10754	64	6	be	be	AUX
aiua-10754	64	7	evaluated	evaluate	VERB
aiua-10754	64	8	in	in	ADP
aiua-10754	64	9	the	the	DET
aiua-10754	64	10	entire	entire	ADJ
aiua-10754	64	11	prostate	prostate	NOUN
aiua-10754	64	12	specimen	speciman	NOUN
aiua-10754	64	13	and	and	CCONJ
aiua-10754	64	14	not	not	PART
aiua-10754	64	15	in	in	ADP
aiua-10754	64	16	biopsy	biopsy	NOUN
aiua-10754	64	17	histology	histology	NOUN
aiua-10754	64	18	.	.	PUNCT
aiua-10754	65	1	finally	finally	ADV
aiua-10754	65	2	,	,	PUNCT
aiua-10754	65	3	a	a	DET
aiua-10754	65	4	68ga	68ga	ADJ
aiua-10754	65	5	-	-	PUNCT
aiua-10754	65	6	psma	psma	NOUN
aiua-10754	65	7	pet	pet	NOUN
aiua-10754	65	8	/	/	SYM
aiua-10754	65	9	tc	tc	NOUN
aiua-10754	65	10	fusion	fusion	NOUN
aiua-10754	65	11	platform	platform	NOUN
aiua-10754	65	12	would	would	AUX
aiua-10754	65	13	increase	increase	VERB
aiua-10754	65	14	the	the	DET
aiua-10754	65	15	accuracy	accuracy	NOUN
aiua-10754	65	16	of	of	ADP
aiua-10754	65	17	targeted	target	VERB
aiua-10754	65	18	prostate	prostate	NOUN
aiua-10754	65	19	biopsy	biopsy	NOUN
aiua-10754	65	20	.	.	PUNCT
aiua-10754	66	1	conclusions	conclusion	NOUN
aiua-10754	66	2	68gapsma	68gapsma	PROPN
aiua-10754	67	1	pet	pet	PROPN
aiua-10754	67	2	/	/	SYM
aiua-10754	67	3	ct	ct	PROPN
aiua-10754	67	4	tpbx	tpbx	PROPN
aiua-10754	67	5	demonstrated	demonstrate	VERB
aiua-10754	67	6	good	good	ADJ
aiua-10754	67	7	accuracy	accuracy	NOUN
aiua-10754	67	8	in	in	ADP
aiua-10754	67	9	the	the	DET
aiua-10754	67	10	diagnosis	diagnosis	NOUN
aiua-10754	67	11	of	of	ADP
aiua-10754	67	12	cspca	cspca	NOUN
aiua-10754	67	13	,	,	PUNCT
aiua-10754	67	14	which	which	PRON
aiua-10754	67	15	was	be	AUX
aiua-10754	67	16	not	not	PART
aiua-10754	67	17	inferior	inferior	ADJ
aiua-10754	67	18	to	to	AUX
aiua-10754	67	19	mpmri	mpmri	PROPN
aiua-10754	67	20	tpbx	tpbx	PROPN
aiua-10754	67	21	(	(	PUNCT
aiua-10754	67	22	76.9	76.9	NUM
aiua-10754	67	23	%	%	NOUN
aiua-10754	67	24	vs.	vs.	ADP
aiua-10754	67	25	84.9	84.9	NUM
aiua-10754	67	26	%	%	NOUN
aiua-10754	67	27	)	)	PUNCT
aiua-10754	67	28	improving	improve	VERB
aiua-10754	67	29	the	the	DET
aiua-10754	67	30	detection	detection	NOUN
aiua-10754	67	31	rate	rate	NOUN
aiua-10754	67	32	for	for	ADP
aiua-10754	67	33	cancer	cancer	NOUN
aiua-10754	67	34	of	of	ADP
aiua-10754	67	35	systematic	systematic	ADJ
aiua-10754	67	36	biopsy	biopsy	NOUN
aiua-10754	67	37	.	.	PUNCT
aiua-10754	68	1	authors	author	NOUN
aiua-10754	68	2	’	'	PUNCT
aiua-10754	68	3	contributions	contribution	NOUN
aiua-10754	68	4	the	the	DET
aiua-10754	68	5	authors	author	NOUN
aiua-10754	68	6	contributed	contribute	VERB
aiua-10754	68	7	equally	equally	ADV
aiua-10754	68	8	to	to	ADP
aiua-10754	68	9	all	all	DET
aiua-10754	68	10	aspects	aspect	NOUN
aiua-10754	68	11	of	of	ADP
aiua-10754	68	12	this	this	DET
aiua-10754	68	13	study	study	NOUN
aiua-10754	68	14	.	.	PUNCT
aiua-10754	69	1	references	reference	NOUN
aiua-10754	69	2	1	1	NUM
aiua-10754	69	3	.	.	PUNCT
aiua-10754	69	4	panebianco	panebianco	PROPN
aiua-10754	69	5	v	v	NOUN
aiua-10754	69	6	,	,	PUNCT
aiua-10754	69	7	barchetti	barchetti	NOUN
aiua-10754	69	8	g	g	NOUN
aiua-10754	69	9	,	,	PUNCT
aiua-10754	69	10	simone	simone	NOUN
aiua-10754	69	11	g	g	NOUN
aiua-10754	69	12	,	,	PUNCT
aiua-10754	69	13	et	et	PROPN
aiua-10754	69	14	al	al	PROPN
aiua-10754	69	15	.	.	PROPN
aiua-10754	70	1	negative	negative	ADJ
aiua-10754	70	2	multiparametric	multiparametric	ADJ
aiua-10754	70	3	magnetic	magnetic	ADJ
aiua-10754	70	4	resonance	resonance	NOUN
aiua-10754	70	5	imaging	imaging	NOUN
aiua-10754	70	6	for	for	ADP
aiua-10754	70	7	prostate	prostate	NOUN
aiua-10754	70	8	cancer	cancer	NOUN
aiua-10754	70	9	:	:	PUNCT
aiua-10754	70	10	what	what	PRON
aiua-10754	70	11	’s	’	VERB
aiua-10754	70	12	next	next	ADJ
aiua-10754	70	13	?	?	PUNCT
aiua-10754	71	1	eur	eur	PROPN
aiua-10754	71	2	urol	urol	NOUN
aiua-10754	71	3	.	.	PUNCT
aiua-10754	71	4	2018	2018	NUM
aiua-10754	71	5	;	;	PUNCT
aiua-10754	71	6	74	74	NUM
aiua-10754	71	7	:	:	SYM
aiua-10754	71	8	48	48	NUM
aiua-10754	71	9	-	-	SYM
aiua-10754	71	10	54	54	NUM
aiua-10754	71	11	.	.	PUNCT
aiua-10754	72	1	2	2	X
aiua-10754	72	2	.	.	X
aiua-10754	72	3	pepe	pepe	PROPN
aiua-10754	72	4	p	p	PROPN
aiua-10754	72	5	,	,	PUNCT
aiua-10754	72	6	pepe	pepe	PROPN
aiua-10754	72	7	l	l	PROPN
aiua-10754	72	8	,	,	PUNCT
aiua-10754	72	9	cosentino	cosentino	PROPN
aiua-10754	72	10	s	s	PROPN
aiua-10754	72	11	,	,	PUNCT
aiua-10754	72	12	et	et	PROPN
aiua-10754	72	13	al	al	PROPN
aiua-10754	72	14	.	.	PUNCT
aiua-10754	72	15	detection	detection	NOUN
aiua-10754	72	16	rate	rate	NOUN
aiua-10754	72	17	of	of	ADP
aiua-10754	72	18	68ga	68ga	ADJ
aiua-10754	72	19	-	-	PUNCT
aiua-10754	72	20	psma	psma	NOUN
aiua-10754	72	21	pet	pet	NOUN
aiua-10754	72	22	/	/	SYM
aiua-10754	72	23	ct	ct	PROPN
aiua-10754	72	24	vs.	vs.	X
aiua-10754	72	25	mpmri	mpmri	PROPN
aiua-10754	72	26	targeted	target	VERB
aiua-10754	72	27	biopsy	biopsy	NOUN
aiua-10754	72	28	for	for	ADP
aiua-10754	72	29	clinically	clinically	ADV
aiua-10754	72	30	significant	significant	ADJ
aiua-10754	72	31	prostate	prostate	NOUN
aiua-10754	72	32	cancer	cancer	NOUN
aiua-10754	72	33	.	.	PUNCT
aiua-10754	73	1	anticancer	anticancer	NOUN
aiua-10754	73	2	research	research	NOUN
aiua-10754	73	3	.	.	PUNCT
aiua-10754	74	1	2022	2022	NUM
aiua-10754	74	2	;	;	PUNCT
aiua-10754	74	3	42:3011	42:3011	X
aiua-10754	74	4	-	-	SYM
aiua-10754	74	5	3015	3015	NUM
aiua-10754	74	6	.	.	PUNCT
aiua-10754	75	1	3	3	X
aiua-10754	75	2	.	.	X
aiua-10754	75	3	sheikhbahaei	sheikhbahaei	PROPN
aiua-10754	75	4	s	s	PROPN
aiua-10754	75	5	,	,	PUNCT
aiua-10754	75	6	afshar	afshar	ADJ
aiua-10754	75	7	-	-	PUNCT
aiua-10754	75	8	oromieh	oromieh	NOUN
aiua-10754	75	9	a	a	PRON
aiua-10754	75	10	,	,	PUNCT
aiua-10754	75	11	eiber	eiber	NOUN
aiua-10754	75	12	m	m	PROPN
aiua-10754	75	13	,	,	PUNCT
aiua-10754	75	14	et	et	PROPN
aiua-10754	75	15	al	al	PROPN
aiua-10754	75	16	.	.	PUNCT
aiua-10754	75	17	pearls	pearl	NOUN
aiua-10754	75	18	and	and	CCONJ
aiua-10754	75	19	pitfalls	pitfall	NOUN
aiua-10754	75	20	in	in	ADP
aiua-10754	75	21	clinical	clinical	ADJ
aiua-10754	75	22	interpretation	interpretation	NOUN
aiua-10754	75	23	of	of	ADP
aiua-10754	75	24	prostate	prostate	NOUN
aiua-10754	75	25	-	-	PUNCT
aiua-10754	75	26	specific	specific	ADJ
aiua-10754	75	27	membrane	membrane	NOUN
aiua-10754	75	28	antigen	antigen	NOUN
aiua-10754	75	29	(	(	PUNCT
aiua-10754	75	30	psma)-targeted	psma)-targete	VERB
aiua-10754	75	31	pet	pet	ADJ
aiua-10754	75	32	imaging	imaging	NOUN
aiua-10754	75	33	.	.	PUNCT
aiua-10754	76	1	eur	eur	PROPN
aiua-10754	76	2	j	j	PROPN
aiua-10754	76	3	nucl	nucl	PROPN
aiua-10754	76	4	med	me	VERB
aiua-10754	76	5	mol	mol	ADP
aiua-10754	76	6	imaging	imaging	PROPN
aiua-10754	76	7	2017	2017	NUM
aiua-10754	76	8	;	;	PUNCT
aiua-10754	76	9	44:2117	44:2117	NUM
aiua-10754	76	10	-	-	SYM
aiua-10754	76	11	2136	2136	NUM
aiua-10754	76	12	.	.	PUNCT
aiua-10754	77	1	4	4	X
aiua-10754	77	2	.	.	X
aiua-10754	77	3	pepe	pepe	PROPN
aiua-10754	77	4	p	p	PROPN
aiua-10754	77	5	,	,	PUNCT
aiua-10754	77	6	roscigno	roscigno	PROPN
aiua-10754	77	7	m	m	PROPN
aiua-10754	77	8	,	,	PUNCT
aiua-10754	77	9	pepe	pepe	PROPN
aiua-10754	77	10	l	l	PROPN
aiua-10754	77	11	,	,	PUNCT
aiua-10754	77	12	et	et	PROPN
aiua-10754	77	13	al	al	PROPN
aiua-10754	77	14	.	.	PROPN
aiua-10754	77	15	could	could	AUX
aiua-10754	77	16	68ga	68ga	ADV
aiua-10754	77	17	-	-	PUNCT
aiua-10754	77	18	psma	psma	NOUN
aiua-10754	77	19	pet	pet	NOUN
aiua-10754	77	20	/	/	SYM
aiua-10754	77	21	ct	ct	PROPN
aiua-10754	77	22	evaluation	evaluation	NOUN
aiua-10754	77	23	reduce	reduce	VERB
aiua-10754	77	24	the	the	DET
aiua-10754	77	25	number	number	NOUN
aiua-10754	77	26	of	of	ADP
aiua-10754	77	27	scheduled	schedule	VERB
aiua-10754	77	28	prostate	prostate	NOUN
aiua-10754	77	29	biopsy	biopsy	NOUN
aiua-10754	77	30	in	in	ADP
aiua-10754	77	31	men	man	NOUN
aiua-10754	77	32	enrolled	enrol	VERB
aiua-10754	77	33	in	in	ADP
aiua-10754	77	34	active	active	ADJ
aiua-10754	77	35	surveillance	surveillance	NOUN
aiua-10754	77	36	protocols	protocol	NOUN
aiua-10754	77	37	?	?	PUNCT
aiua-10754	78	1	j	j	PROPN
aiua-10754	78	2	clin	clin	PROPN
aiua-10754	78	3	med	med	PROPN
aiua-10754	78	4	.	.	PUNCT
aiua-10754	78	5	2022	2022	NUM
aiua-10754	78	6	;	;	PUNCT
aiua-10754	78	7	11:3473	11:3473	NUM
aiua-10754	78	8	.	.	NOUN
aiua-10754	79	1	5	5	NUM
aiua-10754	79	2	.	.	X
aiua-10754	79	3	perera	perera	PROPN
aiua-10754	79	4	m	m	PROPN
aiua-10754	79	5	,	,	PUNCT
aiua-10754	79	6	papa	papa	PROPN
aiua-10754	79	7	n	n	CCONJ
aiua-10754	79	8	,	,	PUNCT
aiua-10754	79	9	roberts	roberts	PROPN
aiua-10754	79	10	m	m	PROPN
aiua-10754	79	11	,	,	PUNCT
aiua-10754	79	12	et	et	PROPN
aiua-10754	79	13	al	al	PROPN
aiua-10754	79	14	.	.	PUNCT
aiua-10754	79	15	gallium-68	gallium-68	PROPN
aiua-10754	79	16	prostate	prostate	NOUN
aiua-10754	79	17	-	-	PUNCT
aiua-10754	79	18	specific	specific	ADJ
aiua-10754	79	19	membrane	membrane	NOUN
aiua-10754	79	20	antigen	antigen	NOUN
aiua-10754	79	21	positron	positron	NOUN
aiua-10754	79	22	emission	emission	NOUN
aiua-10754	79	23	tomography	tomography	NOUN
aiua-10754	79	24	in	in	ADP
aiua-10754	79	25	advanced	advanced	ADJ
aiua-10754	79	26	prostate	prostate	NOUN
aiua-10754	79	27	cancer	cancer	NOUN
aiua-10754	79	28	-	-	PUNCT
aiua-10754	79	29	updated	update	VERB
aiua-10754	79	30	diagnostic	diagnostic	ADJ
aiua-10754	79	31	utility	utility	NOUN
aiua-10754	79	32	,	,	PUNCT
aiua-10754	79	33	sensitivity	sensitivity	NOUN
aiua-10754	79	34	,	,	PUNCT
aiua-10754	79	35	specificity	specificity	NOUN
aiua-10754	79	36	,	,	PUNCT
aiua-10754	79	37	and	and	CCONJ
aiua-10754	79	38	distribution	distribution	NOUN
aiua-10754	79	39	of	of	ADP
aiua-10754	79	40	prostate	prostate	NOUN
aiua-10754	79	41	-	-	PUNCT
aiua-10754	79	42	specific	specific	ADJ
aiua-10754	79	43	membrane	membrane	NOUN
aiua-10754	79	44	antigen	antigen	NOUN
aiua-10754	79	45	-	-	PUNCT
aiua-10754	79	46	avid	avid	NOUN
aiua-10754	79	47	lesions	lesion	NOUN
aiua-10754	79	48	:	:	PUNCT
aiua-10754	79	49	a	a	DET
aiua-10754	79	50	systematic	systematic	ADJ
aiua-10754	79	51	review	review	NOUN
aiua-10754	79	52	and	and	CCONJ
aiua-10754	79	53	meta	meta	ADJ
aiua-10754	79	54	-	-	PUNCT
aiua-10754	79	55	analysis	analysis	NOUN
aiua-10754	79	56	.	.	PUNCT
aiua-10754	80	1	eur	eur	PROPN
aiua-10754	80	2	urol	urol	PROPN
aiua-10754	80	3	.	.	PUNCT
aiua-10754	81	1	2020	2020	NUM
aiua-10754	81	2	;	;	PUNCT
aiua-10754	81	3	77:403	77:403	NUM
aiua-10754	81	4	-	-	SYM
aiua-10754	81	5	417	417	NUM
aiua-10754	81	6	.	.	NOUN
aiua-10754	82	1	6	6	NUM
aiua-10754	82	2	.	.	X
aiua-10754	82	3	privé	privé	PROPN
aiua-10754	82	4	bm	bm	PROPN
aiua-10754	82	5	,	,	PUNCT
aiua-10754	82	6	israël	israël	NOUN
aiua-10754	82	7	b	b	PROPN
aiua-10754	82	8	,	,	PUNCT
aiua-10754	82	9	schilham	schilham	PROPN
aiua-10754	82	10	mgm	mgm	PROPN
aiua-10754	82	11	,	,	PUNCT
aiua-10754	82	12	et	et	PROPN
aiua-10754	82	13	al	al	PROPN
aiua-10754	82	14	.	.	PUNCT
aiua-10754	82	15	evaluating	evaluate	VERB
aiua-10754	82	16	f-18psma-1007	f-18psma-1007	NOUN
aiua-10754	82	17	-	-	PUNCT
aiua-10754	82	18	pet	pet	NOUN
aiua-10754	82	19	in	in	ADP
aiua-10754	82	20	primary	primary	ADJ
aiua-10754	82	21	prostate	prostate	NOUN
aiua-10754	82	22	cancer	cancer	NOUN
aiua-10754	82	23	and	and	CCONJ
aiua-10754	82	24	comparing	compare	VERB
aiua-10754	82	25	it	it	PRON
aiua-10754	82	26	to	to	ADP
aiua-10754	82	27	multi	multi	ADJ
aiua-10754	82	28	-	-	ADJ
aiua-10754	82	29	parametric	parametric	ADJ
aiua-10754	82	30	mri	mri	NOUN
aiua-10754	82	31	and	and	CCONJ
aiua-10754	82	32	histopathology	histopathology	NOUN
aiua-10754	82	33	.	.	PUNCT
aiua-10754	83	1	prostate	prostate	NOUN
aiua-10754	83	2	cancer	cancer	NOUN
aiua-10754	83	3	prostatic	prostatic	PROPN
aiua-10754	83	4	dis	dis	PROPN
aiua-10754	83	5	.	.	PUNCT
aiua-10754	83	6	2021	2021	NUM
aiua-10754	83	7	;	;	PUNCT
aiua-10754	83	8	24:423	24:423	NUM
aiua-10754	83	9	-	-	SYM
aiua-10754	83	10	430	430	NUM
aiua-10754	83	11	.	.	PUNCT
aiua-10754	84	1	7	7	X
aiua-10754	84	2	.	.	X
aiua-10754	84	3	uprimny	uprimny	PROPN
aiua-10754	84	4	c	c	PROPN
aiua-10754	84	5	,	,	PUNCT
aiua-10754	84	6	kroiss	kroiss	VERB
aiua-10754	84	7	as	as	ADP
aiua-10754	84	8	,	,	PUNCT
aiua-10754	84	9	decristoforo	decristoforo	PROPN
aiua-10754	84	10	c	c	AUX
aiua-10754	84	11	,	,	PUNCT
aiua-10754	84	12	et	et	PROPN
aiua-10754	84	13	al	al	PROPN
aiua-10754	84	14	.	.	PUNCT
aiua-10754	85	1	68ga	68ga	ADJ
aiua-10754	85	2	-	-	PUNCT
aiua-10754	85	3	psma-11	psma-11	NOUN
aiua-10754	85	4	pet/	pet/	NOUN
aiua-10754	85	5	ct	ct	NUM
aiua-10754	85	6	in	in	ADP
aiua-10754	85	7	primary	primary	ADJ
aiua-10754	85	8	staging	staging	NOUN
aiua-10754	85	9	of	of	ADP
aiua-10754	85	10	prostate	prostate	NOUN
aiua-10754	85	11	cancer	cancer	NOUN
aiua-10754	85	12	:	:	PUNCT
aiua-10754	85	13	psa	psa	VERB
aiua-10754	85	14	and	and	CCONJ
aiua-10754	85	15	gleason	gleason	PROPN
aiua-10754	85	16	score	score	NOUN
aiua-10754	85	17	predict	predict	VERB
aiua-10754	85	18	the	the	DET
aiua-10754	85	19	intensity	intensity	NOUN
aiua-10754	85	20	of	of	ADP
aiua-10754	85	21	tracer	tracer	NOUN
aiua-10754	85	22	accumulation	accumulation	NOUN
aiua-10754	85	23	in	in	ADP
aiua-10754	85	24	the	the	DET
aiua-10754	85	25	primary	primary	ADJ
aiua-10754	85	26	tumour	tumour	NOUN
aiua-10754	85	27	.	.	PUNCT
aiua-10754	86	1	eur	eur	PROPN
aiua-10754	86	2	j	j	PROPN
aiua-10754	86	3	nucl	nucl	PROPN
aiua-10754	86	4	mol	mol	ADP
aiua-10754	86	5	imaging	imaging	PROPN
aiua-10754	86	6	.	.	PUNCT
aiua-10754	87	1	2017	2017	NUM
aiua-10754	87	2	;	;	PUNCT
aiua-10754	87	3	44:941	44:941	NUM
aiua-10754	87	4	-	-	SYM
aiua-10754	87	5	49	49	NUM
aiua-10754	87	6	.	.	PUNCT
aiua-10754	88	1	8	8	NUM
aiua-10754	88	2	.	.	PUNCT
aiua-10754	89	1	emmett	emmett	PROPN
aiua-10754	89	2	l	l	PROPN
aiua-10754	89	3	,	,	PUNCT
aiua-10754	89	4	buteau	buteau	PROPN
aiua-10754	89	5	j	j	PROPN
aiua-10754	89	6	,	,	PUNCT
aiua-10754	89	7	papa	papa	PROPN
aiua-10754	89	8	n	n	CCONJ
aiua-10754	89	9	,	,	PUNCT
aiua-10754	89	10	et	et	PROPN
aiua-10754	89	11	al	al	PROPN
aiua-10754	89	12	.	.	PUNCT
aiua-10754	90	1	the	the	DET
aiua-10754	90	2	additive	additive	ADJ
aiua-10754	90	3	diagnostic	diagnostic	ADJ
aiua-10754	90	4	value	value	NOUN
aiua-10754	90	5	of	of	ADP
aiua-10754	90	6	prostate	prostate	NOUN
aiua-10754	90	7	-	-	PUNCT
aiua-10754	90	8	specific	specific	ADJ
aiua-10754	90	9	membrane	membrane	NOUN
aiua-10754	90	10	antigen	antigen	NOUN
aiua-10754	90	11	positron	positron	NOUN
aiua-10754	90	12	emission	emission	NOUN
aiua-10754	90	13	tomography	tomography	NOUN
aiua-10754	90	14	computed	compute	VERB
aiua-10754	90	15	tomography	tomography	NOUN
aiua-10754	90	16	to	to	ADP
aiua-10754	90	17	multiparametric	multiparametric	ADJ
aiua-10754	90	18	magnetic	magnetic	ADJ
aiua-10754	90	19	resonance	resonance	NOUN
aiua-10754	90	20	imaging	imaging	NOUN
aiua-10754	90	21	triage	triage	NOUN
aiua-10754	90	22	in	in	ADP
aiua-10754	90	23	the	the	DET
aiua-10754	90	24	diagnosis	diagnosis	NOUN
aiua-10754	90	25	of	of	ADP
aiua-10754	90	26	prostate	prostate	NOUN
aiua-10754	90	27	cancer	cancer	NOUN
aiua-10754	90	28	(	(	PUNCT
aiua-10754	90	29	primary	primary	NOUN
aiua-10754	90	30	):	):	PUNCT
aiua-10754	90	31	a	a	DET
aiua-10754	90	32	prospective	prospective	ADJ
aiua-10754	90	33	multicentre	multicentre	NOUN
aiua-10754	90	34	study	study	NOUN
aiua-10754	90	35	.	.	PUNCT
aiua-10754	91	1	eur	eur	PROPN
aiua-10754	91	2	urol	urol	PROPN
aiua-10754	91	3	.	.	PUNCT
aiua-10754	91	4	2021	2021	NUM
aiua-10754	91	5	;	;	PUNCT
aiua-10754	91	6	80:682	80:682	NUM
aiua-10754	91	7	-	-	SYM
aiua-10754	91	8	689	689	NUM
aiua-10754	91	9	.	.	PUNCT
aiua-10754	92	1	9	9	X
aiua-10754	92	2	.	.	X
aiua-10754	92	3	eiber	eiber	PROPN
aiua-10754	92	4	m	m	PROPN
aiua-10754	92	5	,	,	PUNCT
aiua-10754	92	6	weirich	weirich	PRON
aiua-10754	92	7	g	g	NOUN
aiua-10754	92	8	,	,	PUNCT
aiua-10754	92	9	holzapfel	holzapfel	NOUN
aiua-10754	93	1	k	k	NOUN
aiua-10754	93	2	,	,	PUNCT
aiua-10754	93	3	et	et	PROPN
aiua-10754	93	4	al	al	PROPN
aiua-10754	93	5	.	.	PUNCT
aiua-10754	94	1	simultaneous	simultaneous	PROPN
aiua-10754	94	2	68gapsma	68gapsma	PROPN
aiua-10754	94	3	hbed	hbed	NOUN
aiua-10754	94	4	-	-	PUNCT
aiua-10754	94	5	cc	cc	NOUN
aiua-10754	94	6	pet	pet	NOUN
aiua-10754	94	7	/	/	SYM
aiua-10754	94	8	mri	mri	NOUN
aiua-10754	94	9	improves	improve	VERB
aiua-10754	94	10	the	the	DET
aiua-10754	94	11	localization	localization	NOUN
aiua-10754	94	12	of	of	ADP
aiua-10754	94	13	primary	primary	ADJ
aiua-10754	94	14	prostate	prostate	NOUN
aiua-10754	94	15	cancer	cancer	NOUN
aiua-10754	94	16	.	.	PUNCT
aiua-10754	95	1	eur	eur	PROPN
aiua-10754	95	2	urol	urol	PROPN
aiua-10754	95	3	2016	2016	NUM
aiua-10754	95	4	;	;	PUNCT
aiua-10754	95	5	70	70	NUM
aiua-10754	95	6	:	:	PUNCT
aiua-10754	95	7	829	829	NUM
aiua-10754	95	8	-	-	SYM
aiua-10754	95	9	836	836	NUM
aiua-10754	95	10	.	.	PUNCT
aiua-10754	95	11	10	10	NUM
aiua-10754	95	12	.	.	PUNCT
aiua-10754	96	1	pepe	pepe	PROPN
aiua-10754	96	2	p	p	PROPN
aiua-10754	96	3	,	,	PUNCT
aiua-10754	96	4	pennisi	pennisi	VERB
aiua-10754	96	5	m	m	PRON
aiua-10754	96	6	:	:	PUNCT
aiua-10754	96	7	should	should	AUX
aiua-10754	96	8	68ga	68ga	ADJ
aiua-10754	96	9	-	-	PUNCT
aiua-10754	96	10	psma	psma	NOUN
aiua-10754	96	11	pet	pet	NOUN
aiua-10754	96	12	/	/	SYM
aiua-10754	96	13	ct	ct	PROPN
aiua-10754	96	14	replace	replace	NOUN
aiua-10754	96	15	ct	ct	NOUN
aiua-10754	96	16	and	and	CCONJ
aiua-10754	96	17	bone	bone	NOUN
aiua-10754	96	18	scan	scan	NOUN
aiua-10754	96	19	in	in	ADP
aiua-10754	96	20	clinical	clinical	ADJ
aiua-10754	96	21	staging	staging	NOUN
aiua-10754	96	22	of	of	ADP
aiua-10754	96	23	high	high	ADJ
aiua-10754	96	24	-	-	PUNCT
aiua-10754	96	25	risk	risk	NOUN
aiua-10754	96	26	prostate	prostate	NOUN
aiua-10754	96	27	cancer	cancer	NOUN
aiua-10754	96	28	?	?	PUNCT
aiua-10754	97	1	anticancer	anticancer	NOUN
aiua-10754	97	2	research	research	NOUN
aiua-10754	97	3	.	.	PUNCT
aiua-10754	98	1	2022	2022	NUM
aiua-10754	98	2	;	;	PUNCT
aiua-10754	98	3	42:1495	42:1495	NUM
aiua-10754	98	4	-	-	SYM
aiua-10754	98	5	1498	1498	NUM
aiua-10754	98	6	.	.	PUNCT
aiua-10754	99	1	11	11	NUM
aiua-10754	99	2	.	.	PUNCT
aiua-10754	100	1	carvalho	carvalho	PROPN
aiua-10754	100	2	j	j	PROPN
aiua-10754	100	3	,	,	PUNCT
aiua-10754	100	4	nunes	nunes	PROPN
aiua-10754	100	5	p	p	X
aiua-10754	100	6	,	,	PUNCT
aiua-10754	100	7	da	da	PROPN
aiua-10754	100	8	silva	silva	PROPN
aiua-10754	100	9	et	et	PROPN
aiua-10754	100	10	,	,	PUNCT
aiua-10754	100	11	et	et	PROPN
aiua-10754	100	12	al	al	PROPN
aiua-10754	100	13	.	.	PUNCT
aiua-10754	101	1	[	[	X
aiua-10754	101	2	68ga	68ga	NOUN
aiua-10754	101	3	]	]	X
aiua-10754	101	4	ga	ga	PROPN
aiua-10754	101	5	-	-	PUNCT
aiua-10754	101	6	psma-11	psma-11	NOUN
aiua-10754	101	7	pet	pet	NOUN
aiua-10754	101	8	-	-	PUNCT
aiua-10754	101	9	ct	ct	NOUN
aiua-10754	101	10	:	:	PUNCT
aiua-10754	101	11	local	local	ADJ
aiua-10754	101	12	preliminary	preliminary	ADJ
aiua-10754	101	13	experience	experience	NOUN
aiua-10754	101	14	in	in	ADP
aiua-10754	101	15	prostate	prostate	NOUN
aiua-10754	101	16	cancer	cancer	NOUN
aiua-10754	101	17	biochemical	biochemical	ADJ
aiua-10754	101	18	recurrence	recurrence	NOUN
aiua-10754	101	19	patients	patient	NOUN
aiua-10754	101	20	.	.	PUNCT
aiua-10754	102	1	arch	arch	ADJ
aiua-10754	102	2	ital	ital	PROPN
aiua-10754	102	3	urol	urol	PROPN
aiua-10754	102	4	androl	androl	PROPN
aiua-10754	102	5	.	.	PROPN
aiua-10754	102	6	2021	2021	NUM
aiua-10754	102	7	;	;	PUNCT
aiua-10754	102	8	93:21	93:21	NUM
aiua-10754	102	9	-	-	SYM
aiua-10754	102	10	25	25	NUM
aiua-10754	102	11	.	.	NOUN
aiua-10754	102	12	12	12	NUM
aiua-10754	102	13	.	.	PUNCT
aiua-10754	103	1	epstein	epstein	PROPN
aiua-10754	103	2	ji	ji	PROPN
aiua-10754	103	3	,	,	PUNCT
aiua-10754	103	4	egevad	egevad	PROPN
aiua-10754	103	5	l	l	PROPN
aiua-10754	103	6	,	,	PUNCT
aiua-10754	103	7	amin	amin	NOUN
aiua-10754	103	8	mb	mb	PROPN
aiua-10754	103	9	,	,	PUNCT
aiua-10754	103	10	et	et	PROPN
aiua-10754	103	11	al	al	PROPN
aiua-10754	103	12	.	.	PUNCT
aiua-10754	103	13	grading	grade	VERB
aiua-10754	103	14	committee	committee	NOUN
aiua-10754	103	15	:	:	PUNCT
aiua-10754	103	16	the	the	DET
aiua-10754	103	17	2014	2014	NUM
aiua-10754	103	18	international	international	ADJ
aiua-10754	103	19	society	society	NOUN
aiua-10754	103	20	of	of	ADP
aiua-10754	103	21	urological	urological	ADJ
aiua-10754	103	22	pathology	pathology	NOUN
aiua-10754	103	23	(	(	PUNCT
aiua-10754	103	24	isup	isup	NOUN
aiua-10754	103	25	)	)	PUNCT
aiua-10754	103	26	consensus	consensus	NOUN
aiua-10754	103	27	conference	conference	NOUN
aiua-10754	103	28	on	on	ADP
aiua-10754	103	29	gleason	gleason	PROPN
aiua-10754	103	30	grading	grade	VERB
aiua-10754	103	31	of	of	ADP
aiua-10754	103	32	prostatic	prostatic	ADJ
aiua-10754	103	33	carcinoma	carcinoma	NOUN
aiua-10754	103	34	:	:	PUNCT
aiua-10754	103	35	definition	definition	NOUN
aiua-10754	103	36	of	of	ADP
aiua-10754	103	37	grading	grade	VERB
aiua-10754	103	38	patterns	pattern	NOUN
aiua-10754	103	39	and	and	CCONJ
aiua-10754	103	40	proposal	proposal	NOUN
aiua-10754	103	41	for	for	ADP
aiua-10754	103	42	a	a	DET
aiua-10754	103	43	new	new	ADJ
aiua-10754	103	44	grading	grade	VERB
aiua-10754	103	45	system	system	NOUN
aiua-10754	103	46	.	.	PUNCT
aiua-10754	103	47	am	be	AUX
aiua-10754	103	48	j	j	PROPN
aiua-10754	103	49	surg	surg	PROPN
aiua-10754	103	50	pathol	pathol	NOUN
aiua-10754	103	51	.	.	PUNCT
aiua-10754	104	1	2016	2016	NUM
aiua-10754	104	2	;	;	PUNCT
aiua-10754	104	3	40:244	40:244	NUM
aiua-10754	104	4	-	-	SYM
aiua-10754	104	5	252	252	NUM
aiua-10754	104	6	.	.	PUNCT
aiua-10754	105	1	13	13	NUM
aiua-10754	105	2	.	.	PUNCT
aiua-10754	106	1	aragona	aragona	PROPN
aiua-10754	106	2	f	f	PROPN
aiua-10754	106	3	,	,	PUNCT
aiua-10754	106	4	pepe	pepe	PROPN
aiua-10754	106	5	p	p	PROPN
aiua-10754	106	6	,	,	PUNCT
aiua-10754	106	7	motta	motta	PROPN
aiua-10754	106	8	m	m	PROPN
aiua-10754	106	9	,	,	PUNCT
aiua-10754	106	10	et	et	PROPN
aiua-10754	106	11	al	al	PROPN
aiua-10754	106	12	.	.	PROPN
aiua-10754	106	13	incidence	incidence	NOUN
aiua-10754	106	14	of	of	ADP
aiua-10754	106	15	prostate	prostate	NOUN
aiua-10754	106	16	cancer	cancer	NOUN
aiua-10754	106	17	in	in	ADP
aiua-10754	106	18	sicily	sicily	ADV
aiua-10754	106	19	:	:	PUNCT
aiua-10754	106	20	results	result	NOUN
aiua-10754	106	21	of	of	ADP
aiua-10754	106	22	a	a	DET
aiua-10754	106	23	multicenter	multicenter	ADJ
aiua-10754	106	24	case	case	NOUN
aiua-10754	106	25	-	-	PUNCT
aiua-10754	106	26	findings	finding	NOUN
aiua-10754	106	27	protocol	protocol	NOUN
aiua-10754	106	28	.	.	PUNCT
aiua-10754	107	1	eur	eur	PROPN
aiua-10754	107	2	urol	urol	PROPN
aiua-10754	107	3	.	.	PUNCT
aiua-10754	108	1	2005	2005	NUM
aiua-10754	108	2	;	;	PUNCT
aiua-10754	108	3	47:569	47:569	NUM
aiua-10754	108	4	-	-	SYM
aiua-10754	108	5	74	74	NUM
aiua-10754	108	6	.	.	PUNCT
aiua-10754	109	1	14	14	NUM
aiua-10754	109	2	.	.	PUNCT
aiua-10754	110	1	pepe	pepe	PROPN
aiua-10754	110	2	p	p	NOUN
aiua-10754	110	3	,	,	PUNCT
aiua-10754	110	4	panella	panella	NOUN
aiua-10754	110	5	p	p	NOUN
aiua-10754	110	6	,	,	PUNCT
aiua-10754	110	7	savoca	savoca	PROPN
aiua-10754	110	8	f	f	PROPN
aiua-10754	110	9	,	,	PUNCT
aiua-10754	110	10	et	et	PROPN
aiua-10754	110	11	al	al	PROPN
aiua-10754	110	12	.	.	PUNCT
aiua-10754	111	1	prevalence	prevalence	NOUN
aiua-10754	111	2	and	and	CCONJ
aiua-10754	111	3	clinical	clinical	ADJ
aiua-10754	111	4	significance	significance	NOUN
aiua-10754	111	5	of	of	ADP
aiua-10754	111	6	prostate	prostate	NOUN
aiua-10754	111	7	cancer	cancer	NOUN
aiua-10754	111	8	among	among	ADP
aiua-10754	111	9	12,682	12,682	NUM
aiua-10754	111	10	men	man	NOUN
aiua-10754	111	11	with	with	ADP
aiua-10754	111	12	normal	normal	ADJ
aiua-10754	111	13	dre	dre	NOUN
aiua-10754	111	14	,	,	PUNCT
aiua-10754	111	15	low	low	ADJ
aiua-10754	111	16	psa	psa	NOUN
aiua-10754	111	17	(	(	PUNCT
aiua-10754	111	18	≤	≤	NUM
aiua-10754	111	19	4	4	NUM
aiua-10754	111	20	ng	ng	NOUN
aiua-10754	111	21	/	/	SYM
aiua-10754	111	22	ml	ml	NOUN
aiua-10754	111	23	)	)	PUNCT
aiua-10754	111	24	and	and	CCONJ
aiua-10754	111	25	%	%	INTJ
aiua-10754	111	26	fpsa	fpsa	PROPN
aiua-10754	111	27	cut	cut	NOUN
aiua-10754	111	28	-	-	PUNCT
aiua-10754	111	29	off	off	NOUN
aiua-10754	111	30	of	of	ADP
aiua-10754	111	31	15	15	NUM
aiua-10754	111	32	%	%	NOUN
aiua-10754	111	33	and	and	CCONJ
aiua-10754	111	34	20	20	NUM
aiua-10754	111	35	%	%	NOUN
aiua-10754	111	36	.	.	PUNCT
aiua-10754	112	1	urologia	urologia	PROPN
aiua-10754	112	2	internationalis	internationalis	PROPN
aiua-10754	112	3	.	.	PUNCT
aiua-10754	113	1	2007	2007	NUM
aiua-10754	113	2	;	;	PUNCT
aiua-10754	113	3	78:308	78:308	NUM
aiua-10754	113	4	-	-	SYM
aiua-10754	113	5	312	312	NUM
aiua-10754	113	6	.	.	NOUN
aiua-10754	113	7	15	15	NUM
aiua-10754	113	8	.	.	PUNCT
aiua-10754	114	1	pepe	pepe	PROPN
aiua-10754	114	2	p	p	NOUN
aiua-10754	114	3	,	,	PUNCT
aiua-10754	114	4	garufi	garufi	ADJ
aiua-10754	114	5	a	a	PRON
aiua-10754	114	6	,	,	PUNCT
aiua-10754	114	7	priolo	priolo	ADJ
aiua-10754	114	8	gd	gd	NOUN
aiua-10754	114	9	,	,	PUNCT
aiua-10754	114	10	et	et	PROPN
aiua-10754	114	11	al	al	PROPN
aiua-10754	114	12	.	.	PROPN
aiua-10754	114	13	is	be	AUX
aiua-10754	114	14	it	it	PRON
aiua-10754	114	15	time	time	NOUN
aiua-10754	114	16	to	to	PART
aiua-10754	114	17	perform	perform	VERB
aiua-10754	114	18	only	only	ADV
aiua-10754	114	19	mri	mri	NOUN
aiua-10754	114	20	targeted	target	VERB
aiua-10754	114	21	biopsy	biopsy	NOUN
aiua-10754	114	22	?	?	PUNCT
aiua-10754	115	1	our	our	PRON
aiua-10754	115	2	experience	experience	NOUN
aiua-10754	115	3	in	in	ADP
aiua-10754	115	4	1032	1032	NUM
aiua-10754	115	5	men	man	NOUN
aiua-10754	115	6	submitted	submit	VERB
aiua-10754	115	7	to	to	ADP
aiua-10754	115	8	prostate	prostate	NOUN
aiua-10754	115	9	biopsy	biopsy	NOUN
aiua-10754	115	10	.	.	PUNCT
aiua-10754	116	1	j	j	PROPN
aiua-10754	116	2	urol	urol	PROPN
aiua-10754	116	3	.	.	PROPN
aiua-10754	116	4	2018	2018	NUM
aiua-10754	116	5	;	;	PUNCT
aiua-10754	116	6	200:774	200:774	NOUN
aiua-10754	116	7	-	-	PUNCT
aiua-10754	116	8	778	778	NUM
aiua-10754	116	9	.	.	PUNCT
aiua-10754	117	1	16	16	NUM
aiua-10754	117	2	.	.	PUNCT
aiua-10754	118	1	pepe	pepe	PROPN
aiua-10754	118	2	p	p	PROPN
aiua-10754	118	3	,	,	PUNCT
aiua-10754	118	4	pennisi	pennisi	VERB
aiua-10754	118	5	m	m	PROPN
aiua-10754	118	6	,	,	PUNCT
aiua-10754	118	7	fraggetta	fraggetta	PROPN
aiua-10754	118	8	f.	f.	PROPN
aiua-10754	119	1	how	how	SCONJ
aiua-10754	119	2	many	many	ADJ
aiua-10754	119	3	cores	core	NOUN
aiua-10754	119	4	should	should	AUX
aiua-10754	119	5	be	be	AUX
aiua-10754	119	6	obtained	obtain	VERB
aiua-10754	119	7	during	during	ADP
aiua-10754	119	8	saturation	saturation	NOUN
aiua-10754	119	9	biopsy	biopsy	NOUN
aiua-10754	119	10	in	in	ADP
aiua-10754	119	11	the	the	DET
aiua-10754	119	12	ra	ra	PROPN
aiua-10754	119	13	of	of	ADP
aiua-10754	119	14	multiparametric	multiparametric	PROPN
aiua-10754	119	15	magnetic	magnetic	ADJ
aiua-10754	119	16	resonance	resonance	NOUN
aiua-10754	119	17	?	?	PUNCT
aiua-10754	120	1	experience	experience	NOUN
aiua-10754	120	2	in	in	ADP
aiua-10754	120	3	875	875	NUM
aiua-10754	120	4	patients	patient	NOUN
aiua-10754	120	5	submitted	submit	VERB
aiua-10754	120	6	to	to	PART
aiua-10754	120	7	repeat	repeat	VERB
aiua-10754	120	8	prostate	prostate	NOUN
aiua-10754	120	9	biopsy	biopsy	NOUN
aiua-10754	120	10	.	.	PUNCT
aiua-10754	121	1	urology	urology	NOUN
aiua-10754	121	2	.	.	PUNCT
aiua-10754	122	1	2020	2020	NUM
aiua-10754	122	2	;	;	PUNCT
aiua-10754	123	1	137:133	137:133	X
aiua-10754	123	2	-	-	SYM
aiua-10754	123	3	137	137	NUM
aiua-10754	123	4	.	.	PUNCT
aiua-10754	124	1	17	17	NUM
aiua-10754	124	2	.	.	PUNCT
aiua-10754	125	1	pepe	pepe	PROPN
aiua-10754	125	2	p	p	PROPN
aiua-10754	125	3	,	,	PUNCT
aiua-10754	125	4	pennisi	pennisi	VERB
aiua-10754	125	5	m.	m.	NOUN
aiua-10754	125	6	prostate	prostate	NOUN
aiua-10754	125	7	cancer	cancer	NOUN
aiua-10754	125	8	diagnosis	diagnosis	NOUN
aiua-10754	125	9	and	and	CCONJ
aiua-10754	125	10	management	management	NOUN
aiua-10754	125	11	accross	accross	ADV
aiua-10754	125	12	twenty	twenty	NUM
aiua-10754	125	13	years	year	NOUN
aiua-10754	125	14	of	of	ADP
aiua-10754	125	15	clinical	clinical	ADJ
aiua-10754	125	16	practice	practice	NOUN
aiua-10754	125	17	:	:	PUNCT
aiua-10754	125	18	a	a	DET
aiua-10754	125	19	songle	songle	NOUN
aiua-10754	125	20	-	-	PUNCT
aiua-10754	125	21	center	center	NOUN
aiua-10754	125	22	experience	experience	NOUN
aiua-10754	125	23	on	on	ADP
aiua-10754	125	24	2,500	2,500	NUM
aiua-10754	125	25	cases	case	NOUN
aiua-10754	125	26	.	.	PUNCT
aiua-10754	126	1	anticancer	anticancer	NOUN
aiua-10754	126	2	res	re	NOUN
aiua-10754	126	3	.	.	PROPN
aiua-10754	126	4	2019	2019	NUM
aiua-10754	126	5	;	;	PUNCT
aiua-10754	126	6	39:1397	39:1397	NUM
aiua-10754	126	7	-	-	SYM
aiua-10754	126	8	1401	1401	NUM
aiua-10754	126	9	.	.	PUNCT
aiua-10754	127	1	18	18	NUM
aiua-10754	127	2	.	.	PUNCT
aiua-10754	128	1	moore	moore	PROPN
aiua-10754	128	2	cm	cm	PROPN
aiua-10754	128	3	,	,	PUNCT
aiua-10754	128	4	kasivisvanathan	kasivisvanathan	PRON
aiua-10754	128	5	v	v	NOUN
aiua-10754	128	6	,	,	PUNCT
aiua-10754	128	7	eggener	eggener	NOUN
aiua-10754	128	8	s	s	PROPN
aiua-10754	128	9	,	,	PUNCT
aiua-10754	128	10	et	et	PROPN
aiua-10754	128	11	al	al	PROPN
aiua-10754	128	12	.	.	PROPN
aiua-10754	128	13	,	,	PUNCT
aiua-10754	128	14	and	and	CCONJ
aiua-10754	128	15	start	start	VERB
aiua-10754	128	16	consortium	consortium	NOUN
aiua-10754	128	17	standards	standard	NOUN
aiua-10754	128	18	of	of	ADP
aiua-10754	128	19	reporting	report	VERB
aiua-10754	128	20	for	for	ADP
aiua-10754	128	21	mri	mri	NOUN
aiua-10754	128	22	-	-	PUNCT
aiua-10754	128	23	targeted	target	VERB
aiua-10754	128	24	biopsy	biopsy	NOUN
aiua-10754	128	25	studies	study	NOUN
aiua-10754	128	26	(	(	PUNCT
aiua-10754	128	27	start	start	NOUN
aiua-10754	128	28	)	)	PUNCT
aiua-10754	128	29	of	of	ADP
aiua-10754	128	30	the	the	DET
aiua-10754	128	31	prostate	prostate	NOUN
aiua-10754	128	32	:	:	PUNCT
aiua-10754	128	33	recommendations	recommendation	NOUN
aiua-10754	128	34	from	from	ADP
aiua-10754	128	35	an	an	DET
aiua-10754	128	36	international	international	ADJ
aiua-10754	128	37	working	working	NOUN
aiua-10754	128	38	group	group	NOUN
aiua-10754	128	39	.	.	PUNCT
aiua-10754	129	1	eur	eur	PROPN
aiua-10754	129	2	urol	urol	PROPN
aiua-10754	129	3	.	.	PUNCT
aiua-10754	130	1	2013	2013	NUM
aiua-10754	130	2	;	;	PUNCT
aiua-10754	130	3	64:544	64:544	NUM
aiua-10754	130	4	-	-	SYM
aiua-10754	130	5	552	552	NUM
aiua-10754	130	6	.	.	NOUN
aiua-10754	131	1	19	19	NUM
aiua-10754	131	2	.	.	PUNCT
aiua-10754	132	1	dindo	dindo	PROPN
aiua-10754	132	2	d	d	PROPN
aiua-10754	132	3	,	,	PUNCT
aiua-10754	132	4	demartines	demartine	NOUN
aiua-10754	132	5	n	n	CCONJ
aiua-10754	132	6	,	,	PUNCT
aiua-10754	132	7	clavien	clavien	PROPN
aiua-10754	132	8	pa	pa	PROPN
aiua-10754	132	9	.	.	PUNCT
aiua-10754	133	1	classification	classification	NOUN
aiua-10754	133	2	of	of	ADP
aiua-10754	133	3	surgical	surgical	ADJ
aiua-10754	133	4	complications	complication	NOUN
aiua-10754	133	5	.	.	PUNCT
aiua-10754	134	1	a	a	DET
aiua-10754	134	2	new	new	ADJ
aiua-10754	134	3	proposal	proposal	NOUN
aiua-10754	134	4	with	with	ADP
aiua-10754	134	5	evaluation	evaluation	NOUN
aiua-10754	134	6	in	in	ADP
aiua-10754	134	7	a	a	DET
aiua-10754	134	8	cohort	cohort	NOUN
aiua-10754	134	9	of	of	ADP
aiua-10754	134	10	6336	6336	NUM
aiua-10754	134	11	patients	patient	NOUN
aiua-10754	134	12	and	and	CCONJ
aiua-10754	134	13	results	result	NOUN
aiua-10754	134	14	of	of	ADP
aiua-10754	134	15	survey	survey	NOUN
aiua-10754	134	16	.	.	PUNCT
aiua-10754	135	1	ann	ann	PROPN
aiua-10754	135	2	surg	surg	PROPN
aiua-10754	135	3	.	.	PUNCT
aiua-10754	136	1	2004	2004	NUM
aiua-10754	136	2	;	;	PUNCT
aiua-10754	136	3	2:205	2:205	NOUN
aiua-10754	136	4	-	-	SYM
aiua-10754	136	5	213	213	NUM
aiua-10754	136	6	.	.	PUNCT
aiua-10754	137	1	277archivio	277archivio	NUM
aiua-10754	137	2	italiano	italiano	NOUN
aiua-10754	137	3	di	di	X
aiua-10754	137	4	urologia	urologia	PROPN
aiua-10754	137	5	e	e	PROPN
aiua-10754	137	6	andrologia	andrologia	PROPN
aiua-10754	137	7	2022	2022	NUM
aiua-10754	137	8	;	;	PUNCT
aiua-10754	137	9	94	94	NUM
aiua-10754	137	10	,	,	PUNCT
aiua-10754	137	11	3	3	NUM
aiua-10754	137	12	68ga	68ga	ADJ
aiua-10754	137	13	-	-	PUNCT
aiua-10754	137	14	psma	psma	NOUN
aiua-10754	137	15	pet	pet	NOUN
aiua-10754	137	16	/	/	SYM
aiua-10754	137	17	ct	ct	PROPN
aiua-10754	137	18	and	and	CCONJ
aiua-10754	137	19	pca	pca	NOUN
aiua-10754	137	20	diagnosis	diagnosis	NOUN
aiua-10754	137	21	20	20	NUM
aiua-10754	137	22	.	.	PUNCT
aiua-10754	138	1	pepe	pepe	PROPN
aiua-10754	138	2	p	p	NOUN
aiua-10754	138	3	,	,	PUNCT
aiua-10754	138	4	garufi	garufi	NOUN
aiua-10754	138	5	a	a	ADP
aiua-10754	138	6	,	,	PUNCT
aiua-10754	138	7	priolo	priolo	NOUN
aiua-10754	138	8	g	g	NOUN
aiua-10754	138	9	,	,	PUNCT
aiua-10754	138	10	pennisi	pennisi	VERB
aiua-10754	138	11	m.	m.	NOUN
aiua-10754	138	12	can	can	AUX
aiua-10754	138	13	mri	mri	VERB
aiua-10754	138	14	/	/	SYM
aiua-10754	138	15	trus	trus	NOUN
aiua-10754	138	16	fusion	fusion	NOUN
aiua-10754	138	17	targeted	target	VERB
aiua-10754	138	18	biopsy	biopsy	NOUN
aiua-10754	138	19	replace	replace	NOUN
aiua-10754	138	20	saturation	saturation	NOUN
aiua-10754	138	21	prostate	prostate	NOUN
aiua-10754	138	22	biopsy	biopsy	NOUN
aiua-10754	138	23	in	in	ADP
aiua-10754	138	24	the	the	DET
aiua-10754	138	25	re	re	NOUN
aiua-10754	138	26	-	-	NOUN
aiua-10754	138	27	evaluation	evaluation	NOUN
aiua-10754	138	28	of	of	ADP
aiua-10754	138	29	men	man	NOUN
aiua-10754	138	30	in	in	ADP
aiua-10754	138	31	active	active	ADJ
aiua-10754	138	32	surveillance	surveillance	NOUN
aiua-10754	138	33	?	?	PUNCT
aiua-10754	139	1	world	world	PROPN
aiua-10754	139	2	j	j	PROPN
aiua-10754	139	3	urol	urol	PROPN
aiua-10754	139	4	.	.	PROPN
aiua-10754	140	1	2016	2016	NUM
aiua-10754	140	2	;	;	PUNCT
aiua-10754	141	1	34:12491253	34:12491253	NUM
aiua-10754	141	2	.	.	PUNCT
aiua-10754	142	1	21	21	NUM
aiua-10754	142	2	.	.	PUNCT
aiua-10754	143	1	rosenkrantz	rosenkrantz	PROPN
aiua-10754	143	2	ab	ab	PROPN
aiua-10754	143	3	,	,	PUNCT
aiua-10754	143	4	verma	verma	PROPN
aiua-10754	143	5	s	s	PROPN
aiua-10754	143	6	,	,	PUNCT
aiua-10754	143	7	choyke	choyke	VERB
aiua-10754	143	8	p	p	NOUN
aiua-10754	143	9	,	,	PUNCT
aiua-10754	143	10	et	et	PROPN
aiua-10754	143	11	al	al	PROPN
aiua-10754	143	12	.	.	PROPN
aiua-10754	143	13	prostate	prostate	PROPN
aiua-10754	143	14	magnetic	magnetic	ADJ
aiua-10754	143	15	resonance	resonance	NOUN
aiua-10754	143	16	imaging	imaging	NOUN
aiua-10754	143	17	and	and	CCONJ
aiua-10754	143	18	magnetic	magnetic	ADJ
aiua-10754	143	19	resonance	resonance	NOUN
aiua-10754	143	20	imaging	image	VERB
aiua-10754	143	21	targeted	target	VERB
aiua-10754	143	22	biopsy	biopsy	NOUN
aiua-10754	143	23	in	in	ADP
aiua-10754	143	24	patients	patient	NOUN
aiua-10754	143	25	with	with	ADP
aiua-10754	143	26	a	a	DET
aiua-10754	143	27	prior	prior	ADJ
aiua-10754	143	28	negative	negative	ADJ
aiua-10754	143	29	biopsy	biopsy	NOUN
aiua-10754	143	30	:	:	PUNCT
aiua-10754	143	31	a	a	DET
aiua-10754	143	32	consensus	consensus	NOUN
aiua-10754	143	33	statement	statement	NOUN
aiua-10754	143	34	by	by	ADP
aiua-10754	143	35	aua	aua	PROPN
aiua-10754	143	36	and	and	CCONJ
aiua-10754	143	37	sar	sar	PROPN
aiua-10754	143	38	.	.	PROPN
aiua-10754	144	1	j	j	PROPN
aiua-10754	144	2	urol	urol	PROPN
aiua-10754	144	3	.	.	PROPN
aiua-10754	144	4	2016	2016	NUM
aiua-10754	144	5	;	;	PUNCT
aiua-10754	144	6	196:1613	196:1613	NUM
aiua-10754	144	7	-	-	SYM
aiua-10754	144	8	1618	1618	NUM
aiua-10754	144	9	.	.	PUNCT
aiua-10754	145	1	22	22	NUM
aiua-10754	145	2	.	.	PUNCT
aiua-10754	146	1	hofman	hofman	PROPN
aiua-10754	146	2	ms	ms	PROPN
aiua-10754	146	3	,	,	PUNCT
aiua-10754	146	4	lawrentschuk	lawrentschuk	NOUN
aiua-10754	146	5	n	n	CCONJ
aiua-10754	146	6	,	,	PUNCT
aiua-10754	146	7	francis	francis	PROPN
aiua-10754	146	8	rj	rj	PROPN
aiua-10754	146	9	,	,	PUNCT
aiua-10754	146	10	et	et	PROPN
aiua-10754	146	11	al	al	PROPN
aiua-10754	146	12	.	.	PUNCT
aiua-10754	146	13	prostate	prostate	NOUN
aiua-10754	146	14	-	-	PUNCT
aiua-10754	146	15	specific	specific	ADJ
aiua-10754	146	16	membrane	membrane	NOUN
aiua-10754	146	17	antigen	antigen	NOUN
aiua-10754	146	18	pet	pet	NOUN
aiua-10754	146	19	-	-	PUNCT
aiua-10754	146	20	ct	ct	NOUN
aiua-10754	146	21	in	in	ADP
aiua-10754	146	22	patients	patient	NOUN
aiua-10754	146	23	with	with	ADP
aiua-10754	146	24	high	high	ADJ
aiua-10754	146	25	-	-	PUNCT
aiua-10754	146	26	risk	risk	NOUN
aiua-10754	146	27	prostate	prostate	NOUN
aiua-10754	146	28	cancer	cancer	NOUN
aiua-10754	146	29	before	before	ADP
aiua-10754	146	30	curative	curative	ADJ
aiua-10754	146	31	-	-	PUNCT
aiua-10754	146	32	intent	intent	NOUN
aiua-10754	146	33	surgery	surgery	NOUN
aiua-10754	146	34	or	or	CCONJ
aiua-10754	146	35	radiotherapy	radiotherapy	NOUN
aiua-10754	146	36	(	(	PUNCT
aiua-10754	146	37	propsma	propsma	PROPN
aiua-10754	146	38	):	):	PUNCT
aiua-10754	146	39	a	a	DET
aiua-10754	146	40	prospective	prospective	ADJ
aiua-10754	146	41	,	,	PUNCT
aiua-10754	146	42	randomised	randomise	VERB
aiua-10754	146	43	,	,	PUNCT
aiua-10754	146	44	multicentre	multicentre	NOUN
aiua-10754	146	45	study	study	NOUN
aiua-10754	146	46	.	.	PUNCT
aiua-10754	147	1	lancet	lancet	PROPN
aiua-10754	147	2	.	.	PUNCT
aiua-10754	148	1	2020	2020	NUM
aiua-10754	148	2	;	;	PUNCT
aiua-10754	148	3	395:1208	395:1208	NUM
aiua-10754	148	4	-	-	SYM
aiua-10754	148	5	1216	1216	NUM
aiua-10754	148	6	.	.	PUNCT
aiua-10754	149	1	23	23	NUM
aiua-10754	149	2	.	.	PUNCT
aiua-10754	150	1	kwan	kwan	PROPN
aiua-10754	150	2	tn	tn	PROPN
aiua-10754	150	3	,	,	PUNCT
aiua-10754	150	4	spremo	spremo	NOUN
aiua-10754	150	5	s	s	PROPN
aiua-10754	150	6	,	,	PUNCT
aiua-10754	150	7	teh	teh	NOUN
aiua-10754	150	8	aym	aym	PROPN
aiua-10754	150	9	,	,	PUNCT
aiua-10754	150	10	et	et	PROPN
aiua-10754	150	11	al	al	PROPN
aiua-10754	150	12	.	.	PUNCT
aiua-10754	150	13	performance	performance	NOUN
aiua-10754	150	14	of	of	ADP
aiua-10754	150	15	ga-68	ga-68	PUNCT
aiua-10754	150	16	psma	psma	PROPN
aiua-10754	150	17	pet	pet	PROPN
aiua-10754	150	18	/	/	SYM
aiua-10754	150	19	ct	ct	PROPN
aiua-10754	150	20	for	for	ADP
aiua-10754	150	21	diagnosis	diagnosis	NOUN
aiua-10754	150	22	and	and	CCONJ
aiua-10754	150	23	grading	grading	NOUN
aiua-10754	150	24	of	of	ADP
aiua-10754	150	25	local	local	ADJ
aiua-10754	150	26	prostate	prostate	NOUN
aiua-10754	150	27	cancer	cancer	NOUN
aiua-10754	150	28	.	.	PUNCT
aiua-10754	151	1	prostate	prostate	NOUN
aiua-10754	151	2	international	international	PROPN
aiua-10754	151	3	.	.	PUNCT
aiua-10754	152	1	2021	2021	NUM
aiua-10754	152	2	;	;	PUNCT
aiua-10754	153	1	9:107	9:107	X
aiua-10754	153	2	-	-	SYM
aiua-10754	153	3	112	112	NUM
aiua-10754	153	4	.	.	PUNCT
aiua-10754	154	1	24	24	NUM
aiua-10754	154	2	.	.	PUNCT
aiua-10754	155	1	franklin	franklin	PROPN
aiua-10754	155	2	a	a	PROPN
aiua-10754	155	3	,	,	PUNCT
aiua-10754	155	4	yaxley	yaxley	PROPN
aiua-10754	155	5	wj	wj	PROPN
aiua-10754	155	6	,	,	PUNCT
aiua-10754	155	7	raveenthiran	raveenthiran	VERB
aiua-10754	155	8	s	s	PROPN
aiua-10754	155	9	,	,	PUNCT
aiua-10754	155	10	et	et	PROPN
aiua-10754	155	11	al	al	PROPN
aiua-10754	155	12	.	.	PUNCT
aiua-10754	156	1	histological	histological	ADJ
aiua-10754	156	2	comparison	comparison	NOUN
aiua-10754	156	3	between	between	ADP
aiua-10754	156	4	predictive	predictive	ADJ
aiua-10754	156	5	value	value	NOUN
aiua-10754	156	6	of	of	ADP
aiua-10754	156	7	preoperative	preoperative	ADJ
aiua-10754	156	8	3	3	NUM
aiua-10754	156	9	-	-	PUNCT
aiua-10754	156	10	t	t	NOUN
aiua-10754	156	11	multiparametric	multiparametric	ADJ
aiua-10754	156	12	mri	mri	NOUN
aiua-10754	156	13	and	and	CCONJ
aiua-10754	156	14	68ga	68ga	ADJ
aiua-10754	156	15	-	-	PUNCT
aiua-10754	156	16	psma	psma	NOUN
aiua-10754	156	17	pet	pet	NOUN
aiua-10754	156	18	/	/	SYM
aiua-10754	156	19	ct	ct	PROPN
aiua-10754	156	20	scan	scan	NOUN
aiua-10754	156	21	for	for	ADP
aiua-10754	156	22	pathological	pathological	ADJ
aiua-10754	156	23	outcomes	outcome	NOUN
aiua-10754	156	24	at	at	ADP
aiua-10754	156	25	radical	radical	ADJ
aiua-10754	156	26	prostatectomy	prostatectomy	NOUN
aiua-10754	156	27	and	and	CCONJ
aiua-10754	156	28	pelvic	pelvic	ADJ
aiua-10754	156	29	lymph	lymph	NOUN
aiua-10754	156	30	node	node	NOUN
aiua-10754	156	31	dissection	dissection	NOUN
aiua-10754	156	32	for	for	ADP
aiua-10754	156	33	prostate	prostate	NOUN
aiua-10754	156	34	cancer	cancer	NOUN
aiua-10754	156	35	.	.	PUNCT
aiua-10754	157	1	bju	bju	NOUN
aiua-10754	157	2	int	int	PROPN
aiua-10754	157	3	.	.	PUNCT
aiua-10754	158	1	2021	2021	NUM
aiua-10754	158	2	;	;	PUNCT
aiua-10754	159	1	127:71	127:71	PROPN
aiua-10754	159	2	-	-	SYM
aiua-10754	159	3	79	79	NUM
aiua-10754	159	4	.	.	PUNCT
aiua-10754	159	5	25	25	NUM
aiua-10754	159	6	.	.	PUNCT
aiua-10754	159	7	ma	ma	PROPN
aiua-10754	159	8	l	l	PROPN
aiua-10754	159	9	,	,	PUNCT
aiua-10754	159	10	wan	wan	PROPN
aiua-10754	159	11	-	-	PUNCT
aiua-10754	159	12	chun	chun	PROPN
aiua-10754	159	13	zhang	zhang	PROPN
aiua-10754	159	14	wc	wc	PROPN
aiua-10754	159	15	,	,	PUNCT
aiua-10754	159	16	ya	ya	PROPN
aiua-10754	159	17	-	-	PUNCT
aiua-10754	159	18	xin	xin	PROPN
aiua-10754	159	19	hao	hao	PROPN
aiua-10754	159	20	yx	yx	PROPN
aiua-10754	159	21	.	.	PUNCT
aiua-10754	159	22	current	current	ADJ
aiua-10754	159	23	state	state	NOUN
aiua-10754	159	24	of	of	ADP
aiua-10754	159	25	prostate	prostate	NOUN
aiua-10754	159	26	-	-	PUNCT
aiua-10754	159	27	specific	specific	ADJ
aiua-10754	159	28	membrane	membrane	NOUN
aiua-10754	159	29	antigen	antigen	NOUN
aiua-10754	159	30	pet	pet	NOUN
aiua-10754	159	31	/	/	SYM
aiua-10754	159	32	ct	ct	PROPN
aiua-10754	159	33	imaging	imaging	NOUN
aiua-10754	159	34	-	-	PUNCT
aiua-10754	159	35	targeted	target	VERB
aiua-10754	159	36	biopsy	biopsy	NOUN
aiua-10754	159	37	techniques	technique	NOUN
aiua-10754	159	38	for	for	ADP
aiua-10754	159	39	detection	detection	NOUN
aiua-10754	159	40	of	of	ADP
aiua-10754	159	41	clinically	clinically	ADV
aiua-10754	159	42	significant	significant	ADJ
aiua-10754	159	43	prostate	prostate	NOUN
aiua-10754	159	44	cancer	cancer	NOUN
aiua-10754	159	45	j	j	PROPN
aiua-10754	159	46	med	med	PROPN
aiua-10754	159	47	imaging	imaging	PROPN
aiua-10754	159	48	radiat	radiat	PROPN
aiua-10754	159	49	oncol	oncol	ADJ
aiua-10754	159	50	.	.	PUNCT
aiua-10754	159	51	2022	2022	NUM
aiua-10754	159	52	;	;	PUNCT
aiua-10754	159	53	66:776	66:776	NUM
aiua-10754	159	54	-	-	SYM
aiua-10754	159	55	780	780	NUM
aiua-10754	159	56	.	.	PUNCT
aiua-10754	159	57	26	26	NUM
aiua-10754	159	58	.	.	PUNCT
aiua-10754	160	1	demirci	demirci	PROPN
aiua-10754	160	2	e	e	PROPN
aiua-10754	160	3	,	,	PUNCT
aiua-10754	160	4	kabasakal	kabasakal	PROPN
aiua-10754	160	5	l	l	PROPN
aiua-10754	160	6	,	,	PUNCT
aiua-10754	160	7	sahin	sahin	PROPN
aiua-10754	160	8	oe	oe	PROPN
aiua-10754	160	9	,	,	PUNCT
aiua-10754	160	10	et	et	PROPN
aiua-10754	160	11	al	al	PROPN
aiua-10754	160	12	.	.	PUNCT
aiua-10754	161	1	can	can	AUX
aiua-10754	161	2	suvmax	suvmax	VERB
aiua-10754	161	3	values	value	NOUN
aiua-10754	161	4	of	of	ADP
aiua-10754	161	5	ga-68	ga-68	NOUN
aiua-10754	161	6	-	-	PUNCT
aiua-10754	161	7	psma	psma	NOUN
aiua-10754	161	8	pet	pet	NOUN
aiua-10754	161	9	/	/	SYM
aiua-10754	161	10	ct	ct	PROPN
aiua-10754	161	11	scan	scan	AUX
aiua-10754	161	12	predict	predict	VERB
aiua-10754	161	13	the	the	DET
aiua-10754	161	14	clinically	clinically	ADV
aiua-10754	161	15	significant	significant	ADJ
aiua-10754	161	16	prostate	prostate	NOUN
aiua-10754	161	17	cancer	cancer	NOUN
aiua-10754	161	18	?	?	PUNCT
aiua-10754	162	1	nucl	nucl	PROPN
aiua-10754	162	2	med	med	PROPN
aiua-10754	162	3	commun	commun	PROPN
aiua-10754	162	4	.	.	PUNCT
aiua-10754	163	1	2019	2019	NUM
aiua-10754	163	2	;	;	PUNCT
aiua-10754	163	3	40:86	40:86	NUM
aiua-10754	163	4	-	-	SYM
aiua-10754	163	5	91	91	NUM
aiua-10754	163	6	.	.	PUNCT
aiua-10754	164	1	27	27	NUM
aiua-10754	164	2	.	.	PUNCT
aiua-10754	165	1	rüschoff	rüschoff	PROPN
aiua-10754	165	2	jh	jh	PROPN
aiua-10754	165	3	,	,	PUNCT
aiua-10754	165	4	ferraro	ferraro	PROPN
aiua-10754	165	5	da	da	PROPN
aiua-10754	165	6	,	,	PUNCT
aiua-10754	165	7	muehlematter	muehlematter	PROPN
aiua-10754	165	8	uj	uj	PROPN
aiua-10754	165	9	,	,	PUNCT
aiua-10754	165	10	et	et	PROPN
aiua-10754	165	11	al	al	PROPN
aiua-10754	165	12	.	.	PUNCT
aiua-10754	166	1	what	what	PRON
aiua-10754	166	2	's	be	AUX
aiua-10754	166	3	behind	behind	ADP
aiua-10754	166	4	68ga	68ga	ADJ
aiua-10754	166	5	-	-	PUNCT
aiua-10754	166	6	psma-11	psma-11	NOUN
aiua-10754	166	7	uptake	uptake	ADJ
aiua-10754	166	8	in	in	ADP
aiua-10754	166	9	primary	primary	ADJ
aiua-10754	166	10	prostate	prostate	NOUN
aiua-10754	166	11	cancer	cancer	NOUN
aiua-10754	166	12	pet	pet	NOUN
aiua-10754	166	13	?	?	PUNCT
aiua-10754	167	1	investigation	investigation	NOUN
aiua-10754	167	2	of	of	ADP
aiua-10754	167	3	histopathological	histopathological	ADJ
aiua-10754	167	4	parameters	parameter	NOUN
aiua-10754	167	5	and	and	CCONJ
aiua-10754	167	6	immunohistochemical	immunohistochemical	ADJ
aiua-10754	167	7	psma	psma	NOUN
aiua-10754	167	8	expression	expression	NOUN
aiua-10754	167	9	patterns	pattern	NOUN
aiua-10754	167	10	.	.	PUNCT
aiua-10754	168	1	eur	eur	PROPN
aiua-10754	168	2	j	j	PROPN
aiua-10754	168	3	nucl	nucl	PROPN
aiua-10754	168	4	med	me	VERB
aiua-10754	168	5	mol	mol	ADP
aiua-10754	168	6	imaging	imaging	PROPN
aiua-10754	168	7	.	.	PUNCT
aiua-10754	169	1	2021	2021	NUM
aiua-10754	169	2	;	;	PUNCT
aiua-10754	169	3	48:4042	48:4042	NUM
aiua-10754	169	4	-	-	SYM
aiua-10754	169	5	53	53	NUM
aiua-10754	169	6	.	.	PUNCT
aiua-10754	170	1	28	28	NUM
aiua-10754	170	2	.	.	PUNCT
aiua-10754	171	1	zhang	zhang	PROPN
aiua-10754	171	2	ll	ll	PROPN
aiua-10754	171	3	,	,	PUNCT
aiua-10754	171	4	li	li	PROPN
aiua-10754	171	5	wc	wc	PROPN
aiua-10754	171	6	,	,	PUNCT
aiua-10754	171	7	xu	xu	PROPN
aiua-10754	172	1	z	z	PROPN
aiua-10754	172	2	,	,	PUNCT
aiua-10754	172	3	et	et	PROPN
aiua-10754	172	4	al	al	PROPN
aiua-10754	172	5	.	.	PUNCT
aiua-10754	173	1	68ga	68ga	ADJ
aiua-10754	173	2	-	-	PUNCT
aiua-10754	173	3	psma	psma	NOUN
aiua-10754	173	4	pet	pet	NOUN
aiua-10754	173	5	/	/	SYM
aiua-10754	173	6	ct	ct	NUM
aiua-10754	173	7	targeted	target	VERB
aiua-10754	173	8	biopsy	biopsy	NOUN
aiua-10754	173	9	for	for	ADP
aiua-10754	173	10	the	the	DET
aiua-10754	173	11	diagnosis	diagnosis	NOUN
aiua-10754	173	12	of	of	ADP
aiua-10754	173	13	clinically	clinically	ADV
aiua-10754	173	14	significant	significant	ADJ
aiua-10754	173	15	prostate	prostate	NOUN
aiua-10754	173	16	cancer	cancer	NOUN
aiua-10754	173	17	compared	compare	VERB
aiua-10754	173	18	with	with	ADP
aiua-10754	173	19	transrectal	transrectal	ADJ
aiua-10754	173	20	ultrasound	ultrasound	NOUN
aiua-10754	173	21	guided	guide	VERB
aiua-10754	173	22	biopsy	biopsy	NOUN
aiua-10754	173	23	:	:	PUNCT
aiua-10754	173	24	a	a	DET
aiua-10754	173	25	prospective	prospective	ADJ
aiua-10754	173	26	randomized	randomized	ADJ
aiua-10754	173	27	single	single	ADJ
aiua-10754	173	28	-	-	PUNCT
aiua-10754	173	29	centre	centre	NOUN
aiua-10754	173	30	study	study	NOUN
aiua-10754	173	31	.	.	PUNCT
aiua-10754	174	1	eur	eur	PROPN
aiua-10754	174	2	j	j	PROPN
aiua-10754	174	3	nucl	nucl	PROPN
aiua-10754	174	4	med	me	VERB
aiua-10754	174	5	mol	mol	ADP
aiua-10754	174	6	imaging	imaging	PROPN
aiua-10754	174	7	.	.	PUNCT
aiua-10754	175	1	2021	2021	NUM
aiua-10754	175	2	;	;	PUNCT
aiua-10754	175	3	48:483	48:483	NUM
aiua-10754	175	4	-	-	SYM
aiua-10754	175	5	492	492	NUM
aiua-10754	175	6	.	.	PUNCT
aiua-10754	176	1	29	29	NUM
aiua-10754	176	2	.	.	PUNCT
aiua-10754	177	1	liu	liu	PROPN
aiua-10754	177	2	y	y	PROPN
aiua-10754	177	3	,	,	PUNCT
aiua-10754	177	4	yu	yu	PROPN
aiua-10754	177	5	h	h	PROPN
aiua-10754	177	6	,	,	PUNCT
aiua-10754	177	7	liu	liu	PROPN
aiua-10754	177	8	j	j	PROPN
aiua-10754	177	9	,	,	PUNCT
aiua-10754	177	10	et	et	PROPN
aiua-10754	177	11	al	al	PROPN
aiua-10754	177	12	.	.	PUNCT
aiua-10754	178	1	a	a	DET
aiua-10754	178	2	pilot	pilot	NOUN
aiua-10754	178	3	study	study	NOUN
aiua-10754	178	4	of	of	ADP
aiua-10754	178	5	18	18	NUM
aiua-10754	178	6	f	f	X
aiua-10754	178	7	-	-	PUNCT
aiua-10754	178	8	dcfpyl	dcfpyl	VERB
aiua-10754	178	9	pet	pet	NOUN
aiua-10754	178	10	/	/	SYM
aiua-10754	178	11	ct	ct	PROPN
aiua-10754	178	12	or	or	CCONJ
aiua-10754	178	13	pet	pet	ADJ
aiua-10754	178	14	/	/	SYM
aiua-10754	178	15	mri	mri	NOUN
aiua-10754	178	16	and	and	CCONJ
aiua-10754	178	17	ultrasound	ultrasound	NOUN
aiua-10754	178	18	fusion	fusion	NOUN
aiua-10754	178	19	targeted	target	VERB
aiua-10754	178	20	prostate	prostate	NOUN
aiua-10754	178	21	biopsy	biopsy	NOUN
aiua-10754	178	22	for	for	ADP
aiua-10754	178	23	intraprostatic	intraprostatic	ADJ
aiua-10754	178	24	pet	pet	ADJ
aiua-10754	178	25	-	-	PUNCT
aiua-10754	178	26	positive	positive	ADJ
aiua-10754	178	27	lesions	lesion	NOUN
aiua-10754	178	28	.	.	PUNCT
aiua-10754	179	1	front	front	ADJ
aiua-10754	179	2	oncol	oncol	ADJ
aiua-10754	179	3	.	.	PUNCT
aiua-10754	180	1	2021	2021	NUM
aiua-10754	180	2	;	;	PUNCT
aiua-10754	180	3	11:612157	11:612157	NUM
aiua-10754	180	4	.	.	PROPN
aiua-10754	180	5	30	30	NUM
aiua-10754	180	6	.	.	PUNCT
aiua-10754	181	1	kalapara	kalapara	PROPN
aiua-10754	181	2	aa	aa	PROPN
aiua-10754	181	3	,	,	PUNCT
aiua-10754	181	4	nzenza	nzenza	PROPN
aiua-10754	181	5	t	t	PROPN
aiua-10754	181	6	,	,	PUNCT
aiua-10754	181	7	pan	pan	NOUN
aiua-10754	181	8	hyc	hyc	PROPN
aiua-10754	181	9	,	,	PUNCT
aiua-10754	181	10	et	et	PROPN
aiua-10754	181	11	al	al	PROPN
aiua-10754	181	12	.	.	PUNCT
aiua-10754	181	13	detection	detection	NOUN
aiua-10754	181	14	and	and	CCONJ
aiua-10754	181	15	localisation	localisation	NOUN
aiua-10754	181	16	of	of	ADP
aiua-10754	181	17	primary	primary	ADJ
aiua-10754	181	18	prostate	prostate	NOUN
aiua-10754	181	19	cancer	cancer	NOUN
aiua-10754	181	20	using	use	VERB
aiua-10754	181	21	68gallium	68gallium	NUM
aiua-10754	181	22	prostate	prostate	NOUN
aiua-10754	181	23	-	-	PUNCT
aiua-10754	181	24	specific	specific	ADJ
aiua-10754	181	25	membrane	membrane	NOUN
aiua-10754	181	26	antigen	antigen	NOUN
aiua-10754	181	27	positron	positron	NOUN
aiua-10754	181	28	emission	emission	NOUN
aiua-10754	181	29	tomography	tomography	NOUN
aiua-10754	181	30	/	/	SYM
aiua-10754	181	31	computed	compute	VERB
aiua-10754	181	32	tomography	tomography	NOUN
aiua-10754	181	33	compared	compare	VERB
aiua-10754	181	34	with	with	ADP
aiua-10754	181	35	multiparametric	multiparametric	ADJ
aiua-10754	181	36	magnetic	magnetic	ADJ
aiua-10754	181	37	resonance	resonance	NOUN
aiua-10754	181	38	imaging	imaging	NOUN
aiua-10754	181	39	and	and	CCONJ
aiua-10754	181	40	radical	radical	ADJ
aiua-10754	181	41	prostatectomy	prostatectomy	ADP
aiua-10754	181	42	specimen	speciman	NOUN
aiua-10754	181	43	pathology	pathology	PROPN
aiua-10754	181	44	.	.	PUNCT
aiua-10754	182	1	bju	bju	PROPN
aiua-10754	182	2	int	int	PROPN
aiua-10754	182	3	.	.	PUNCT
aiua-10754	183	1	2020	2020	NUM
aiua-10754	183	2	;	;	PUNCT
aiua-10754	183	3	126:83	126:83	NUM
aiua-10754	183	4	-	-	SYM
aiua-10754	183	5	90	90	NUM
aiua-10754	183	6	.	.	PUNCT
aiua-10754	184	1	31	31	NUM
aiua-10754	184	2	.	.	PUNCT
aiua-10754	185	1	xue	xue	PROPN
aiua-10754	185	2	al	al	PROPN
aiua-10754	185	3	,	,	PUNCT
aiua-10754	185	4	kalapara	kalapara	PROPN
aiua-10754	185	5	aa	aa	PROPN
aiua-10754	185	6	,	,	PUNCT
aiua-10754	185	7	ballok	ballok	PROPN
aiua-10754	185	8	ze	ze	PROPN
aiua-10754	185	9	,	,	PUNCT
aiua-10754	185	10	et	et	PROPN
aiua-10754	185	11	al	al	PROPN
aiua-10754	185	12	.	.	PUNCT
aiua-10754	186	1	68ga	68ga	ADJ
aiua-10754	186	2	-	-	PUNCT
aiua-10754	186	3	prostate	prostate	NOUN
aiua-10754	186	4	-	-	PUNCT
aiua-10754	186	5	specific	specific	ADJ
aiua-10754	186	6	membrane	membrane	NOUN
aiua-10754	186	7	antigen	antigen	NOUN
aiua-10754	186	8	positron	positron	NOUN
aiua-10754	186	9	emission	emission	NOUN
aiua-10754	186	10	tomography	tomography	NOUN
aiua-10754	186	11	maximum	maximum	ADV
aiua-10754	186	12	standardized	standardize	VERB
aiua-10754	186	13	uptake	uptake	ADJ
aiua-10754	186	14	value	value	NOUN
aiua-10754	186	15	as	as	ADP
aiua-10754	186	16	a	a	DET
aiua-10754	186	17	predictor	predictor	NOUN
aiua-10754	186	18	of	of	ADP
aiua-10754	186	19	gleason	gleason	PROPN
aiua-10754	186	20	pattern	pattern	NOUN
aiua-10754	186	21	4	4	NUM
aiua-10754	186	22	and	and	CCONJ
aiua-10754	186	23	pathological	pathological	ADJ
aiua-10754	186	24	upgrading	upgrading	NOUN
aiua-10754	186	25	in	in	ADP
aiua-10754	186	26	intermediate	intermediate	ADJ
aiua-10754	186	27	-	-	PUNCT
aiua-10754	186	28	risk	risk	NOUN
aiua-10754	186	29	prostate	prostate	NOUN
aiua-10754	186	30	cancer	cancer	NOUN
aiua-10754	186	31	.	.	PUNCT
aiua-10754	187	1	2022	2022	NUM
aiua-10754	187	2	;	;	PUNCT
aiua-10754	187	3	207:341	207:341	NOUN
aiua-10754	187	4	-	-	SYM
aiua-10754	187	5	349	349	NUM
aiua-10754	187	6	.	.	PUNCT
aiua-10754	188	1	32	32	NUM
aiua-10754	188	2	.	.	PUNCT
aiua-10754	189	1	ferraro	ferraro	PROPN
aiua-10754	189	2	da	da	PROPN
aiua-10754	189	3	,	,	PUNCT
aiua-10754	189	4	becker	becker	PROPN
aiua-10754	189	5	as	as	ADP
aiua-10754	189	6	,	,	PUNCT
aiua-10754	189	7	kranzbühler	kranzbühler	PROPN
aiua-10754	189	8	b	b	PROPN
aiua-10754	189	9	,	,	PUNCT
aiua-10754	189	10	et	et	PROPN
aiua-10754	189	11	al	al	PROPN
aiua-10754	189	12	.	.	PUNCT
aiua-10754	190	1	diagnostic	diagnostic	ADJ
aiua-10754	190	2	performance	performance	NOUN
aiua-10754	190	3	of	of	ADP
aiua-10754	190	4	68ga	68ga	ADJ
aiua-10754	190	5	-	-	PUNCT
aiua-10754	190	6	psma-11	psma-11	VERB
aiua-10754	190	7	pet	pet	NOUN
aiua-10754	190	8	/	/	SYM
aiua-10754	190	9	mri	mri	NOUN
aiua-10754	190	10	-	-	PUNCT
aiua-10754	190	11	guided	guide	VERB
aiua-10754	190	12	biopsy	biopsy	NOUN
aiua-10754	190	13	in	in	ADP
aiua-10754	190	14	patients	patient	NOUN
aiua-10754	190	15	with	with	ADP
aiua-10754	190	16	suspected	suspect	VERB
aiua-10754	190	17	prostate	prostate	NOUN
aiua-10754	190	18	cancer	cancer	NOUN
aiua-10754	190	19	:	:	PUNCT
aiua-10754	190	20	a	a	DET
aiua-10754	190	21	prospective	prospective	ADJ
aiua-10754	190	22	single	single	ADJ
aiua-10754	190	23	-	-	PUNCT
aiua-10754	190	24	center	center	NOUN
aiua-10754	190	25	study	study	NOUN
aiua-10754	190	26	.	.	PUNCT
aiua-10754	191	1	eur	eur	PROPN
aiua-10754	191	2	j	j	PROPN
aiua-10754	191	3	nucl	nucl	PROPN
aiua-10754	191	4	med	me	VERB
aiua-10754	191	5	mol	mol	ADP
aiua-10754	191	6	imaging	imaging	PROPN
aiua-10754	191	7	.	.	PUNCT
aiua-10754	192	1	2021	2021	NUM
aiua-10754	192	2	;	;	PUNCT
aiua-10754	192	3	48:3315	48:3315	X
aiua-10754	192	4	-	-	NOUN
aiua-10754	192	5	3324	3324	NUM
aiua-10754	192	6	.	.	PUNCT
aiua-10754	193	1	33	33	NUM
aiua-10754	193	2	.	.	PUNCT
aiua-10754	194	1	pepe	pepe	PROPN
aiua-10754	194	2	p	p	PROPN
aiua-10754	194	3	,	,	PUNCT
aiua-10754	194	4	dibenedetto	dibenedetto	PROPN
aiua-10754	194	5	g	g	PROPN
aiua-10754	194	6	,	,	PUNCT
aiua-10754	194	7	pepe	pepe	PROPN
aiua-10754	194	8	l	l	PROPN
aiua-10754	194	9	,	,	PUNCT
aiua-10754	194	10	pennisi	pennisi	VERB
aiua-10754	194	11	m.	m.	NOUN
aiua-10754	194	12	multiparametric	multiparametric	PROPN
aiua-10754	194	13	mri	mri	NOUN
aiua-10754	194	14	vs	vs	ADP
aiua-10754	194	15	select	select	ADJ
aiua-10754	194	16	mdx	mdx	NOUN
aiua-10754	194	17	accuracy	accuracy	NOUN
aiua-10754	194	18	in	in	ADP
aiua-10754	194	19	the	the	DET
aiua-10754	194	20	diagnosis	diagnosis	NOUN
aiua-10754	194	21	of	of	ADP
aiua-10754	194	22	clinically	clinically	ADV
aiua-10754	194	23	significant	significant	ADJ
aiua-10754	194	24	pca	pca	NOUN
aiua-10754	194	25	in	in	ADP
aiua-10754	194	26	men	man	NOUN
aiua-10754	194	27	enrolled	enrol	VERB
aiua-10754	194	28	in	in	ADP
aiua-10754	194	29	active	active	ADJ
aiua-10754	194	30	surveillance	surveillance	NOUN
aiua-10754	194	31	.	.	PUNCT
aiua-10754	195	1	in	in	ADP
aiua-10754	195	2	vivo	vivo	NOUN
aiua-10754	195	3	.	.	PUNCT
aiua-10754	196	1	2020	2020	NUM
aiua-10754	196	2	;	;	PUNCT
aiua-10754	196	3	34:393	34:393	NUM
aiua-10754	196	4	-	-	SYM
aiua-10754	196	5	396	396	NUM
aiua-10754	196	6	.	.	PUNCT
aiua-10754	197	1	34	34	NUM
aiua-10754	197	2	.	.	PUNCT
aiua-10754	198	1	roscigno	roscigno	PROPN
aiua-10754	198	2	m	m	PROPN
aiua-10754	198	3	,	,	PUNCT
aiua-10754	198	4	stabile	stabile	VERB
aiua-10754	198	5	a	a	PRON
aiua-10754	198	6	,	,	PUNCT
aiua-10754	198	7	lughezzani	lughezzani	ADJ
aiua-10754	198	8	g	g	PROPN
aiua-10754	198	9	,	,	PUNCT
aiua-10754	198	10	et	et	PROPN
aiua-10754	198	11	al	al	PROPN
aiua-10754	198	12	.	.	PUNCT
aiua-10754	199	1	the	the	DET
aiua-10754	199	2	use	use	NOUN
aiua-10754	199	3	of	of	ADP
aiua-10754	199	4	multiparametric	multiparametric	ADJ
aiua-10754	199	5	resonance	resonance	NOUN
aiua-10754	199	6	imaging	imaging	NOUN
aiua-10754	199	7	for	for	ADP
aiua-10754	199	8	follow	follow	NOUN
aiua-10754	199	9	-	-	PUNCT
aiua-10754	199	10	up	up	NOUN
aiua-10754	199	11	of	of	ADP
aiua-10754	199	12	patients	patient	NOUN
aiua-10754	199	13	included	include	VERB
aiua-10754	199	14	in	in	ADP
aiua-10754	199	15	active	active	ADJ
aiua-10754	199	16	surveillance	surveillance	NOUN
aiua-10754	199	17	protocol	protocol	NOUN
aiua-10754	199	18	,	,	PUNCT
aiua-10754	199	19	can	can	AUX
aiua-10754	199	20	psa	psa	VERB
aiua-10754	199	21	density	density	NOUN
aiua-10754	199	22	discriminate	discriminate	VERB
aiua-10754	199	23	patients	patient	NOUN
aiua-10754	199	24	at	at	ADP
aiua-10754	199	25	different	different	ADJ
aiua-10754	199	26	risk	risk	NOUN
aiua-10754	199	27	of	of	ADP
aiua-10754	199	28	reclassification	reclassification	NOUN
aiua-10754	199	29	?	?	PUNCT
aiua-10754	200	1	clin	clin	PROPN
aiua-10754	200	2	genitourin	genitourin	NOUN
aiua-10754	200	3	cancer	cancer	NOUN
aiua-10754	200	4	.	.	PUNCT
aiua-10754	201	1	2020	2020	NUM
aiua-10754	201	2	;	;	PUNCT
aiua-10754	201	3	18	18	NUM
aiua-10754	201	4	:	:	PUNCT
aiua-10754	201	5	e698	e698	PROPN
aiua-10754	201	6	-	-	PUNCT
aiua-10754	201	7	e704	e704	PROPN
aiua-10754	201	8	.	.	PROPN
aiua-10754	201	9	35	35	NUM
aiua-10754	201	10	.	.	PUNCT
aiua-10754	202	1	pepe	pepe	PROPN
aiua-10754	202	2	p	p	PROPN
aiua-10754	202	3	,	,	PUNCT
aiua-10754	202	4	pennisi	pennisi	VERB
aiua-10754	202	5	m.	m.	NOUN
aiua-10754	202	6	morbidity	morbidity	NOUN
aiua-10754	202	7	following	follow	VERB
aiua-10754	202	8	transperineal	transperineal	NOUN
aiua-10754	202	9	prostate	prostate	NOUN
aiua-10754	202	10	biopsy	biopsy	NOUN
aiua-10754	202	11	:	:	PUNCT
aiua-10754	202	12	our	our	PRON
aiua-10754	202	13	experience	experience	NOUN
aiua-10754	202	14	in	in	ADP
aiua-10754	202	15	8,500	8,500	NUM
aiua-10754	202	16	men	man	NOUN
aiua-10754	202	17	.	.	PUNCT
aiua-10754	203	1	arch	arch	ADJ
aiua-10754	203	2	ital	ital	PROPN
aiua-10754	203	3	urol	urol	PROPN
aiua-10754	203	4	androl	androl	PROPN
aiua-10754	203	5	.	.	PROPN
aiua-10754	203	6	2022	2022	NUM
aiua-10754	203	7	;	;	PUNCT
aiua-10754	203	8	94:155	94:155	NUM
aiua-10754	203	9	-	-	SYM
aiua-10754	203	10	159	159	NUM
aiua-10754	203	11	.	.	PUNCT
aiua-10754	204	1	correspondence	correspondence	NOUN
aiua-10754	204	2	pietro	pietro	PROPN
aiua-10754	204	3	pepe	pepe	PROPN
aiua-10754	204	4	,	,	PUNCT
aiua-10754	204	5	md	md	PROPN
aiua-10754	204	6	piepepe@hotmail.com	piepepe@hotmail.com	PROPN
aiua-10754	205	1	michele	michele	PROPN
aiua-10754	205	2	pennisi	pennisi	VERB
aiua-10754	205	3	,	,	PUNCT
aiua-10754	205	4	md	md	PROPN
aiua-10754	205	5	michepennisi2@virgilio.it	michepennisi2@virgilio.it	PROPN
aiua-10754	205	6	ludovica	ludovica	PROPN
aiua-10754	205	7	pepe	pepe	PROPN
aiua-10754	205	8	,	,	PUNCT
aiua-10754	205	9	md	md	PROPN
aiua-10754	205	10	ludopepe97@gmail.com	ludopepe97@gmail.com	X
aiua-10754	205	11	urology	urology	NOUN
aiua-10754	205	12	unit	unit	NOUN
aiua-10754	205	13	,	,	PUNCT
aiua-10754	205	14	cannizzaro	cannizzaro	VERB
aiua-10754	205	15	hospital	hospital	NOUN
aiua-10754	205	16	via	via	ADP
aiua-10754	205	17	messina	messina	PROPN
aiua-10754	205	18	829	829	NUM
aiua-10754	205	19	,	,	PUNCT
aiua-10754	205	20	catania	catania	PROPN
aiua-10754	205	21	(	(	PUNCT
aiua-10754	205	22	italy	italy	PROPN
aiua-10754	205	23	)	)	PUNCT
aiua-10754	205	24	maria	maria	PROPN
aiua-10754	205	25	tamburo	tamburo	PROPN
aiua-10754	205	26	,	,	PUNCT
aiua-10754	205	27	md	md	PROPN
aiua-10754	205	28	marinellatamburo@virgilio.it	marinellatamburo@virgilio.it	PROPN
aiua-10754	205	29	giulia	giulia	PROPN
aiua-10754	205	30	marletta	marletta	NOUN
aiua-10754	205	31	,	,	PUNCT
aiua-10754	205	32	md	md	PROPN
aiua-10754	205	33	marlettagiulia1@gmail.com	marlettagiulia1@gmail.com	PROPN
aiua-10754	205	34	radiotherapy	radiotherapy	NOUN
aiua-10754	205	35	unit	unit	NOUN
aiua-10754	205	36	,	,	PUNCT
aiua-10754	205	37	cannizzaro	cannizzaro	NOUN
aiua-10754	205	38	hospital	hospital	NOUN
aiua-10754	205	39	,	,	PUNCT
aiua-10754	205	40	catania	catania	PROPN
aiua-10754	205	41	(	(	PUNCT
aiua-10754	205	42	italy	italy	PROPN
aiua-10754	205	43	)	)	PUNCT
aiua-10754	206	1	filippo	filippo	PROPN
aiua-10754	206	2	fraggetta	fraggetta	PROPN
aiua-10754	206	3	,	,	PUNCT
aiua-10754	206	4	md	md	PROPN
aiua-10754	206	5	filippofra@hotmail.com	filippofra@hotmail.com	X
aiua-10754	206	6	pathology	pathology	PROPN
aiua-10754	206	7	unit	unit	NOUN
aiua-10754	206	8	,	,	PUNCT
aiua-10754	206	9	cannizzaro	cannizzaro	NOUN
aiua-10754	206	10	hospital	hospital	NOUN
aiua-10754	206	11	,	,	PUNCT
aiua-10754	206	12	catania	catania	PROPN
aiua-10754	206	13	(	(	PUNCT
aiua-10754	206	14	italy	italy	PROPN
aiua-10754	206	15	)	)	PUNCT